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Abstract 
Abstract 
This thesis presents a new approach for the biotransformation of hydrophobic molecules 
using a membrane bioreactor for biotransformations (MSB) and polyimide organic solvent 
nanofiltration (OSN) membranes. The reaction occurs in the aqueous phase from which the 
product is in-situ extracted to the organic phase by diffusion through the membrane. Two 
model biotransformations were used to asymmetrically synthesise: i?-citronellol by 
Saccharomices cerevisiae (Bio-T); .S-phenylethanol by Rhodotorula glutinis (Bio-Il). 
The proposed reactor avoids the formation of emulsions and mitigates the solvent toxicity 
observed in direct contact biphasic (DCB) reactors, thus expanding the range of solvents 
that can be used in biotransformations. Additionally, the use of OSN membranes 
overcomes the problems of phase breakthrough and poor membrane organic solvent 
resistance, previously observed in microporous and non-porous MBBs, respectively. 
Although with lower titer, OSN-MBB reactors provided an acceptable productivity for Bio-
J with a much cleaner product compared to DCB systems. Furthermore, for the synthesis of 
the slightly polar •S'-phenylethanol, OSN-MBB was the only viable alternative, as no DCB 
systems were suitable. Using a study of the kinetics of Bio-II product formation, the direct 
addition of substrate to the bioreactor was determined to be the best feeding strategy. This 
allowed OSN-MBBs with the best overall performance compared to both aqueous and 
DCB bioreactors. 
The main limitation of the OSN-MBBs is the moderate-to-low mass transfer rates obtained 
with OSN membranes. To tackle this challenge, fundamental work was conducted to 
understand the membrane mass transfer mechanisms as a function of the membrane 
formation parameters, evaporation time and casting thickness. Surprisingly, casting 
thickness has the greatest effect on the membrane mass transport rates. An original mass 
transport mechanism was suggested considering the porous asymmetry of the membrane. 
This model illustrated for the first time the importance of the microporous layer on 
membrane mass transport. 
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X cross-section membrane depth from the top of the membrane (m) 
Xn n-factor dependent variable in regression model 
Y independent variable in regression model 
Y' transformed independent variable in regression model 
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Nomenclature 
Greek symbols 
Yw/n surface tension between the wetting (w) and non-wetting phases (n) (Nm"^) 
8 membrane thickness 
Gn membrane porosity in the n membrane layer 
r\ kinematic viscosity (Pa s) 
0r contact angle 
Ks solvent solubility coefficient in membrane material 
H growth rate (h'^) 
Umax Monod maximum growth rate (h" )^ 
V linear liquid velocity (m s"') 
p liquid density (kg.m"^) 
X membrane torotuosity 
(j)B association factor of liquid B 
Subscripts or superscripts 
0 initial condition 
A diffusing solute 
aq aqueous phase 
B diffusing solvent 
est estimated value 
feed dialysis or nanofiltration feed 
inhib inhibitory production period 
m membrane 
max maximum 
mem polymeric membrane material 
pore embedded organic solvent in pores 
pred predicted value 
org organic phase 
rec dialysis receiver 
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Nomenclature 
sub sub-inhibitory production period 
support microporous layer 
top top layer 
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Chapter 1 
Introduction 
Outline 
1.1. Overview 
1.2. Aims of this thesis 
1.3. Thesis structure 
1.1. Overview 
Biotransformations refer to single reactions performed by an enzymatic catalyst 
(biocatalyst). Based on the form in which enzymes are used, biocatalysts can be divided 
into two categories: whole cells (including microorganisms, fungi, plants or animals), or 
their isolated enzymes. Enzymatic redox reactions require a cofactor regeneration system 
for re-establishing the biocatalyst reduction potential. While whole cells use their internal 
metabolism to regenerate such cofactors by utilising inexpensive readily available 
hydrogen-donor substrate materials (Nakamura et al. 2003), isolated enzymes need an 
external cofactor supply. Since these cofactors are very expensive, their use in 
stoichiometric amounts is not economically feasible. Despite considerable research efforts 
to develop in-vitro cofactor regeneration systems for NADH and NADPH, large scale 
applications of these regeneration schemes are rather scarce (Bommarius et al. 1998; 
Wichmann et al. 1981), mainly because they have not yet become economical and practical 
processes (Chartrain et al. 2001; Held et al. 2000). In contrast, whole cells have been 
widely used in large-scale redox biotransformations (Buhler & Schmid 2004; Chartrain et 
al. 1999; Chartrain et al. 2001; Doig et al. 2002; Doig et al. 2001; Kiener 1992; Kometani 
et al. 1996; Kroutil et al. 2004; Patel et al. 2004; Rasor & Voss 2001; Roberge et al. 1996; 
Schrader et al. 2004; Shaw et al. 2003). This work uses whole cell microorganisms as 
biocatalysts for performing redox biotransformations. 
22 
Chapter 1. Introduction 
Biotransformations are established now as a useful tool for the production of intermediates 
in the fine chemical industry. One particularly successful application of biocatalysts is the 
production of enantiomerically pure compounds (Faber 2004). Despite the great potential of 
biotransformations in organic synthesis, a considerable number of substrates and products 
of biotransformations are poorly soluble in water, the medium in which most biocatalysts 
have optimal biological performance. Additionally, substrate and product above critical 
concentrations are known to inhibit biocatalytic activity (D'Arrigo et al. 2000; Held et al. 
2000). Therefore, a significant obstacle to the application of biotransformations in industry 
is the limiting loading of substrate and product allowed in the reactor. 
To overcome these difficulties aqueous/organic direct-contact biphasic (DCB) reactors 
have been developed. In these reactors, the organic solvent acts as an in-situ continuous 
supplier of reaction substrate and as an in-situ extraction phase for recovering of reaction 
product. Since most substrates and products of biotransformations are hydrophobic, DCB 
reactors allow high concentration loadings of substrate or product to the organic phase. 
However, the intensive mixing during the direct contact of the organic phase and 
biomedium inevitably causes the formation of irreversible emulsions. The costs involved in 
the separation of these emulsions can make the process not economically feasible (Conrad 
& Lee 1998; Schmid et al. 1998a; Schroen & Woodley 1997). Furthermore, the solvent 
itself can be toxic or inhibitory for the biocatalyst (Brink & Tramper 1985; Chakraborty et 
al. 2005; Cruz et al. 2004; de Carvalho et al. 2004; Femandes et al. 2002; Husken et al. 
2003; Jiang et al. 2002; Osborne et al. 1990; Rojas et al. 2004). 
To meet this challenge, membrane bioreactors for biotransformations (MBB) have been 
proposed (Hoq et al. 1984; Pronk et al. 1988; Pronk & Van't Triet 1991) based on 
membrane extraction (Kiani et al. 1984; Prasad et al. 1988; Prasad & Sirkar 1988; Prasad & 
Sirkar 1989). In these systems, a membrane separates the aqueous and organic phases. The 
aim is to avoid emulsion formation and phase toxicity of the organic solvent encountered in 
DCB systems, while enabling substrate and product transport. Two types of membranes 
have been used: microporous and non-porous. 
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Microporous membranes run into difficulties maintaining an aqueous-organic interface 
because species present in the biomedium can act as surfactants. These can cause a 
considerable reduction in the membrane breakthrough pressure, which leads to aqueous-
organic phase breakthrough and mixing of the two phases (Hoq et al. 1984; Pronk et al. 
1988; Vaidya et al. 1994b). A mechanism for this phenomenon was outlined by Schroen et 
al. (1994) and Vaidya et al. (1994b); they found that the decrease in the interfacial surface 
tension and breakthrough pressure is caused by surface active compounds, primarily 
proteins, that adsorb progressively onto the membrane pore walls, thus changing the 
wettability of the membrane. This protein adsorption ultimately leads to phase 
breakthrough and emulsion formation. 
To prevent phase breakthrough during microporous MSB operation, the transmembrane 
pressure must be strictly controlled in the 100 mbar range, which is very difficult to achieve 
in actual membrane contactors (Hoq et al. 1984; Vaidya et al. 1994b; Westgate et al. 1998). 
Pronk et al. (1988) reported the use of a Cuprophan hollow fiber membrane with an 
immobilized enzymatic system. The authors reported no phase breakthrough occurring up 
to 1 bar due to the ultrafiltration range of the membrane (MWCO 5,000 g mol"^). However, 
the membranes used were hydrophilic, and not compatible with organic solvents, nor were 
they suitable for extraction of hydrophobic molecules. Liese et al. (1996) and Shin et al. 
(2001) suggested an enzymatic MBB using two membrane stages: an ultrafiltration 
membrane was coupled to a bioreactor for retaining enzymes, and a second microfiltration 
hollow fiber membrane module was used as a two-phase extractor for product recovery. No 
phase breakthrough occurred at the extraction stage because the enzymes were not allowed 
to adsorb into the membrane pores. Chang et al. (1992) reported the use of a similar two-
stage bioreactor-extractor system for an ethanol fermentation using suspended whole-cells. 
Kang et al. (1990) and Shukla et al. (1989) reported no phase breakthrough occurring in 
their microporous membrane bioreactors. They used an immobilised whole-cell operational 
mode which greatly reduced the concentration of proteins and whole cells suspended in the 
biomedium. In contrast, in a suspended whole-cell membrane biotransformation of isoamyl 
alcohol to isovaleraldehyde (Molinari et al. 1997), phase breakthrough took place when the 
microorganisms were suspended in the bioreactor. 
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Silicone rubber has been used as a non-porous membrane material because of its high 
permeability and selectivity to small hydrophobic molecules, and more importantly because 
it prevents aqueous breakthrough. The high permeability is due mainly to extensive 
swelling in the presence of organic solvents (Doig et al. 1999b). However, swelling causes 
expansion, leading to formation of wrinkles and cracks, and ultimately to bursting and 
problems handling the membrane. Therefore, a low degree of membrane swelling is a 
paramount consideration in the design and performance of organic solvent resistant 
membranes (Linder et al. 1993a; White 1993; White 2001). 
This work explores the use of a nanofiltration membrane, which is resistant to a wide range 
of organic solvents, to provide a stable biphasic interface without significantly sacrificing 
mass transfer of solutes. This approach is now possible with the development of organic 
solvent nanofiltration (OSN) membranes, which became commercially available in the 90's 
(Livingston et al. 2003; Machado et al. 2000; Stamatialis et al. 2006; Zhao & Yuan 2006a; 
Zhao & Yuan 2006b). In principle, these membranes conserve their integrity and 
performance in the presence of organic solvents (Linder et al. 1993a; Linder et al. 1993b; 
White 2002). 
In contrast to microporous membranes, the very small pore size of the OSN membranes (in 
the nano-scale) should prevent the adsorption of surfactants into the membrane pores, thus 
preventing phase breakthrough. In addition, the characteristically low swelling of these 
membranes overcomes the problem of poor solvent resistance observed in silicone rubber 
membranes. Therefore, this work assesses the feasibility of using an OSN membrane as a 
selective separating layer between the aqueous and the organic phases, thus assisting 
biotransformations of hydrophobic molecules. 
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1.2. Aims of this thesis 
The main aim of this research was to investigate the application of organic solvent 
nanofiltration (OSN) membranes in two phase biotransformations of hydrophobic 
molecules for the production and in-situ extraction of chiral products. Additionally, this 
thesis aims to assess and compare the performance of the OSN-MBB bioreactor, in terms of 
yield, productivity and product enantiopurity, to other bioreactor technologies currently 
used. To accomplish this, the following particular aims were considered: 
1. To comparatively assess the suitability of coupling OSN membranes to a 
biotransformation reactor to perform an asymmetric redox synthesis of a hydrophobic 
solute, Model Biotransformation I, related to previous MBBs and DCB reactors. 
2. To understand, characterise and mathematically model the transport mechanisms of 
hydrophobic molecules through OSN membranes operated under a concentration 
driving force. 
3. To study and understand the performance of a second reaction system, Model 
Biotransformation II, in a single-phase aqueous media by characterising the product 
formation kinetics and the effect of substrate feeding strategy on the productivity and 
enantioselectivity of the reaction. 
4. To apply the scientific and engineering knowledge gained in the previous objective to 
the design and optimisation of two different aqueous-organic systems (DCB and OSN-
MBB reactors) for Model Biotransformation II; and to understand and quantify the 
difference in performance (enantioselectivity, yield and productivity) comparing the 
OSN-MBB systems with both aqueous and DCB reactors. 
5. To form an overall appraisal of the applicability and reliability of OSN-MBB systems 
for performing reduction biotransformations of hydrophobic chiral molecules. 
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1.3. Thesis structure 
The thesis is comprised of 6 chapters. Chapters 2 to 5 correspond to the specific objectives 
of this thesis outlined in the previous section. Each of these chapters is written in an 
academic paper format and is comprised of the following sections: (1) background and 
literature review; (2) experimental; (3) mathematical modelling (if applicable); (4) results 
and discussion and (5) conclusions. 
Chapter 1 gives an overview of this research in its scientific and technological context and 
underlines the major issues that motivated this work. 
Chapter 2 first provides a comprehensive literature review and theoretical background of 
the fundamentals of biotransformations and reactor technologies which ultimately led to the 
formulation of the scientific and engineering problem this thesis aims to tackle. Then it 
describes the development of an OSN-MBB system for the asymmetric synthesis of a 
hydrophobic chiral molecule, Model Biotransformation I: the reduction of geraniol to R-
citronellol by baker's yeast. Additionally, the feasibility and the usefulness of the OSN-
MBB systems were confirmed in this chapter, which set off the ground for further work on 
the development of these reactors. 
Chapter 3 addresses the understanding of the principles of mass transfer through 
asymmetric polyimide OSN membranes used as aqueous-organic biphasic contactors with 
the aim of improving mass transport rates of hydrophobic solutes. This transport study 
considers the effect of two membrane formation parameters, casting thickness and 
evaporation time, on the membrane mass transport rates. 
In Chapter 4, a second model biotransformation was selected, Model Biotransformation II: 
the reduction of acetophenone to S-phenylethanol by Rhodotorula glutinis. This chapter 
thoroughly studies product formation kinetics and the effect of different processing 
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conditions on the performance of the model biotransformation in aqueous media, aiming at 
obtaining maximum enantiopurity, yield and productivity. 
Chapter 5 details the study of two in-situ aqueous-organic product recovery systems for 
the Model Biotransformation II: emulsion and membrane bioreactors. An organic solvent 
was selected and the biotransformation was performed in both DCS and OSN-MBB 
reactors. Product formation was analysed by using the kinetic model developed in Chapter 
4, and the performance of the OSN-MBB was compared to its aqueous and DCB 
counterparts. 
Finally, Chapter 6 gives an overall appraisal of the OSN-MBB system related to the state-
of-the-art in biotranformation technology. This chapter underlines the benefits that the new 
system provides to the field of biotransformations; it also points out its limitations and 
suggests research strategies to overcome such shortcomings; finally, it gives a final 
comment on the implications of this research to the scientific and technology entities 
related to biotransformations and OSN membranes. 
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Chapter 2 
Model Biotransformation I. 
Implementation of an OSN-MBB System 
Outline 
2.1. Background and Literature Review 
2.2. Materials and Methods 
2.3. Mathematical Analysis 
2.4. Results and Discussion 
2.5. Conclusions 
2.1. Background and Literature Review 
Chapter 2 is the foundation of this work as it deals with the main aims of this thesis: (1) to 
develop an OSN-MBB system for the asymmetric synthesis of hydrophobic chiral 
molecules; and (2) to assess the feasibility and usefulness of the reactor. This chapter 
provides a comprehensive literature review and theoretical background of the fundamentals 
of biotransformations and reactor technology, which ultimately led to the formulation of the 
scientific and engineering problem that this thesis aims to tackle. 
The work presented in this chapter has also been published as: R. Valadez-Blanco, F.C. 
Ferreira, R.F. Jorge, A.G. Livingston, A membrane bioreactor for biotransformations of 
hvdrophobic molecules using organic solvent nanofiltration COSN') membranes, in Journal 
of Membrane Science 317 (1-2) (2008) 50-64, and Desalination 199 (1-3) (2006) 429-431 
(Euromembrane 2006 abstract). 
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2.1.1. Biotransformations 
Biotransformations are selective biologically catalysed chemical reactions of defined pure 
compounds into defined final products (Kieslich 1984). In addition to their natural 
substrates, biocatalysts accept and catalyse other structurally-related compounds which are 
called unnatural. The syntheses of unnatural substrates are the basis of modern 
biotransformations. A biocatalyst is a suitable candidate for biotransformations when the 
product of interest is not further degraded or reacted (Faber 2004; Leuenberger 1984). 
Scientists have used biotransformations widely for the formation of intermediate products 
which can be further used in organic synthesis (Kieslich 1984). The wide range of reactions 
that can be carried out by biological catalysts has importantly enriched and complemented 
classical synthetic organic chemistry (Davies et al. 1989; Faber 2004). However, sequential 
biotransformations alone are seldom used to carry out complete multistage organic 
syntheses (Kieslich 1984), probably because of the inherent complexity of the biological 
systems. 
Biocatalysts (enzymes) possess three major types of selectivities: Chemoselectivity. a 
single enzyme regularly conducts a single reaction type (Faber 2004; Kieslich 1984); 
Regioselectivity: an enzyme attacks at a specific site, even when moieties with similar 
chemical activity are present in the molecule (Faber 2004; Kieslich 1984; Sweers & Wong 
1986); Stereoselectivity: in a racemic mixture, an enzyme preferentially attacks one 
enantiomer. Similarly, when a new chiral centre is formed, the biocatalyst preferentially 
synthesises only one of the possible enantiomers (Faber 2004; Kieslich 1984). This 
characteristic gives biocatalysts the ability to perform asymmetric synthesis (Chen & Sih 
1989). 
The use of biocatalysts for obtaining a desired product needs to be assessed by weighing 
the advantages of the biocatalyst against both total organic synthesis and extraction from 
natural products (plants and animal tissues). Although the latter has been used for many 
decades, this technology offers a characteristic low yield. In contrast, the chemosynthetic 
industry has made significant advances in the last century (Kieslich 1984; Koskinen 1993). 
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Recent progress in the organic synthesis of natural products is based on the need to find 
new functional properties of natural and synthetic products for applications to the 
pharmaceutical and agrochemical industry (Koskinen 1993). 
Generally biotransformations are the method of choice when the analogous chemically 
catalysed reaction is not easy (or feasible) to carry out; or when the aim is to specifically 
modify complex molecules such as antibiotics (Csuk & Glanzer 1991; Leuenberger 1984). 
Biocatalysts can catalyse almost all synthetic organic reactions with a few exceptions and 
they can accomplish reactions that are not possible by organic chemistry. The four most 
important uses of biotransformations in organic synthesis are: 1) resolution of racemates; 2) 
selective conversion of specific functional groups; 3) asymmetric synthesis; and 4) 
functionalisation of non-activated sites (Csuk & Glanzer 1991; Faber 2004). Probably the 
most important application of biotransformations is in the production enantiomerically pure 
compounds (Davies et al. 1989; Faber 2004; Kieslich 1984). 
2.1.1.1. Importance of enantiomeric purity 
Isomers are different compounds with the same molecular formula. When two isomers are 
different from each other only in the way their atoms are arranged in space they are called 
stereoisomers. Additionally, chiral molecules are those that are not superimposable on 
their mirror images. 
Stereoisomers that are mirror-image of each ^ ^ 
other, i.e. chiral compounds, exist as 
w — — Y Y — L ) — w 
enantiomers and those which are not mirror-
image of each other exist as diastereomers 
(Fig. 2 . 1 ) . Enantiomers have identical physical F igure 2.1. Representation of two enantiomers 
with formula CWXYZ. 
properties, except for the direction of rotation 
of the plane of polarised light; and identical chemical properties, except toward optically 
active reagents (Morrison & Boyd 1 9 8 3 ) . An optically active compound rotates the plane of 
polarized light. The specific rotations of two enantiomerically pure solutions are exactly the 
same but of opposite sign (Morrison & Boyd 1 9 8 3 ) . 
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A mixture of equal parts of enantiomers is called a racemic mixture which is optically 
inactive since the rotation caused by one isomer is cancelled by an equal and opposite 
rotation caused by its enantiomer. Thus, optical purity or activity is not a property of 
individual molecules but rather of the random distribution of enantiomers in a mixture of 
such molecules (Morrison & Boyd 1983). For mathematically expressing the amounts of an 
enantiomer, e.g. (R)-entantiomer in a mixture, the enantiomeric excess (ee) can be used: 
% ee {R) = xlOO Eq. 2.1 
Biological systems use enzymes as their principal metabolic catalyst. Since such 
biomolecules are themselves chiral, they select their substrate according to its enantiomeric 
characteristics. The ability of enzymes to identify the stereochemistry of the substrate relies 
on the difference in enzyme-substrate binding energies required for performing the 
reactions (Procter 1996). Thus the stereochemistry of the reactants in biological systems 
and of the biocatalyst determines the products of the biochemical reactions, and also their 
functional, biological or physiological effect (Faber 2004; Procter 1996). This means that in 
a biologically catalysed system, two enantiomers of the same molecule can cause different 
effects. The isomer with the highest, desired activity is called the eutomer, and its 
enantiomeric counterpart is the distomer. The latter can cause three different effects in a 
biological organism: 1) low, although desired; 2) null or negligible; and 3) toxic (Davies et 
al. 1989). When a non-desired effect is caused, the racemic mixture poses a risk to the 
product application (Faber 2004; Procter 1996). Therefore, in biological systems, 
enantiomers of the same molecule must be treated as two different compounds (Faber 2004; 
Procter 1996). 
At present most bioactive agents are still used as racemic compounds due to economical 
factors. However, this situation will change in the near future because of the increasing 
public concern over health issues, which is driving stricter legislation for the approval of 
synthetic products. Therefore, chemical industries will produce increasingly higher 
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amounts of enantiomerically pure compounds with specific biological activities (Crosby 
1991; Stinson 2001; Thayer 2005). Accordingly, modem organic synthesis devotes major 
efforts to studying the formation of enantiopure compounds by using asymmetric synthesis 
(Chartrain et al. 2001; Gotor 2002; Patel 2000; Rasor & Voss 2001; Schmid et al. 2001; 
Shaw et al. 2003; Stinson 2001). 
For obtaining enantiomerically pure compounds five principal chemical and biochemical 
methods are available: 
1. Crystallisation, a) Direct. Unfortunately less than 10% of organic compounds 
crystallise as enantiomerically pure conglomerates, with the remaining forming racemic 
crystals (Faber 2004). h) Diastereomeric crystallisation. This type of crystallisation 
consists of adding a resolving chiral agent (acid or base) to the racemic mixture thus 
forming the corresponding diastereomers and separating them by crystallisation. This 
method has two shortfalls: first, in general it is only suitable for acids and bases; and 
second, the maximum attainable product yield is 50% (Kozma 2002). 
2. Asymmetric synthesis. This uses synthetic or biological catalysts to transform the 
absolute stereochemistry of chiral centres. In this synthesis the catalysts (and/or auxiliaries) 
need to be chiral (Procter 1996). 
3. Chiral pool. The use of enantiomerically pure compounds from natural sources (chiral-
pool) as starting materials is usually economically limited since only 10 to 20 % of 
compounds are commercially available at affordable prices (Scott 1984). Additionally only 
one of the enantiomers of a chiral molecule is available in nature (Crosby 1992). Thus, this 
is a competitive method solely in the following two instances: first, when the compound is 
very difficult to synthesise and is of utmost importance, e.g. the potential anticancer 
compound taxol (Koskinen 1993); and second, when the compound is readily commercially 
available (Crosby 1991). 
4. Kinetic Resolution. Resolution may be expensive and inefficient for two principal 
reasons: first, a suitable resolving agent is required; and second, the maximum obtainable 
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yield through this method is 50%, the unwanted enantiomer is disposed (Koskinen 1993; 
Procter 1996). 
5, Chromatography, Although this is an important technology, its major disadvantage is 
that the stationary phases (made of chiral substrates) are often expensive. Additionally, it is 
complex to implement in a continuous process (Miller et al. 2003; Pais & Rodrigues 2003). 
Summarising, biocatalytic methods evidently provide a valuable alternative and powerful 
complementary aid for the asymmetric synthesis of fine chemicals (Csuk & Glanzer 1991; 
Faber 2004; Koskinen 1993). 
2.1.1.2. Types of biocatalysts: enzyme versus whole cells 
The biocatalysts most frequently used for biotransformations are either isolated enzymes or 
whole cells (microorganisms). Both of them rely on enzymes as biocatalysts; the difference 
is that whole cells contain a large number of enzymes which can perform multiple 
reactions, whereas a single isolated enzyme catalyses just one reaction. 
The existence of several enzymes in whole cells may constitute the principal disadvantage 
of their use, since their reactions can be of opposite effects or they may synthesise 
undesired products (side-reactions). If side-reactions dominate, whole cells are not suitable 
to carry out a biotransformation effectively (Davies et al. 1989). Additionally, in whole 
cells the active enzyme which catalyses a biotransformation constitutes just a small portion 
of the total cells' enzymatic body, thus decreasing their catalytic efficiency (Faber 2004). In 
contrast, isolated enzymes require simple apparatus and are easier to control and work up; 
in addition, they present higher productivity than whole cells due to their reaction 
specificity and tolerance to higher concentrations of substrate or product (Davies et al. 
1989; Faber 2004). 
On the other hand, whole cells may be considered as a viable choice in three cases: first, 
when enzymes are not commercially available or they are expensive; second, when whole 
cells are able to satisfactorily catalyse a desired reaction; and third, when a 
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biotransformation requires cofactor regeneration such as in the case of reduction-oxidation 
reactions. Whole cells use their internal metabolism for cofactor regeneration by using 
inexpensive chemical sources (Nakamura et al. 2003), while isolated enzymes need an 
external cofactor supply. 
2.1.1.3. Cofactor recycling for redox biotransformations 
The majority of the redox enzymes require nicotinamide adenine dinucleotide, NAD(H), or 
its respective phosphate, NADP(H) as a redox cofactor. Although these two cofactors have 
similar structures, enzymes use them distinctly for catabolic and anabolic reactions, 
respectively. Thus, in biological systems, NAD is maintained predominantly in the oxidised 
state while NADP in the reduced form (Davies et al. 1989; Ward & Young 1990). The 
cofactors required for the enzymatic activity of oxidoreductases are difficult to obtain and 
thus expensive; therefore, they cannot be affordably used in stoichiometric amounts for 
large-scale production and their redox potential needs to be regenerated for cofactor 
recycling. 
Cofactor regeneration is in principle not a problem for whole cell systems because such 
catalysts can recycle their cofactors by using their internal metabolism. Whole cells use one 
of two mechanisms to recycle NADP(H) cofactors: the pentose phosphate pathway and the 
Entner-Doudoroff pathway. The latter substitutes the Embden-Meyerhof pathway in some 
prokaryotes for metabolising glucose (Stanier et al. 1987). Whole cells oxidise NAD by 
reducing dihydroxyacetone phosphate to glycerol (Gancedo & Serrano 1989). This cofactor 
regeneration may compete with a biotransformation in the case of bioreductions (Cheng & 
Ma 1997). On the other hand, NAD reduction in whole cells occurs by the oxidation of 
ethanol to acetate (Gancedo & Serrano 1989) as well as by the Embden-Meyerhof-Parnas 
pathway and the tricarboxylic acid cycle where part of the formed NADH is oxidised again 
in the respiratory chain (Bailey & Ollis 1987; Stryer 1995). 
Despite considerable research efforts to develop in-vitro cofactor regeneration systems for 
NADH and NADPH, large scale applications of these regeneration schemes are rather 
scarce (Bommarius et al. 1998; Wichmann et al. 1981) mainly because they have not yet 
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become economical and practical processes (Chartrain et al. 2001; Faber 2004; Held et al. 
2000; Ward & Young 1990). In contrast, whole cells have been widely used in large-scale 
redox biotransformations (Buhler & Schmid 2004; Chartrain et al. 1999; Chartrain et al. 
2001; Doig et al. 2002; Doig et al. 2001; Kiener 1992; Kometani et al. 1996; Kroutil et al. 
2004; Patel et al. 2004; Rasor & Voss 2001; Roberge et al. 1996; Schrader et al. 2004; 
Shaw et al. 2003). 
With these considerations, it is clear that whole cells currently provide the best catalyst 
choice for reduction reactions. The trend in the development of redox biocatalysts is the use 
of recombinant microbial technology to assemble whole cell biocatalysts (cell factories) 
equipped with the enzymes needed for the biotransformation and with efficient in-vivo 
cofactor regeneration enzymes (Kataoka et al. 1998; Kataoka et al. 2003; Kizaki et al. 
2001; Shaw et al. 2003; Shimizu et al. 1990; Yasohara et al. 2001). Thus, this technology 
combines most of the advantages of whole cells and isolated enzymes; however the 
biocatalyst development can take more than 2 years, so in this regard directed evolution 
provides an alternative for the search of new biocatalysts (Bornscheuer 1998; Eggert et al. 
2004; Lutz & Patrick 2004). Whole cells were used in this work to perform redox 
biotransformations. 
2.1.2. Direct contact two-phase reactors for biotransformations 
Substrate 
Biomedium 
Single-phase aqueous bioreactors (Fig. 2.2) may present 
several pitfalls for carrying out biotransformations. A 
considerable number of substrates and products of 
biotransformations are poorly soluble in water, the 
medium in which most biocatalysts have optimal 
biological performance (Csuk & Glanzer 1991; Faber 
2004; Koskinen 1993). Additionally, substrate and product 
above critical concentrations are known to inhibit 
biocatalytic activity (DArrigo et al. 2000; Faber 2004; Held et al. 2000). Therefore, a 
significant obstacle to the application of biotransformations in industry is the limiting 
loading of substrate and product achievable in the reactor. 
Figure 2.2. Diagram of aqueous 
bioreactor for biotransformations 
with direct substrate addition. 
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To overcome these difficulties aqueous-organic direct-contact biphasic (DCB) reactors 
have been developed. These reactors employ a second organic phase in direct contact with 
the biomedium (Fig. 2.3). The organic solvent acts as an in-situ continuous supplier of 
reaction substrate and an in-situ recovering phase of reaction product (Buhler et al. 2003b; 
Lilly 1982; Vansonsbeek et al. 1993; Woodley & Lilly 1990; Wubbolts et al. 1996). The 
second phase should not be toxic or inhibitory to the biocatalyst. These systems offer 
several advantages over single-phase bioreactors: (1) since most substrates and products of 
biotransformations are hydrophobic, DCB reactors allow high concentration loadings of 
substrate or product to the organic phase thus overcoming the solubility limitations of 
single phase reactors; (2) product and substrate inhibition of the biocatalyst is greatly 
reduced because these components are kept mainly in the organic phase; (3) since high 
stirring speed can be used, a very high mass transfer of product and reactants from, or to, 
the catalyst can be achieved, so these systems are generally not mass transfer limited 
(Freeman et al. 1993; Lilly 1982; Vansonsbeek et al. 1993; Wubbolts et al. 1996). 
Substrate in 
organic solvent 
Biomedium 
Two-phase 
emulsion 
Organic 
phase 
Aqueous 
phase • 5 
# « 
• • 
Figure 2.3. Schematic of direct-contact biphasic (DCB) aqueous-organic bioreactor for biotransformations. 
However, the intensive mixing during the direct contact of the organic phase and 
biomedium inevitably causes the formation of irreversible emulsions. The costs involved in 
the separation of these emulsions can make the process not economically feasible (Conrad 
& Lee 1998; Schmid et al. 1998a; Schroen & Woodley 1997). Furthermore, the solvent 
itself can be toxic or inhibitory for the biocatalyst (Brink & Tramper 1985; Chakraborty et 
al. 2005; Cruz et al. 2004; de Carvalho et al. 2004; Fernandes et al. 2002; Husken et al. 
2003; Jiang et al. 2002; Osborne et al. 1990; Rojas et al. 2004). 
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2.1.3. Membrane bioreactor for biotransformations (MSB) 
2.1.3.1. Extractive membrane bioreactors 
In this type of bioreactor the 
membrane, or membrane module, is 
coupled in situ to a two-phase 
bioreactor system thus separating the 
phases (Fig. 2.4). Membrane bioreac-
tors present a number of advantages 
over conventional reactors (some of 
these are common to DCB bioreac-
tors): 
Aqueous phase 
(Bioreactor) 
Substrate 
Bioctatalyst 
Organic phase 
Product 
Product 
Membrane 
Figure 2.4. Diagram of extractive aqueous-organic 
membrane bioreactor. 
1) Removal of inhibitory products during fermentations (Chang et al. 1992; Cho & 
Shuler 1986; Groot et al. 1990; Kang et al. 1990; Shukla et al. 1989; Solichien et al. 
1995) and biotransformations (Boontawan & Stuckey 2006; Bosetti et al. 1996; 
Doig et al. 1999a; Liese et al. 1996); 
2) Mitigation of the toxic or inhibitory effects caused by the contact of the cells with 
the organic phase in comparison with DCB reactors (Cho & Shuler 1986; Husken et 
Ed.2002% 
3) Efficient in-situ product extraction. The extraction solvent is selected with a 
favourable partition coefficient for the solute (Brink & Tramper 1985; Bruce & 
Daugulis 1991; Chakraborty et al. 2005; Collins & Daugulis 1999; Cruz et al. 2004; 
Jiang et al. 2002; Laane et al. 1987; Osborne et al. 1990; Rojas et al. 2004; Villela et 
211.2003% 
4) The equilibrium of the reactions can be controlled by the removal of product from 
the bioreactor (Faber 2004; Lye & Woodley 1999; Netke & Pangarkar 1996; Prasad 
& Sirkar 1992; Schroen et al. 1993); 
5) Since these bioreactors are non-dispersive, formation of an emulsion is prevented 
and the product is obtained directly in a clean organic phase, thus circumventing the 
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cumbersome emulsion separation needed in DCB reactors (Boontawan & Stuckey 
2006; Doig et al. 1998a; Doig et al. 1999a); 
6) The bioreactor and membrane module can be independently operated, allowing for 
versatile process design (Boontawan & Stuckey 2006; Chang et al. 1992; Doig et al. 
1999a; Freeman et al. 1993; Liese et al. 1996); 
7) Since the membrane serves as a barrier for catalysts and other bioreactor 
components, catalysts and cofactors, usually expensive, can be recycled (Hummel et 
al. 1987; Katayama et al. 1983; Liese et al. 1996; Wichmann et al. 1981); 
8) In-situ product extraction prevents further product reaction in the aqueous media 
(Molinari et al. 1997) 
On the other hand, the major issues related to the use of membrane extraction are: 
1) The membrane consitutes an additional barrier for the mass transfer of substrates 
and products. This is the major issue of membrane contactors and can become an 
important limitation on the applicability of these systems to fast biotransformations 
(Boontawan & Stuckey 2006; Doig et al. 1999a). 
2) Porous membranes are prone to aqueous breakthrough into the organic phase which 
leads to emulsion formation. This issue will be treated in more detail in the 
following section. 
3) Membranes need to be resistant to a relatively wide range of organic solvents; i.e., 
they should conserve their integrity and performance in the presence of organic 
solvents (Linder et al. 1993a; Linder et al. 1993b). This issue will be further 
discussed in Section 2.1.3.3. 
According to the polymeric structure, two types of membranes have been used in MBB 
systems: microporous and non-porous, which are subsequently described in the following 
sections. 
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2.1,3.2. Membrane bioreactors for biotransformations (MBB) using porous membranes 
Several porous MBBs have been reported in the literature for whole cell biotransformations 
(Husken et al. 2002; Leon et al. 2001; Molinari et al. 1997; Onken & Berger 1999; Schroen 
et al. 1993; Westgate et al. 1998) and for enzymatic biotransformations (Hoq et al. 1984; 
Hoq et al. 1985; Hummel et al. 1987; Jandel et al. 1982; Katayama et al. 1983; Pronk et al. 
1988; Wichmann et al. 1981). 
In two-phase porous-membrane extraction, a wetting liquid first flows on the back side of 
the membrane (i.e., the side facing the membrane support). To prevent free permeation of 
the wetting liquid, a non-wetting liquid needs to be pumped through the opposite side of the 
membrane at a higher static pressure. The static pressure of the non-wetting phase 
counterbalances the pressure of the wetting phase, thus creating a liquid-liquid interface. 
The interfaces, located at the non-wetting-liquid side pore mouths, permit the extraction of 
a solute from one phase to the other (Hoq et al. 1984; Kiani et al. 1984; Prasad & Sirkar 
1992). As solute diffusion occurs through the solvent wetting the membrane mass transport 
rates are fast compared with non-porous membranes. The main advantage of these reactors 
is the high mass transport rates that can be achieved with microporous membranes. 
When the pressure of the non-wetting phase exceeds the surface tension of the wetting 
liquid at the liquid-liquid interface, the non-wetting phase permeates freely through the 
membrane, thus causing a dispersion of the two liquid phases. This is called phase 
breakthrough. The minimum pressure at which the non-wetting phase can freely permeate 
through a membrane is called minimum breakthrough pressure (Prasad & Sirkar 1992; 
Schroen et al. 1994; Vaidya et al. 1994b). 
For an ideal porous membrane with cylindrical homogeneous pore size distribution, the 
Laplace-Young equation, the basic capillarity equation, can be used to describe the 
breakthrough pressure behaviour in a membrane two-phase contactor. Equation 2.2 is a 
special case of the Laplace-Young equation in which the pressure difference, APL-Y, 
balances the surface tension acting on a film (Adamson 1990). 
40 
Chapter 2. Model biotransformation I 
^L-Y -
2r 
R 
Eq. 2.2 
where APL-Y is the pressure difference, Yw/N is the surface tension between the wetting (w) 
and non-wetting (n) phases, and R is the curvature of the film interface inside the pore. 
Thus, minimum breakthrough pressure (APB) is the pressure that needs to be applied to the 
interface film to counterbalance the surface tension force. In cylindrical pores R is equal to 
rp/cosOr, where rp is the pore radius, and 0r is the contact angle at which the non-wetting 
liquid meets the cylindrical capillary wall with respect to the plane of the membrane (Fig. 
2.5). Eq. 2.2 can be expressed as (Adamson 1990); 
Af . = ^ ^ c o s 6 Eq. 2.3 
Wetting phase 
(organic solvent) 
rp 
Membrane 
material 
Membrane 
material 
Non-wetting phase 
(aqueous solution) 
Figure 2.5. Representation of the aqueous-organic interface in porous membranes used as two-phase 
contactors. A membrane with cylindrical homogeneous pore distribution is considered. 
When the pressure at the pore interface exceeds APB, the non-wetting liquid freely 
disperses into the wetting phase. Evidently, a low APB needs to be avoided. Therefore, non-
dispersive liquid extraction based on porous membranes crucially requires a very strict 
transmembrane pressure control not to exceed the APB-
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Aqueous 
I 
Membrane 
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Aqueous breakthrough 
Schroen et al. (1994) found that the 
decrease in the interface surface tension 
is caused by surface active compounds, 
such as enzymes, that adsorb 
progressively onto the membrane's pore 
walls, thus progressively changing the 
membrane's wettability (Fig. 2.6). They 
observed that adsorption of surfactant to 
the interface was necessary for observing 
a change in APg. When extensive change 
of wettability occurs, the non-wetting 
phase wets the membrane and this phase freely permeates through the membrane pores 
(Delia et al. 1986; Netke & Pangarkar 1996; Schroen et al. 1994; Vaidya et al. 1994b). The 
control of the transmembrane pressure becomes yet more difficult to achieve as APg 
decreases with the presence of surface active molecules (Delia et al. 1986; Hoq et al. 1984; 
Prasad & Sirkar 1992; Schroen et al. 1994; Vaidya et al. 1994a; Vaidya et al. 1994b). 
^ Surfactant molecule 
Figure 2.6. Schematic of the mechanism of aqueous 
breakthtrough in aqueous-organic porous membrane 
contactors. 
However, not only are enzymes capable of adsorbing onto the membrane surface —any 
other surface active compounds present in the membrane bioreactor can also adsorb 
(Keurentjes et al. 1990; Schroen et al. 1994; Vaidya et al. 1994a). The bioreactor phase 
may contain surface active compounds in the form of substrates, products or cells. Vaidya 
et al. (1994b) found that lauric acid (a surface active substrate) reduced the APg with and 
without the presence of an immobilised enzyme; thus, they concluded that the substrate was 
adsorbed onto the membrane. In the same vein, Keurentjes et al. (1990) noted that sodium 
oleate (soap) adsorbed onto a UF membrane causing a very low APB . 
Through a quick examination of Eq. 2.3, it can be seen that the breakthrough pressure 
depends on both interfacial tension and pore radius. The APB increases with the interfacial 
tension between the two liquid phases; whereas it decreases with pore size. A reduction in 
the pore size causes an increase in APe, which is desirable for preventing phase 
breakthrough. Nevertheless, as a smaller pore size will be accompanied by a reduced 
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porosity, this will cause a decrease on the solute flux through the membrane —the 
membrane mass transfer coefficient is directly proportional to the membrane porosity: 
Eq.2.4 
/ T 
where the mass transfer coefficient of a solute through the membrane pores (km) is a 
function of the porosity (s), the organic difusion coefficient (Dorg), the membrane thickness 
(/) and the totuosity (x). 
Therefore the optimisation of an extractive membrane system by reducing the membrane 
porosity implies a trade-off between two contrary effects: increase in APB, thus preventing 
phase breakthrough and facilitating operation control, and reduction or hindrance of solute 
flux (Netke & Pangarkar 1996; Prasad & Sirkar 1992; Schroen et al. 1993). In this respect, 
asymmetric membranes with pore size variation across their thickness can provide 
acceptable APB without drastically reducing the flux across the membrane (Prasad & Sirkar 
1992^ 
Vaidya et al. (1992; 1994a; 1994b) have recommended the use of membranes with smaller 
pore size for preventing the decrease in the minimum breakthrough pressure in the presence 
of surfactants. They compared the performance of ultrafiltration (UF) and microfiltration 
(MF) membranes for an MBB system. Although the smaller pore size of UF membranes 
prevented APB from dramatically decreasing, it also resulted in low biocatalytic activity due 
to mass transfer limitations. 
Pronk et al. (1988) reported the use of a Cuprophan hollow fiber UF membrane with an 
immobilized enzymatic system. This membrane is made of regenerated cellulose acetate 
with a 2 nm nominal pore size. The authors reported no phase breakthrough occurring up to 
1 bar due to the UF range of the membrane (MWCO 5,000 g mol"'). Another UF membrane 
reported in the literature is BM5 (Vaidya et al. 1994a), made of meta-aramid and supplied 
by Berghof (500 g mof ' MWCO). However, the membranes used were hydrophilic (or 
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amphiphilic in the case of the latter (Vaidya et al. 1994a)), and not compatible with organic 
solvents, nor were they suitable for extraction of hydrophobic molecules; they have been 
used only in a hydrophilic extraction mode, i.e., using the aqueous phase to wet the 
membrane and transferring hydrophilic solutes from the organic to the aqueous phase. No 
use of hydrophobic UF membranes in an extraction mode has been reported in the literature 
prior to this work (Liese et al. 1996; Lopez & Matson 1997; Pronk et al. 1988; Pronk & 
Van't Triet 1991; Schroen et al. 1993; Vaidya et al. 1992; Vaidya et al. 1994a; Vaidya et al. 
1994b). 
On the other hand, the applications of UF membranes to MBB systems have only used 
chemically-mild solvents as the organic phase: ethyl laurate, soybean, sunflower and 
triglyceride oil; so the resistance of UF membrane materials to a wide range of organic 
solvents has not been addressed in the literature (Liese et al. 1996; Lopez & Matson 1997; 
Pronk et al. 1988; Pronk & Van't Triet 1991; Schroen et al. 1993; Vaidya et al. 1992; 
Vaidya et al. 1994a; Vaidya et al. 1994b). 
An alternative reactor design has been developed by a number of authors (Chang et al. 
1992; Liese et al. 1996; Shin et al. 2001) using two membrane stages: an ultrafiltration 
membrane was coupled to a bioreactor for retaining the biocatalyst, and a second 
microfiltration hollow fiber membrane module was used as a two-phase extractor for 
product recovery. No phase breakthrough occurred at the extraction stage because the 
enzymes were not allowed to adsorb into the membrane pores. 
A similar principle was applied in a couple of whole-cell membrane bioreactors for alcohol 
(Kang et al. 1990) and alcohol-acetone-butanol fermentations (Shukla et al. 1989). In these 
systems the biocatalysts were immobilised, which prevented cells and large biomolecules 
such as proteins —which are surface active— from diffusing and adsorbing into the 
micropores: the suspended biomass concentration was very low (0.15 g L"') compared with 
the entrapped biomass (2 g L"'). No breakthrough occurred in these bioreactors. On the 
other hand, Molinari et al. (1997) performed the suspended whole-cell biotransformation of 
isoamyl alcohol to isovaleraldehyde using a hollow-fiber membrane reactor. The membrane 
consisted of hydrophobic, microporous, polypropylene, Celgard fibres. After the authors 
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had stabilised the membrane interface without biomass present, they reported phase 
breakthrough occurring when the microorganisms were suspended in the bioreactor. 
In general, phase breakthrough can be addressed using the five following methods: 
1) Strict control of the transmembrane pressure above the breakthrough pressure (Delia 
et al. 1986; Netke & Pangarkar 1996; Schroen et al. 1994; Vaidya et al. 1994a). 
Nevertheless, when surfactants are contained in the membrane bioreactor the 
transmembrane pressure becomes extremely difficult to control (Hoq et al. 1984; 
Hoq et al. 1985; Vaidya et al. 1994b; Westgate et al. 1998). 
2) Modification of the membrane surface; e.g., Schroen et al. (1993) modified a 
hydrophobic polypropylene membrane with block copolymers of propylene oxide 
and ethylene oxide. Such block copolymers, which acted as steric hindrance for 
surfactant adsorption, enhanced the membrane stability by causing low or null APB 
reductions. However, a problem encountered in the copolymer-modified membrane 
was a reduction in the solute flux. 
3) Adjustment of membrane surface tension to prevent surfactant adsorption 
(Keurentjes et al. 1990). 
4) The use of alternative reactor configurations as to reduce the presence of surface 
active compounds in the membrane contactor (Chang et al. 1992; Kang et al. 1990; 
Liese et al. 1996; Shin et al. 2001; Shukla et al. 1989). 
5) Careful selection of the membrane considering hydrophobicity and pore radius 
(Vaidya et al. 1992). 
2.1.3.3. Non-porous membrane bioreactors 
Silicone rubber has been used as a non-porous membrane material for MBBs because of its 
high permeability and selectivity to small hydrophobic molecules, and more importantly 
because it prevents aqueous breakthrough (Doig et al. 1998a). In addition this material is 
inexpensive and readily available. A number of applications of non-porous MBBs have 
been reported in the literature (Boontawan & Stuckey 2006; Choi et al. 1992; Doig et al. 
1998a; Doig et al. 1999a; Groot et al. 1990; Kaur et al. 1997; Wehtje et al. 1997). 
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In the work which precedes this research, Doig et al. (1998a) designed a membrane 
bioreactor for the biotransformation of geraniol to citronellol by baker's yeast. The system 
consisted of two aqueous and organic phases contacted by a tubular silicone rubber 
membrane. The specific activity of the biotransformation in the membrane bioreactor was 
90-95% of that of a direct-contact two-phase bioreactor. Furthermore the MBB system 
offered a final product with a far better quality because it prevented the formation of 
irreversible emulsions which were inevitable in the DCB system. 
The high permeability of silicone rubber is due mainly to extensive swelling in the presence 
of organic solvents (Doig et al. 1999b). Doig et al. (1999b) reported a conspicuously high 
degree of silicone rubber swelling of up to 43% in the presence of hexadecane and 72% for 
phenylethanol. The swelling of silicon rubber has been widely studied and found to be an 
important parameter for mass transport across non-porous membranes. Doig et al. (1999b) 
and Paul and Ebra-Lima (1970) indicated the usefulness of such swelling: it enhanced 
solute and solvent permeation through the membranes. They concluded that membrane 
swelling increased both the partition coefficient of a solute in the membrane and the 
membrane diffusion coefficient; thus, it reduced the mass transfer resistance of the 
membrane. 
In contrast, the disadvantages of swelling for the practical implementation of membrane 
reactors have been barely reported. Membrane swelling is difficult to predict (Doig et al. 
1999b; Paul & Ebra-Lima 1970) and thus in a system based on silicone rubber, the 
membrane reactor design may become a major issue. In his PhD thesis, Boam (1996) 
described the technical difficulties of silicone rubber swelling for the actual implementation 
of a silicone rubber membrane bioreactor using organic solvents: sealing problems, design 
difficulties, and more seriously, membrane cracking and failure. Furthermore, because of 
these problems, the membrane material was switched to polypropylene even though this 
compromised the mass transfer rate of the reactor. 
Additionally, in a couple of US patents on organic-solvent-resistant nanofiltration (OSN) 
membranes, Linder et al. (1993a; 1993b) emphasized the importance of low swelling (less 
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than 10%) in the resistance of membranes to organic solvents: membrane swelling under 
pressure causes solvent/membrane interactions and thus polymer chain mobility, which in 
turn results in compaction and loss of flux. Also, in another US patent, White (1993) 
mentioned that swelling of the membrane's polymeric materials causes expansion of the 
membrane sheets, leading to formation of wrinkles and cracks, and ultimately to bursting 
and problems handling the membrane. Therefore, a low degree of membrane swelling is a 
paramount consideration in the design and performance of organic solvent resistant 
membranes. 
2,1.4. Organic solvent nanofiltration (OSN) membranes 
2.1.4.1. General structure of OSN membranes 
Most nanofiltration (NF) membranes have an asymmetric and/or thin-film composite 
structure. Non-homogeneous (asymmetric) membranes have a non-uniform density across 
their thickness. When the active and support layers are formed from a single material, the 
membranes are referred to as integrally skinned; whereas if the active layer is a coating 
added to the support layer, the membranes are referred to as composite (Zolandz & Fleming 
1992^ 
To date, membrane scientists have considered that the upper skin of asymmetric 
membranes (top layer) provides the membrane with permeate selectivity (i.e., achieves 
separation), and that this layer governs the molecular transport rate across the membrane 
(Zolandz & Fleming 1992). On the other hand, the microporous support layer has been 
considered as giving the membrane mechanical strength thus increasing its resistance to 
manufacturing process and pressure differences during operation (Bhattacharyya & 
Williams 1992a; Zolandz & Fleming 1992). Chapter 3 addresses the issue of mass transport 
rates through polyimide asymmetric OSN membranes. 
Polymers are the most common materials for the majority of the commercial membranes, 
such as polysulfone, cellulose acetate, polyimides, polyamides and various fluoropolymers; 
even though inorganic membranes have become commercially available recently (Zolandz 
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& Fleming 1992). Asymmetric membranes are typically made using the phase inversion 
method in which a homogeneous polymer solution is converted into a microporous polymer 
film through exchange of a solvent with a precipitating non-solvent (Kulkami et al. 1992). 
2.1.4.2. Nanofiltration membrane bioreactors 
A few applications of nanofiltration membranes have been reported for asymmetric 
biotransformations: Lin and co-workers performed the continuous asymmetric synthesis of 
L-glutamate (1997a), L-camitine (1999) and L-alanine (1997b) with NAD(H) regeneration 
by using an UTC-20 NF membrane in an immobilised enzymatic bioreactor. Nidetzky et al. 
(1996) developed a similar system but using free-suspended enzymes for the synthesis of 
manitol and gluconic acid with NAD(H) regeneration. Jeantet et al. (1996) reported the 
semicontinuous production of lactic acid from whey by using suspended whole cells in a 
CSTR-NF membrane bioreactor. However, these processes are based on aqueous pressure-
driven nanofiltration; no application of OSN membranes to a concentration-driven MBB 
has been reported in the literature. 
2.1.4.3. OSN membranes commercially available 
Organic solvent resistant nanofiltration (OSN) membranes have become commercially 
available just recently in the late 1990's (Livingston et al. 2003; Machado et al. 2000). In 
principle, these membranes are resistant to a wide range of organic solvents; i.e., they 
conserve their integrity and performance in the presence of organic solvents (Linder et al. 
1993a; Linder et al. 1993b). To be suitable for MBB operation, while possessing high 
chemical resistance, these membranes should permit acceptable solute's selectivity and flux 
(White 2002). This work explores the use of commercial nanofiltration membranes 
(Starmem™'') into an MBB system to provide a stable biphasic interface without 
significantly sacrificing mass transfer of solutes. 
' StarmemTM is a trademark of W.R. Grace and Co. These membranes are known to be stable in organic 
solvents such as alcohols, alkanes, aromatics some ethers and ketones (e.g. methyl -tert-butyl -eth er, m ethyl-
ethyl-ketone, methyl-iso-butyl-ketone), as well as in acetic acid, butyraldehyde and ethyl acetate. 
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STARMEM series (120, 122, 280 and 240), manufactured by W. R. Grace, are 
polyimide integral asymmetric membranes made of polyimides on a non-woven polyester 
backing material (Fig. 2.7). The membranes are supplied filled with lubricating oil as a 
conditioning agent to preserve the integrity of their porous structure when they are dried. 
Before using these membranes, the lubricating oil needs to be removed from the porous 
structure and the flux of solvents needs to be stabilised; this is called membrane 
preconditioning. Polyimide is a fully imidized polymer based on 5(6)-amino-l-(4'-
aminophenyl)-1,3-trimethylindane polymer and benzophenone tetracarboxylic dianhydride 
(White 1993; White 2001; White 2002). Their nature is mainly hydrophobic with nominal 
molecular weight cut-off (MW^CO) ranging from 200 to 400 g mol"'. Starmem™ 122 was 
selected on the basis of reactant and product molecular size. 
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Figure 2.7. Scanning electron micrographs of Starmem™ 122 polyimide integral membrane on non-woven 
backing at magnifications; (a) 500% and (b) 10,000x (top layer). (Courtesy of W.R. Grace, USA.) 
2.1.5. Model biotransformation I 
2.1.5.1. Baker's yeast as biotransformation catalyst 
Baker's yeast has been widely used as a biotransformation catalyst due to five main factors; 
(1) inexpensive; (2) readily available because it is produced in a large commercial scale — 
annual world output of 600,000 tons according to Kolbl et al. (1988) and 1 million tons 
according to Russel et al. (1987); (3) it performs a very wide range of biotransformations 
(Csuk & Glanzer 1991; Ward & Young 1990) such as, reduction, oxidation, hydrolysis, 
carboxylations, from which the oxidation-reduction reactions are the most widely exploited 
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and studied (Ward & Young 1990); (4) relatively easy to work with; it can be used as a 
resting-cell catalyst so the reaction mixture does not require supplementation of growth 
factors and complex nutrients (Csuk & Glanzer 1991; Davies et al. 1989; Faber 2004; 
Leuenberger 1984; Ward & Young 1990). (5) Baker's yeast has commonly been used as a 
resting-cell catalyst because its activity is not associated with growth (Bailey & Ollis 1987; 
Leuenberger 1984). 
Besides these factors, baker's yeast was selected as the Model Biotransformation I 
biocatalyst for three reasons: (1) baker's yeast can catalyse the asymmetric reduction of 
carbon-carbon double bonds, which is well documented and has been extensively used for 
biotransformations (Csuk & Glanzer 1991; Davies et al. 1989; Faber 2004; Ward & Young 
1990); (2) as baker's yeast whole cells can be readily used, there is no need for 
implementing an in-vitro cofactor regeneration system; (3) previous research in our group 
utilised baker's yeast to perform a model biotransformation (Doig et al. 1998a; Doig et al. 
1998b^ 
2.1.5.2. Reduction ofgeraniol to R-citronellol by baker's yeast 
Fischer and Wiedemann (1934) first reported 
the C=C reduction of geraniol, an aliphatic 
allylic alcohol, to citronellol by baker's 
yeast; later, Gramatica et al. (1982), using a 
highly dense suspension of baker's yeast 
resting cells (1x10^ cell mL"'), by using H-
NMR studies, showed that the biotrans-
formation yielded 25% of enantiomerically 
NADPH m ^ NADP" 
(or NADH) + H* Baker's (or NAD") 
yeast 
Geraniol 
HO 
(R)-Citronellol 
Figure 2.8. Model Biotransformation I. 
Baker's yeast catalysed biotransformation 
from geraniol to f7?^-(+)-citronellol. 
pure (i?)-(+)-citronellol (Fig. 2.8). Doig et al. (1999) implemented this biocatalytic reaction 
in an MBB using a non-porous silicon rubber membrane. 
Since the achiral geraniol is readily available, this biotransformation has a great synthetic 
potential: (i?)-(+) citronellol and its 6,7 dihydriderivative are key intermediates in the 
synthesis of important natural products such as a-tocopherol (vitamin E), 1-menthol, and 
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optically active y-methyl-s-caprolactone (Gramatica et al. 1982). Furthermore, compounds 
of the family (i?)-(+) citronellol are present in several biologically important natural 
products such as phytoquinones (vitamin Kl); insect pheromones of pine sawflies 
(Hogberg et al. 1992), of tsetse flies, and red flour beetles; and fasciculatin (a marine 
sponge sesquiterpenoid) (Gramatica et al. 1985b). In addition, Gramatica et al. (1985a; 
1987), from geraniol-reduction products, have prepared three other natural products: (1) 
phytol; (2) a component of the secretion of the male African Monarch butterfly; and (3) a 
pheromone of the azuki bean weevil. 
Young and Ward (1991) studied the biotransformation of citronellal to citronellol by 
baker's yeast with satisfactory conversion; even though, they did not report the ee. Oda et 
al. (1995) studied the enantioselective biotransformation of racemic citronellol by 
Hansenula saturnus IFO 0809. The reaction was carried out at the interface of a 
hydrophilic carrier and a hydrophobic organic solvent in a large-scale two-phase pad-
packed bioreactor. In this reactor S'-citronellic acid (70-85 % ee) was extracted in the 
hydrophilic phase and i?-citronellol (65-70 % ee) remained in the organic solvent layer. 
2.1.5.3. Enzymatic mechanism 
Although the metabolism, physiology and kinetics of baker's yeast have been widely 
studied, there is an important lack of knowledge about the specific enzymes that catalyse 
reduction biotransformations (Ward & Young 1990). In principle, the important enzymes 
for reduction reactions in whole bakers' yeast are those which possess broad substrate 
specificity (Ward & Young 1990). Since the enoyl reductase component of the fatty-acid 
synthetase (FAS) complex of baker's yeast has a broad specificity with respect to fatty acid 
chain length, chain length from 4-16 (Dixon & Webb 1979), this enzyme may play an 
important role in C=C reductions of unnatural substrates by baker's yeast. 
Surprisingly, some disagreement exists in the literature regarding the cofactor utilised by 
the enoyl reductase enzyme: Ward and Young (1990) reported that NAD(H) was used by 
enoyl reductase, whereas Clarke and Daffom (1998), in a more thorough review, reported 
that enoyl reductase uses NADP(H) as its source of reducing power. Considering that 
51 
Chapter 2. Model biotransformation I 
NADP(H) is used during synthetic cellular process, enoyl reductase probably uses this 
cofactor for performing reduction reactions. 
2.1.6. Development of an MBB system using OSN membranes 
An integrally skinned asymmetric membrane, Starmem'^ '^  122, was integrated into an MBB 
bioreactor. Either n-hexadecane or toluene was used as the organic solvent. The production 
of JZ-citronellol (Mw 156 g mol'^) from geraniol (Mw 154 g mol"^) by baker's yeast was 
selected as Model Biotransformation I (Fig. 2.8). In this system, the reduced form of the 
cofactor, NADP(H) or NAD(H), is used to provide the reaction reduction potential which is 
regenerated by the cells. 
The mass transfer rates of product and substrate through the OSN membrane were 
measured to gain insight into the transport phenomena. Then, the effectiveness of the 
MBB-OSN system was explored by comparing its performance with that of a DCB 
bioreactor in terms of volumetric productivity, enantiomeric excess (ee) and product 
quality. 
2.2. Materials and Methods 
2.2.1. Chemicals and membrane 
Citronellol (95%) and geraniol (99%) were purchased from Acros Organics (Belgium), n-
Hexadecane (99%), R and /S-citronellol (standards for ee analyses), glucose and fast dried 
baker's yeast type 2 {Saccharomyces cerevisiae) were purchased from Sigma-Aldrich 
(Germany). K2HPO4 (>98%) and dichloromethane (99%) were purchased from BDH-VWR 
(UK). Toluene, n-hexane and isopropanol (HPLC grade) were purchased from Fisher 
Scientific Ltd (UK). KOH (97%) was obtained from Rose Chemicals (UK). Starmemi""^ 
122 membranes (W.R. Grace & Co.), polyimide asymmetric membranes with a nominal 
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molecular weight cut off of 220 g L ' \ were kindly supplied by Membrane Extraction 
Technology Ltd. (UK). 
2.2.2. Analytical methods 
Two GC systems have been employed in the citronellol and geraniol concentration 
analyses: (a) a Unicam GC, equipped with a 19477-088 Supelco wax-10 column, 30 m x 
0.25 mm x 0.25 pim film thickness, and (b) an Agilent 6850 Series II Network Gas 
Chromatograph system (USA) with an Agilent HP-1 capillary column, 30 m x 0.32 mm 
nominal diameter x 0.25 [am film thickness, 100% dimethylpolysiloxane phase. No. 
19091Z-413E (AnaChem, UK). Both systems were equipped with a flame ionisation 
detector. The Agilent GC was used for the mass transfer tests, whereas the 
biotransformation samples were analysed with the Unicam GC, where citronellol and 
geraniol needed to be resolved. The coefficient of variation of five repeated measurements 
of citronellol in dichloromethane with the Agilent GC was 3.5%, and that for the Unicam 
GC measurements was 0.8% using five repeated measurements of citronellol in n-
hexadecane samples (2,000 mg L"^). External standards were prepared and injected for all 
the sample runs. 
For the quantification of citronellol and geraniol in the organic phase of the MSB (n-
hexadecane or toluene), 1 fxL of the organic phase was injected directly into the GC. In the 
case of the DCS biotransformations the emulsified samples (1.2 mL) were first centrifuged 
in an MSE Micro Centaur centrifuge (MSE, UK) at 13,000 x g for 5 min. For analyses of 
citronellol and geraniol in the aqueous phase, 8 mL of samples of this phase were vortexed 
(Heidolph Reax Top tube vortex. Model 541, Germany) for 30 s together with 2 mL of 
dichloromethane. Then 1 \iL of the organic phase was analysed by GC as described above. 
The ee of the bioreactor final products was determined by HPLC using a Daicel chiral 
column, Chiracel OJ-H (250 mm x 4.6 mm I.D.), purchased from Chiral Technologies 
Europe, France. A Unicam 200 HPLC pump (Unicam, UK) was fitted to an autosampler 
and to a 2550 Varian UV variable detector (Varian Instruments, Japan) set to a wavelength 
of 215 nm. The mobile phase, 97.5:2.5 n-hexane/isopropanol, was pumped at a 0.5 mL 
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min"^ flow rate at room temperature. Prior to HPLC analysis, samples in n-hexadecane were 
diluted 10 times with the mobile phase. Toluene samples (2 mL) were evaporated for 1 day 
in a water bath at 50 °C; then 5 mL of fresh mobile phase were added to solubilise the 
residue. Three samples were run for each of the ee determinations. The coefficients of 
variation were below 1% for the n-hexadecane samples, and 6.7% for the toluene analyses. 
2.2.3. Shake-flasks biotransformations 
The initial shake flask and bioreactor conditions used in this work were based on the 
optimised bioreactor conditions obtained by Doig et al. (1998b). These authors studied the 
effect of pH (from 2 to 12) and temperature (from 25 °C to 45 °C) and reported maximum 
specific activity for the model biotransformation at pH = 9.5 and T = 37 °C, respectively. 
The aqueous phase comprised 40 mM of K2HPO4 (pH 9), 20 g L"' glucose and 15 g L"' 
biomass (baker's yeast). In all the shake flask experiments, 200 mL of biomedium and 20 
mL of organic solvent were used. The shake flasks were incubated at 37 °C and 200 rpm 
shaking speed in a Gallenkamp orbital incubator. 
A series of four biphasic shake flasks was prepared to test the effect of toluene on the 
biocatalytic performance. The first test was used as a blank, in which no toluene was added 
to the n-hexadecane organic phase (0 wt%). In the second and third tests, toluene was 
dissolved in the n-hexadecane phase at concentrations of 20 and 140 g L"' (3 and 18 wt%), 
respectively. Finally, in the fourth test, the 20 mL n-hexadecane phase was replaced by a 20 
mL toluene phase (100 wt%). The geraniol concentration was 20 g L"' in n-hexadecane for 
the first three shake flasks and 40 g L'^  in toluene for the last test to compensate for the 
higher partition of geraniol into toluene compared to that into n-hexadecane. 
2.2.4. DCB bioreactor biotransformations 
A New Brunswick Bioflo I (New Brunswick Scientific Ltd, UK) 2 L continuously stirred 
bioreactor was fitted with a Toledo O2 probe, a thermocouple and a VWR glass pH probe. 
Air at a flow rate of 0.5 L min"' was bubbled into the bioreactor. The pH was controlled at 
9.5 by addition of 4 M KOH. No acid addition was required to control the pH. The reactor 
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was maintained at 37 °C using a heating jacket. Dissolved oxygen concentration, pH and 
temperature were read periodically. 
Initial volumes of 1,500 mL of aqueous phase and 150 mL of organic phase were used. The 
aqueous phase was prepared by dissolving 10.5 g (7 g L"') of K2HPO4, 30 g (20 g L"') of 
glucose and 22.5 g (15 g L"^ ) of baker's yeast into 1,500 mL of RO deionised water. Cells 
were not subject to conditioning prior to the biotransformation. Cappaert and Larroche 
(2004) reported no difference in biotransformation performance when using either dry or 
previously-grown baker's yeast. Finally, a 150 mL organic phase was added; this consisted 
of n-hexadecane or toluene with a geraniol concentration of 20 g L"' or 60 g L"', 
respectively. 
2.2.5. Recovery of organic solvent from DCB emulsions. 
DCB mixtures were prepared using both n-hexadecane and toluene as the organic phases. 
After stirring, the mixtures were left to settle for 1 h and then centrifuged at 8,500 x g for 
10 min in a Biofuge centrifuge (Heraeus Instruments, Germany). Finally, the organic phase 
was pipetted out from the centrifuge tubes and the organic volumes were measured before 
and after the recovery. 
2.2.6, Measurement of organic/aqueous partition coefficients 
Citronellol and geraniol were completely dissolved in a known volume of distilled water at 
initial concentrations slightly below their water solubility. A known volume of organic 
solvent was then added and the mixture was vortexed for 30 s. After a 24 h settling period 
at room temperature, the aqueous and organic phases were separated and solute 
concentrations were determined by GC as described above. All partition coefficients 
obtained in this work are the average of three independent measurements. The coefficients 
of variation for the geraniol and citronellol partition coefficients were calculated as 2% and 
10%, respectively, and the mass balance error for the experiments was 3.6% and 1.5%, 
respectively. 
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2.2.7. Mass transfer experiments and MBB 
The apparatus used in the mass 
transfer and MBB experiments is 
illustrated in Figure 2.9 (Han et al. 
2003). The membrane, with an 
effective area of 0.015 m^, was placed 
in the middle of two stainless-steel 
half-cells with the active layer facing 
the aqueous phase. The membrane 
gaskets and tubing connections were 
made of PTFE. The average 
volumetric flow rates were 94 and 14 
L h'' for the aqueous and organic sides 
respectively, except when otherwise 
stated. The membrane cell was adapted 
for mass transfer and MBB "reduced 
volume" experiments by modifying 
one of the half-cells: Its interior height 
was decreased from 5 to 2.5 mm, and 
its width and length were maintained. 
(D-
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Figure 2.9. Schematic of aqueous-organic membrane cell 
used for; (1) mass transfer experiments and (2) 
membrane bioreactor for biotransformations (MBB) 
using organic solvent nanofiltration (OSN) membranes. 
The OSN membrane was preconditioned by circulating toluene overnight across both sides 
of the membrane in order to remove the preservative oil from inside the membrane and to 
fill the porous side of the membrane with the organic solvent. Toluene was then purged 
from both sides of the membrane; the active side of the membrane was flushed with water 
until no drops of organic solvents were observed, whereas the other side was flushed with 
several volumes of fresh organic solvent (n-hexadecane or toluene) to wash out the toluene 
used for preconditioning. Higher pressure (0.4 bar) was applied on the active side of the 
membrane, facing the aqueous solution, whereas 0.05 bar was applied to the organic side of 
the membrane. 
56 
Chapter 2. Model biotransformation I 
For mass transfer experiments a solution of 200 mg L'' of citronellol or geraniol in distilled 
water was used as the feed aqueous solution, and n-hexadecane or toluene was the organic 
extracting phase. After circulation of the solutions through the membrane cell for 15 min, 
samples of the organic and aqueous reservoirs were taken at different time intervals and 
analysed by GC. Two to three runs were carried out for each test, and coefficients of 
variation of 4.4% and 10% were estimated for the measurements of the overall mass 
transfer coefficients (Kaq) of geraniol and citronellol, respectively, using n-hexadecane. 
Mass balances are also reported in Section 2.4.3. Additionally, a membrane cell with 
"reduced volume" was used for measuring the mass transfer at two different sets of flow 
rates: High (aqueous: 95 L h"\ organic 18 L h"') and Low (aqueous: 50 L h ' \ organic; 9 L 
h - ^ 
The same bioreactor conditions (aqueous phase composition, air, temperature and pH) and 
initial geraniol concentrations in the organic phase were employed for DCB and MBB 
experiments. In the MBB system, the aqueous phase containing 7 g L"^  of K2PO4 (pH 9), 20 
g L"' of glucose and 0.3 g L"' of geraniol, was circulated through the membrane cell 
followed by the organic flow on the other side of the membrane. The MBB was left running 
overnight for equilibration of the substrate concentration between phases. Then, baker's 
yeast was added to the bioreactor and air was admitted into the system. Finally, periodic 
sampling of the organic and aqueous vessels was carried out, as well as readings of the 
bioreactor conditions (O2, temperature and pH). All MBB experiments were run for at least 
five days (120 h). Two different organic solvents were employed: n-hexadecane and 
toluene. The MBB experiments used an aqueous:organic volume ratio of 2,000 mL:200 
mL, with the exception of the reduced-volume n-hexadecane MBB (600 mL:60 mL). 
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2.3. Mathematical Analysis 
2.3.1. Mass transfer resistances in an OSN membrane biphasic system 
Figure 2.10 shows a schematic of 
the transport model for a solute 
transferred from the aqueous to the 
organic phase through an 
asymmetric OSN membrane, 
constructed based on SEM pictures 
and comments by See-Toh et al. 
(2007). 
To date, the specific mass transfer 
mechanism inside the membrane is 
not known —later in this thesis, 
Chapter 3 addresses this in a 
fundamental study. For mass 
transfer analysis of the OSN 
Undefined transport of solute 
through the membrane phase. 
Parallel diffusion of solute 
through polymer layers and 
embedded organic solvent. 
Solute transport 
ra*-® 
^aq, bulk 
^ ( e ^ e ^ t e ^ y e r of po lyme ^org, bulk 
interconnected 
-backing I 
material' 
Aqueous 
liquid film 
OSN 
membrane 
Organic 
liquid film 
Figure 2,10. Schematic of mass transport model of solutes 
membrane biphasic system in this through flat-sheet, hydrophobic, asymmetric, polyimide, 
, ^ 1 OSN membranes separating an organic and an aqueous 
chapter, the OSN membrane was phase (based on SEM pictures and comments by See-Toh 
considered as non-porous, and a 
solution diffusion model was used. Therefore, the possible existence of a direct liquid-
liquid interface at the porous mouth of the non-wetting membrane side is not taken into 
account. Instead, this chapter regards the membrane as an additional distinct phase (similar 
to a non-porous dense membrane) comprising both the membrane material and the 
absorbed wetting liquid. Polyimide membranes are hydrophobic so the organic solvent was 
the wetting liquid. 
Using the overall mass transfer coefficient definition based on the aqueous phase ( K a q ) , 
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-V dC ( 
N = —^—"-^ = K 
A dt aq 
c f "'•g 
aq 
V 
m 
(Eq. 2.5) 
orglaq y 
where N is the solute mass flux per membrane area through the membrane, A is the 
membrane surface area, and ntorg/aq is the organic/aqueous partition coefficient at 
equilibrium: 
m. 
org / aq 
r * 
_ org 
c* 
(Eq. 2.6) 
aq 
the following resistances-in-series mass transfer model can be obtained for the mass 
transfer of solute from the aqueous bulk to the organic phase bulk through the membrane: 
m. 
+ -
' 1 ' 
m/og \ m / 
(Eq. 2.7) 
• orglaq \ org / 
where kaq, km and korg are the local mass transfer coefficients for the aqueous phase, the 
membrane and the organic phase, respectively; rum/aq is the membrane/aqueous solute 
partition coefficient at equilibrium. 
m, 
C (Eq. 2.8) 
The following mechanism describes the transport of a solute from the bulk aqueous phase 
to the bulk organic phase (Fig. 2.10): 
1. Transfer from the aqueous solution bulk to the aqueous/membrane interface through 
the aqueous liquid film, 
2. Partition into the membrane. 
3. Diffusion across the membrane. 
4. Partition from the membrane into the organic liquid. 
59 
Chapter 2. Model biotransformation I 
5. Transfer from the membrane/organic-liquid interface to the bulk of the organic 
liquid through the organic-liquid film. 
2.3.2. Calculation of the overall mass transfer coefficient 
To compute the overall mass transfer coefficient a solute mass balance is performed 
considering transfer of solute from the aqueous to the organic phase: 
F, (Eq.2.9) 
o 100 
Aqueous 
Organic 
T i m e (s) 
Figure 2.11. Example of the citronellol 
concentration profiles in the aqueous and organic 
reservoirs (toluene) for the determination of the 
overall mass transfer coefficient through a 
Starmem™ 122 membrane. 
lU 12 
£1 
10 15 20 
T i m e (s ) 
Figure 2.12. Example of a plot of the right hand 
side of Eq. 2.10 against time for the calculation 
of the overall mass transfer coefficient based on 
the aqueous concentrations (Kaq) for citronellol 
from an aqueous phase to toluene through a 
Starmem™ 122 membrane. 
Figure 2.11 shows experimental data on the changes of organic and aqueous concentrations 
for the mass transfer of a hydrophobic solute, citronellol in this case, from the aqueous to 
the organic side. The calculations of the overall mass transfer coefficients in this chapter 
are based on the aqueous concentrations (Kaq) as defined in Eq. 2.5. Substituting Eq. 2.9 in 
Eq. 2.5 and integrating. 
V 
t = -
aq y 1 + OC 
-In 
C 09,0 
(l + «)C„^ 0 J 
(Eq. 2.10) 
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where a = aq 
^orglaq^org 
For estimating Kaq, the right hand side of Eq. 2.10 is plotted against time. This plot yields a 
linear curve with the slope (KaqA/Vaq) containing Kaq. An example based on the 
experimental data from Fig. 2.11 is shown in Fig. 2.12. 
2.3.3. Estimation of individual mass transfer coefficients 
For estimating the individual liquid-film coefficients, kaq and korg, the Leveque exact 
solution (Leveque 1928) of the Navier-Stokes and convective mass transfer equations for 
circular pipes (Eq. 2.11) gives a coefficient a=1.62 (Eq. 2.11a). Three different 
correlations were used in this work: (1) Leveque solution for rectangular ducts, Eq. 2.11b 
(Pickett 1979); (2) An empirical correlation obtained from mass transfer data on rectangular 
ducts (Eq. 2.11c) (Pickett 1979); 
Sh = a 
where 
Re Sc 
, L 
a - 1.62 
a = 1.85 
a =2.33 
(Eq. 2.11) 
(Eq. 2.11a) 
(Eq. 2.11b) 
(Eq. 2.11c) 
(3) An additional exact correlation for fully developed flow (Qi & Savinell 1990), 
Sh = Re/3 Sc /s 
r J \0.43 
kLJ 
(Eq. 2.12) 
where Sh = k,.^ , Re = p v d j t ] , Sc = r]/pD AB 
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The diffusivities, Dab, for the solutes (A) in the different solvents (B) were estimated using 
the Wilke-Chang correlation (Wilke & Chang 1955): 
(E,.2.13) 
Vb "A 
An association factor, (|)B, of 2.26 was used for water and 1 for the organic solvents (Perry 
& Green 1997). 
2.3.4, Biotransformation performance parameters 
For characterising the performance of the biotransformations, the following indicators were 
used in this chapter: 
Product yield, Y = ~ 
So 
s — s 
Substrate consumption, SC = —^— 
p 
Volumetric productivity, VP = 
p 
Specific activity, SA = 
Enantiomeric excess (ee), (R) ee (%) = 
[Biomass] x t 
xlOO; 
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2.4. Results and Discussion 
2.4.1. Preliminary biotransformation tests 
Initially the biotransformation of geraniol to citronellol by baker's yeast was tested in DCB 
shake-flasks. n-Hexadecane has been used here and in previous works due to its low 
toxicity to the biocatalyst (Cappaert & Larroche 2004; Doig et al. 1998b; Schmid et al. 
1998b). The log P of a solvent provides a general indication of the toxicity of the solvent to 
bipcatalysts. In general, solvents with log P > 4, i.e., very hydrophobic, do not affect 
biocatalyst activity since they do not distort the essential water shell of the cells (Laane et 
al. 1987). n-Hexadecane possesses a very pronounced hydrophobic nature, given by its log 
P of 8.8 (Table 2.1), which makes it compatible with most biocatalysts. However, it is not a 
suitable solvent for industrial applications because its high viscosity and boiling point make 
difficult to handle it and to recover the reaction final products. 
Table 2.1. Organic/aqueous partition coefficients, Worg/aq. for the model substrate and product in different 
organic solvents and solvent log P. 
^org/aq Log P 
Geraniol Citronellol 
n-Hexadecane® 43 105 8.8 
n-Heptane 38 114 4.4 
n-Hexane 38 119 3.5 
Toluene 318 383 2.4 
'Doigetal . (1998a) 
Toluene is a more widely used solvent in the chemical industry. The Worg/aq in toluene for 
the model substrate and product are about 7 and 4 times greater, respectively, than those in 
n-hexadecane as shown in Table 2.1. Alternative alkanes, such as n-hexane and n-heptane, 
have similar partition coefficients to n-hexadecane (Table 2.1). Therefore, in addition to n-
hexadecane the application of toluene was suggested as an alternative organic solvent for 
the MBB system. However, the log P of toluene (2.4) indicates that this solvent may be 
toxic to the biocatalyst. To evaluate this, a series of DCB shake-flask tests were carried out 
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for one day, in which the effect of toluene was assessed using different organic-aqueous 
preparations. 
When only n-hexadecane was used as the organic phase (Test 1, Fig. 2.13), the citronellol 
yield and volumetric productivity were slightly lower, with 95% confidence interval (CI), 
than when 40 g L"^  of toluene was added to an n-hexadecane organic phase (Test 2). On the 
other hand, in Test 3, with 140 g L"' of toluene in the n-hexadecane phase, the citronellol 
yield was significantly lower (with 95% CI) than Test 1 and 2. However, the results of Test 
3 are inconclusive since the 95% confidence interval for the volumetric productivity 
overlapped with that of Test 1 (Fig. 2.13). Finally, major inhibition of the biocatalyst 
activity occurred when a toluene organic phase was used (Test 4). The solvent may have 
solubilised and destroyed the cellular membrane thus stopping the biotransformation. 
Chakraborty et al. (2005) reported that toluene at concentrations of 0.5, 1.0 and 2.0 vol% 
completely inactivated baker's yeast cells. Therefore, it is concluded that toluene cannot be 
used as the organic phase in a DCB system. Despite this, a DCB bioreactor using toluene is 
used in later work as a control test. 
• • Citronellol yield 
C 3 Volumetric productivity 
0.04 
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.£ 0.02 
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Figure 2.13. Effect of toluene on the baker's yeast biocatalytic activity (24 h) for the production of citronellol 
from geraniol in DCB shake flasks using different toluene concentrations in hexadecane: Test 1 (Tl): n-
hexadecane only (0 wt%); Test 2 (T2): 20 g L"' of toluene in n-hexadecane (3 wt%); Test 3 (T3): 140 g L"' of 
toluene in n-hexadecane (18 wt%); Test 4 (T4): toluene only (100 wt%). Error bars represent the 95% 
confidence interval for two independent experimental runs. 
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2.4.2. DCB bioreactor 
A batch DCB bioreactor was employed for carrying out the model biotransformation. The 
reaction was performed with baker's yeast cells working in a resting mode; i.e., non-
growing. n-Hexadecane and toluene were used as the organic phases, the latter as a control. 
A strong emulsion was formed in these reactors (Fig. 2.14) and the organic phase was 
difficult to recover even after centrifugation as will be discussed below. 
Figure 2.14. a) Picture of the DCB bioreactor for the biotransformation of geraniol to citroneilol by baker's 
yeast using toluene as the organic phase; b) two-phase emulsion after four days left in repose in a separation 
funnel. 
As expected from the observations in the shake-flask tests, the DCB toluene reactor 
completely inhibited the biotransformation and no citroneilol production was detected. It 
appears that the direct contact with the toluene phase destroyed the baker's yeast cells since 
the biomass aggregated at the surface of the reactor mixture. 
When n-hexadecane was used as the organic phase, low production of citroneilol and 
oxygen consumption was observed for the first 48 h. After this productivity lag-phase 
—which refers to a catalytically inactive period rather than to a cell growth phase— the 
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biotransformation progressed at a specific reaction rate comparable to the literature (Doig et 
al. 1998a), approximately 250 nmol min"^ g'^  biomass (Fig. 2.15a). The two repeats of this 
experiment showed similar lag-phase periods for citronellol production and geraniol 
consumption (Fig. 2.15b). The average maximum yield for the first two runs was calculated 
as 0.3 mol equiv. A similar yield was reported by Gramatica et al. (1982) using a dense 
suspension of baker's yeast resting cells (1*10^ cell mL"^) in a single phase aqueous 
biotransformation. Geraniol was almost depleted after the maximum productivity period. 
Then, the production of citronellol stopped and its concentration slowly decreased (Fig. 
2.15a and 2.15b) probably due to further reaction of the product mediated by the 
biocatalyst, or by the components of the biomedium. 
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Figure 2.15. Results for the biotransformation of geraniol to citronellol by baker's yeast using a DCB 
bioreactor and n-hexadecane as the organic solvent with 20 g L"' initial geraniol concentration. Two 
independent batches were performed, a) citronellol and geraniol concentrations in the organic phase as a 
function of time where are the citronellol and " o " the geraniol concentrations; and are the 
respective concentrations for the second run. b) citronellol yield ("A"), and geraniol consumption ("A") as a 
function of time; "T" and "V" are the respective values for the second run. 
Husken et al. (2003) observed a productivity lag period in the two-phase biotransformation 
of 3-methylcatechol from toluene using 1-octanol as the organic phase; however they 
observed no lag-phase in a single-phase aqueous reactor (Husken et al. 2002). Schwartz and 
McCoy (1977) also reported a productivity delay in the epoxidation of 1,7-octadiene by 
growing Pseudomonas oleovorans with cyclohexane as the organic phase. Despite this long 
delay, they reported that all the biotransformations were eventually completed. In 
conclusion, the productivity lag-phase in DCB reactors is probably an adaptation period of 
the biocatalyst metabolism to the new aqueous-organic medium (Grivel & Larroche 2001; 
Husken et al. 2003; Schwartz & Mccoy 1977). 
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2.4.3. Mass transfer tests 
The first step to assess the feasibility of employing OSN membranes in the MBB was to 
characterise the transport of the model substrate and product in an OSN membrane biphasic 
system using n-hexadecane or toluene as the organic phase. Table 2.1 includes the 
organic/aqueous partition coefficients (/Worg/aq) of citronellol and geraniol for these solvents. 
The results for the Kaq measurements of the different solute-solvent systems are listed in 
Table 2.2. 
Table 2.2. Overall mass transfer coefficients based on the aqueous concentrations (Kaq) for citronellol and 
geraniol transfer between organic and aqueous phases through a Starmem^" 122 membrane^. 
Solute Solvent Kaq (x lO 'm s"') Mass balance (%) 
Citronellol 
Geraniol 
Toluene 26.7 (28.7,24.7) 93 (94,91) 
n-Hexadecane 15.9 (15.8, 16.6, 15.2) 87 (79, 86, 96) 
Toluene 45.9(40.2,51.5) 99 (100,99) 
n-Hexadecane 6.9 (6.4, 8.4, 5.8) 77 (63, 96, 71) 
^Averages in bold and individual experimental values in brackets. 
Although in general the Kaq obtained in the OSN system were lower than those reported by 
Doig et al. (1998a) for a non-porous silicone membrane, they still fall in the range reported 
in the literature for large scale applications (0.1-5.0 x 10"^  m s"^ ) (Ferreira et al. 2005; 
Giorno et al. 2006; Pierre et al. 2001; Prasad & Sirkar 1990). 
As is shown below, Eq. 2.11b and Eq. 2.12 underestimated the liquid mass transfer 
coefficients. This inconsistency of the Leveque correlation has been reported previously 
(Livingston et al. 1998; Pickett 1979; Strachan & Livingston 1997). In contrast, Eq. 2.11c 
resulted in values consistent with the resistances-in-series model for the mass transfer data; 
thus, it was further used to calculate the mass transfer resistances (Table 2.3). 
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Table 2.3. Estimated contribution of the individual resistances to the overall mass transfer resistance (%) for 
the transport of geraniol and citronellol from organic solvent to aqueous phase in a flat-sheet membrane cell 
Parameter n-Hexadecane Toluene 
Geraniol Citronellol Geraniol Citronellol 
R C o r g 2&8 26.8 171.5 171.5 
k a q (x 10® m s"') 5.3 5.2 5.3 5.2 
korg ( X 1 0 ® m s " ' ) 2.2 2.1 5.2 5.1 
% Organic liquid film 0.7 0.7 0.3 0.1 
% Aqueous liquid film 13.1 30.7 87.0 51.6 
% Membrane 8&2 68.6 12.7 48.3 
" Two organic solvents were used: n-hexadecane and toluene. Liquid mass transfer coefficients were 
calculated using Eq. 2.11c, Rca, = 809. 
Using the resistances in series model (Eq. 2.7) and Eq. 2.11c, the mass transfer resistances 
for the organic liquid, (niorg/aq korg)'\ the aqueous liquid, kaq'\ as well as for the membrane, 
(mm/aq km)'\ Were calculated and reported as the percentage of the overall mass transfer 
resistance, (Kaq)'\ 
The Kaq of both solutes were significantly higher in toluene than in n-hexadecane. The 
contribution percentages of the organic film resistances for both solvents were below 1%, 
so this resistance was neglected (Table 2.3). From the estimations in Table 2.3 it is 
concluded that the lower Kaq for n-hexadecane than for toluene were due to a significantly 
higher membrane resistance in the n-hexadecane systems. Considering that the membrane 
is comprised of the membrane material and the embedded organic solvent, two main factors 
caused this effect; (i) the lower morg/aq of the solutes in n-hexadecane; and (ii) the higher 
viscosity of n-hexadecane (3.0 mPa s (Fletcher et al. 1996)) compared to toluene (0.6 mPa s 
(Fletcher et al. 1996)) yielding lower diffusion coefficients for the former. 
Additionally, in the toluene experiments the Kaq of geraniol were higher than those of 
citronellol, opposite to the n-hexadecane runs. In the case of n-hexadecane, the system with 
geraniol suffered a higher membrane resistance contribution than the citronellol system 
(Table 2.3). Considering that the membrane is comprised of both membrane material and 
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absorbed solvent, the partition morg/aq played the major effect on Kaq; i.e, the solute with 
greatest morg/aq in n-hexadecane (citronellol) resulted in the highest Kaq. 
On the other hand, in the case of the toluene systems, citronellol had the lowest Kaq (Table 
2.2) even though its morg/aq in toluene is higher than that of geraniol. However, the 
membrane resistance of the geraniol system was much lower than that for citronelloi. This 
indicates that in the toluene systems the morg/aq was not the only factor affecting Kaq; and 
other variables such as the diffusivities (in the membrane) and membrane/aqueous partition 
coefficients, Wm/aq, for the two solutes may be important. 
An additional experiment was 
performed to assess the adequacy of 
the correlations tested. Two flow rate 
levels were used; High (aqueous; 95 L 
h ' \ organic 18 L h" )^ and Low 
(aqueous: 50 L h"\ organic: 9 L h"^); 
toluene was used as the organic 
solvent. Eq. 2.11b and Eq. 2.12 
resulted inconsistent with the 
resistances-in-series equation (Table 
2.4). According to these correlations 
the total resistance was affected mostly 
by the aqueous liquid film for both 
flow-rate levels. However, after 
doubling the Re number for both 
liquids (Table 2.4), the Kaq did not 
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Figure 2.16. Overall mass transfer coefficient based on 
the aqueous-phase concentrations (Kaq) of geraniol from 
the toluene organic phase (60 g L"') to an aqueous phase 
through a Starmem™ 122 membrane. An 
aqueous/organic volume ratio of 10:1 was used (1 L;0.1 
L): Two different flow rate levels were used: High 
(aqueous: 95 L h"', organic 18 L h"') and Low (aqueous: 
50 L h'% organic: 9 L h"'). Error bars represent the 95% 
confidence interval for two independent runs. 
change significantly (with 95% confidence interval) for the High and Low flow rate levels 
tested (Fig. 2.16). So it can be concluded that these equations could not account adequately 
for the contribution of the membrane to the mass transfer resistance. It is noteworthy that 
when the Re numbers of both liquids were doubled (thus reducing the aqueous resistance) 
the contribution of the membrane resistance increased significantly from 3 to 15% (Table 
2.4, Eq. 2.11c). 
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Table 2.4. Effect of the flow rate regime on the mass transfer resistances for geraniol from toluene to aqueous 
in the "reduced volume" mass-transfer membrane cell. 
% Mass transfer resistance Flow rate regime® 
Low (Rcaq = 426, Reorg =115) High (Reaq = 809, Reorg = 229) 
Eq. 2.11b Eq. 2.11c Eq. 2.12 Eq. 2.11b Eq. 2.11c Eq. 2.12 
% Aqueous liquid film ID 96.7 ID ID 84.6 89.0 
% Organic liquid film 0.2 0.2 0.3 0.2 0.2 0.2 
% Membrane ID 3.1 ID ID 15.2 10.8 
^ ID = indefinite value. 
2.4,4. Membrane bioreactor for biotransformations (MBB) 
An MBB was developed to overcome the main problem associated with DCB bioreactors: 
formation of two-phase emulsions. Additionally, an ideal MBB needs to provide acceptable 
mass transfer rates of substrate and product for the biotransformation to take place at 
volumetric productivities comparable to the DCB reactors. 
Two runs were carried out with n-hexadecane as the organic phase and 20 g L"' initial 
geraniol concentration using different aqueous-organic volume ratios. The first MBB 
configuration (MBB-HDl) used a 2,000 mL:200 mL aqueous:organic volume ratio. A 
maximum product concentration (1.6 g L"') in the organic phase was obtained at about 75 h 
(Fig. 2.17.A1). In a second MBB hexadecane experiment, MBB-HD2, an aqueous:organic 
volume ratio of 600 mL:60 mL was used to reduce the reactor volume; thus improving 
solute mass transfer through the membrane by providing more membrane area per reactor 
volume. 
The citronellol concentration increased continuously from the start of the experiment until 
it reached a maximum concentration of 1.9 g L"' at about 68 h, when the reaction stopped 
(Fig. 2.17.A1). Additionally, whereas the citronellol yield followed a similar pattern to that 
of the MBB-HDl experiment, the geraniol consumption was much lower (Fig. 2.17.A2). 
Despite the fact that only one run could be performed for each of the volume ratios tested, 
MBB-HD2 seems to have the greatest maximum product concentration, considering the 
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larger coefficient of variation for these concentrations (12%) in comparison with the DCB 
repeat runs in Section 2.4.2 (8%). Moreover, a comparison of the volumetric productivities 
in the MBB-HDl and MBB-HD2 runs in Table 2.5 more markedly indicates the difference 
in performance between the two runs. 
n-Hexadecane Toluene 
1 
u i 
40 O 
20 e 
100 120 
Time (h) Time (h) 
o 0.8 0.8 o - 0.8 
P 0.2 
80 100 120 80 100 120 
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Figure 2.17. Results for the biotransformation of geraniol to citroneliol by baker's yeast using an MBB 
system with a Starmem™ 122 OSN membrane. Two different solvents were used as the organic phase; A) 
(left) n-hexadecane with 20 g L"' initial geraniol concentration and B) (right) toluene with 60 g L"' initial 
geraniol concentration. Upper plots (A1 and Bl ) : citronellol and geraniol concentrations in the organic phase 
as a function of time where are the citronellol and " o " the geraniol concentrations; and are the 
respective concentrations for the reduced-volume run (MBB-HD2) in A l . Plots below (A2 and B2): 
citronellol yield ("A"), and geraniol consumption ("A") as a function of time; and "T" and "V" were used 
for the respective values of the MBB-HD2 run in A2. 
Finally an MBB experiment was conducted using toluene as the organic phase (MBB-Tol) 
and 60 g L"^  geraniol initial concentration. This concentration was three times higher than 
that used in the n-hexadecane system to provide a sufficient driving force for substrate 
transport to the aqueous phase. The MBB-Tol occurred at two different reaction rates, with 
an initial slow productivity period followed by an increase in the reaction rate at 48 h. 
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Then, the reaction progressed steadily (Fig. 2.17.B1) until it reached a maximum citronellol 
concentration of 4.25 g L"^  at 170 h (data not shown). This concentration was higher than 
that obtained in the MBB-HD runs, and it is comparable to the concentrations obtained in 
the DCB hexadecane experiments. The yield in this experiment (Fig. 2.17.B2) was rather 
low due to the high initial substrate concentration, but the ratio of the product-yield to 
substrate-consumption was 0.24, a value comparable to the MBB-HD 1 run (0.23). 
2.4.5. Overall analyses of the bioreactor performance 
The highest maximum volumetric productivity was achieved in the hexadecane DCB 
system which was 2 to 3 times higher than those obtained in the MBB reactors (Table 2.5). 
The only report in the literature for the ee of the model reaction (Gramatica et al. 1982), 
determined the production of pure i?-citronellol (100% ee), analysed by NMR (chiral 
lanthanide shift reagent) and GLC-MS. Nevertheless, the maximum J?-citronellol ee 
measured in this work was only 85.5% (Table 2.5). 
Table 2.5. Overall performance of different bioreactors and solvents tested for the biotransformation of 
geraniol to /(-citronellol by baker's yeast in terms of % ee (i?-citronellol) and volumetric productivities. 
Organic solvent Reactor system Maximum volumetric productivity i?-Citronellol % 
(mgL"'h"') ee 
Toluene DCB ~ 0 — 
MBB-Tol 2.8 32.7 
n-Hexadecane DCB 6.4 (5.5,7.4) 85.5 
MBB-HD 1 2.1 82.1 
MBB-HD2 (reduced volume) 3.1 68.5 
Cappaert and Larroche (2004) observed a decrease in the product ee during the reduction of 
2-heptanol by baker's yeast in an n-hexadecane DCB reactor. The product ee dropped from 
99%, during the first 15 h, to about 80% ee at the end of the process (60 h). They attributed 
the ee decrease to the activation of further biocatalyst dehydrogenases with opposite 
enantioselectivity as the reaction progressed. Considering that the ee was only measured at 
the end of the run, a similar decrease in the ee possibly occurred in the OSN-MBB. 
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In the first MBB experiment with n-hexadecane, MBB-HD-1, with a 2,000 mL:200 mL 
aqueous/organic volume ratio, the maximum volumetric productivity was about 3 times 
lower than that for the DCB reactor (Table 2.5). The final ee of the MBB-HD-1 product 
was close to that obtained in the DCB experiments, so the enantiomeric specificity of the 
reaction was not affected by the direct contact of n-hexadecane with the cells. 
Considering that no citronellol production was obtained when toluene was used as the 
organic phase in the DCB bioreactor, it was remarkable to observe a higher volumetric 
productivity for the MBB using toluene (MBB-Tol) than that of the corresponding MBB-
HDl run (Table 2.5). This was due mainly to the membrane preventing the solvent coming 
into direct contact with the biocatalyst, thus avoiding biocatalyst inactivation. In addition, 
in this case the contribution of the membrane to (Kaq)"' was lower than that of the n-
hexadecane systems (Table 2.3). 
Unfortunately, the product ee in the MBB-Tol run was considerably lower compared to that 
obtained in either of the n-hexadecane systems (Table 2.5). The reason for this might be 
that toluene diffused to the aqueous side (40 mg L"' average aqueous concentration) thus 
altering the cell enzymes and reducing the biocatalyst enantioselectivity. In addition, the 
toluene concentration constantly present in the aqueous phase may have caused the 
productivity lag-phase observed in this run. This lag-phase was, however, less pronounced 
than those observed in the hexadecane DCB systems. On the other hand, in contrast to the 
DCB reactor, the hexadecane MBBs did not present a lag-phase period. This positive result 
for the MBB system may be caused by the separation of the aqueous and organic phases 
during the reaction. 
The MBB-HDl experiment was mass-transfer limited since its volumetric productivity was 
much lower than that of the DCB runs, with the membrane making a major contribution to 
the overall mass transfer resistance as discussed above. Thus one of the membrane cells 
was modified in order to increase the membrane area per aqueous working volume from 
0.75 to 2.5 m^ m"^  by reducing the aqueousiorganic volume ratio to 600 mL:60 mL. The 
aim was to drive the MBB reactor towards being a kinetically limited system. With this 
redesign, the maximum volumetric productivity of the new system, MBB-HD2, increased 
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from 2.1 to 3.1 mg L'^  h"\ Although 
this result was still two times lower 
than the DCB volumetric productivity, 
it was higher than the value obtained in 
the MBB-Tol experiment. The 
reduced-volume system also seemed to 
be mass-transfer limited since the 
aqueous geraniol concentration 
dropped sharply after 20 h of reaction 
and it did not rise again (Fig. 2.18). 
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Figure 2.18. Aqueous phase concentrations of organic 
solutes (citronellol, geraniol and toluene) in the organic 
phase during the reduced-volume n-hexadecane 
Geraniol consumption continued to experiment, MBB-HD2 (600 mL:60 mL aqueous:organic 
^ , . . . volume ratio). 
mcrease after 60 h of reaction m the 
MBB-HD2 run (Fig. 2.17.A2). So the reason for the low level of geraniol in the aqueous 
phase (Fig. 2.18) —even after citronellol production stopped at about 60 h— may be that 
the baker's yeast continued consuming geraniol for metabolic reactions other than those 
leading to citronellol production. Two alternatives for geraniol utilisation by baker's yeast 
have been reported: (1) biotransformation of geraniol to linalool and a-terpineol (King & 
Dickinson 2000); 2) utilisation of geraniol for the biosynthesis of sterols (Vaudano et al. 
2004). 
The ee for the MBB-HD2 reactor was lower than that for the first MBB-HDl run (Table 
2.5). This was probably due to the presence of toluene in the organic phase remaining from 
the membrane preconditioning stage. After washing the preconditioning solvent (toluene) 
with n-hexadecane, prior to the MBB-HD2 run, some toluene remained in the system, and a 
small aqueous concentration of toluene (12 mg L"', average), was detected during all the 
run (Fig. 2.18). Since the biocatalyst enantioselectivity is very sensitive to the presence of 
toluene, as discussed above, the low aqueous toluene concentration may have reduced the 
enantioselectivity of the biotransformation. 
It appears that for the reactors using n-hexadecane, there is a short active biocatalyst 
lifetime (between 70-80 h) in which baker's yeast is able to produce citronellol; if the 
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substrate is not supplied during this time, the yeast begins to catalyse other reactions. 
However, the MBB-Tol showed a very long biocatalyst active period (about 140 h) 
compared to the n-hexadecane reactors. Apparently, this result can only be attributed to the 
organic-phase effect on the biocatalyst. Since the niorg/aq of citronellol and geraniol in 
toluene are about 4 and 7 times those in n-hexadecane, respectively, the solute aqueous 
concentrations remained higher in the latter solvent. For example, in the n-hexadecane and 
toluene systems the maximum geraniol aqueous concentrations were 300 and 170 mg L ' \ 
and the average citronellol aqueous concentrations 100 and 20 mg L'% respectively. In this 
respect. Bard et al (1988) reported that geraniol inhibits baker's yeast viability by altering 
the cellular membrane. So, it seems that the higher amount of substrate and product in the 
aqueous phase for the n-hexadecane bioreactors reduced the stability and active lifetime of 
the biocatalyst. 
2.4.6. Solvent recovery from DCB 
mixtures 
Although the hexadecane DCB 
experiments yielded the highest 
volumetric productivities, the main 
problem in this type of reactor is the 
formation of a stable emulsion of 
the organic and aqueous phases. The 
emulsified mixture represents an 
important practical issue for the 
downstream separation and product 
recovery; moreover in the case of n-
hexadecane which possesses a very 
high boiling point (287 °C). A 
standard procedure which may be 
used for the separation of the two 
phases is centrifugation. Here such a 
Figure 2.19. Comparison of the final products obtained 
from DCB and MBB systems: A. DCB-toluene, B. MBB-
toluene, C. DCB-hexadecane, D. MBB-hexadecane. 
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separation was carried out at 8,500 x g i n order to quantify the recovery of the organic 
phase and to assess the practicability of the process. 
Figure 2.19 shows a comparison of the DCB mixtures (after 1 h settling) and the MBB final 
product samples. Evidently the quality of the MBB products was much higher than that of 
the DCB mixtures in terms of product cleanness, and the additional separation processing 
needed for the latter. Even after the DCB mixtures were centrifuged, the aqueous and 
organic phases could not be completely separated: a white emulsified interface remained. 
The recovery of the organic phase was quantified as 45.5 and 57.7 vol% for the toluene and 
n-hexadecane solvents, respectively. The final solvent recovery was not only difficult to 
obtain but also very low. 
2,4,7. Comparison to other membrane bioreactors 
Using a silicone rubber MBB for the same model biotransformation described here, Doig et 
al. (1998a) obtained a volumetric productivity similar to that of a DCB bioreactor. The 
mass transfer rates obtained in their reactor were about 10 times higher than those measured 
in the hexadecane OSN-MBB. Paradoxically, whereas the high mass transfer rate in their 
system was due to the high swelling of silicone rubber in contact with organic solvents, the 
main disadvantage of using this material is that its high swelling causes membrane cracks 
and tears, which eventually can lead to phase breakthrough and emulsion formation. 
On the other hand, aqueous breakthrough, the main drawback of microporous MBB 
reactors, was not observed in the OSN-MBB system. In microporous MBBs, the 
breakthrough pressure is dramatically decreased by the presence of surfactants in the 
biomedium which reduce the surface tension between the two liquid phases (Hoq et al. 
1984; Pronk et al. 1988; Pronk & Van't Triet 1991; Schroen et al. 1994; Vaidya et al. 
1994b). Han et al. (2003) reported a 30 bar breakthrough pressure in MPF 50, an OSN 
composite membrane, which is very much above the maximum pressure attainable in the 
OSN-MBB (0.4 bar). Considering the surfactant-adsorption mechanism for the reduction of 
the breakthrough pressure outlined by Schroen et al. (1994) and Vaidya et al. (1994b), a 
decrease in this pressure due to the presence of surfactants in the biomedium, such as 
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enzymes, seems unlikely to occur in the OSN-MBB because the nano-scale of the 
membrane pores prevents adsorption of surfactants into the pore walls. 
2.5. Conclusions 
A new approach was presented for a biphasic biotransformation model of hydrophobic 
molecules using a membrane bioreactor for biotransformations (MBB) and organic solvent 
nanoflltration (OSN) membranes. The new system was successfully employed as a strategy 
for in-situ substrate addition to, and product removal from the bioreactor. The proposed 
reactor avoids the formation of emulsions and mitigates the solvent toxicity observed in 
direct contact biphasic (DCB) reactors, thus expanding the range of solvents that can be 
used to assist biotransformations. For example, it was possible to use toluene in the OSN-
MBB as the organic solvent of the model reaction, whereas no biocatalyst activity occurred 
when this solvent was used in a DCB reactor. Additionally, the use of OSN membranes 
overcomes the problems of phase breakthrough and poor membrane organic solvent 
resistance, previously observed in microporous and non-porous MBBs, respectively. 
However, the OSN-MBB resulted in 2 to 3 times lower volumetric productivities than those 
of the DCB reactor due to limitations in the substrate transfer rate through the membrane. 
Nevertheless, the OSN-MBB produced a much cleaner final product than that of the DCB 
reactor. Further work in the following chapter will aim at improving solute transport rates 
in the OSN-MBB system by increasing the membrane overall mass transfer coefficient. 
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3.1. Background and Literature Review 
In Chapter 2 polyimide OSN membranes were integrated into an MBB reactor; geraniol 
was converted to i?-citronellol by whole cells of baker's yeast. The OSN membranes 
separated the aqueous phase from an organic phase which provided the reaction substrate 
and into which the final product was extracted. Two organic solvents were used, 
hexadecane and toluene. When the OSN-MBB was compared to a direct contact biphasic 
reactor, it was concluded that the MBB system was mass-transfer limited. Similar 
limitations have been reported in the literature for non-porous membranes in MBBs 
(Boontawan & Stuckey 2006; Doig et al. 1999a). Using the liquid-film theory it was found 
that the aqueous liquid film and the membrane were the principal contributors to the overall 
mass transfer resistance in the biphasic contactor for the toluene and hexadecane solvents, 
respectively. To improve solute transfer rates in the OSN-MBB this study addresses the 
mass transfer mechanisms of hydrophobic solutes in biphasic OSN membrane contactors, 
as well as to characterise and control the key system parameters. 
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Several authors have investigated mass transfer mechanisms in aqueous-organic membrane 
contactors using the liquid-film theory and the resistances-in-series model for both 
microporous (Coelhoso et al. 1997; Delia et al. 1986; Kiani et al. 1984; Kosaraju & Sirkar 
2007; Netke & Pangarkar 1996) and non-porous (Boontawan & Stuckey 2005; Brookes & 
Livingston 1995; Doig et al. 1998a; Doig et al. 1999b; Netke & Pangarkar 1996; Ray et al. 
1997) membranes. Han et al. (2003) studied the diffusion mechanisms for mass transfer of 
solutes through three different membranes: a microporous membrane (Accurel), a non-
porous silicone rubber membrane, and a composite MPF-50 OSN membrane. For the OSN-
membrane analysis, these authors considered parallel diffusion through the porous and the 
non-porous materials of the membrane. They concluded that diffusion in the membrane 
occurred mostly through the membrane material. 
However, in non pressure-driven systems the diffusion mechanism for solute mass 
transport through integrally skinned OSN membranes is still unclear, since the 
nanostructure and microporosity of these membranes have not been elucidated. Based on 
the scanning electron microscopy (SEM) observations made by See Toh et al. (2007) on the 
nanostructure of polyimide asymmetric OSN membranes, solute transport was represented 
as shown in Figure 2.10. This assumes that the membrane pore volume is full of organic 
solvent, and the solute diffusses through the membrane from the bulk aqueous phase to the 
bulk organic phase. 
The structure of integrally skinned polyimide OSN membranes is assumed to consist of 
three different layers (Fig. 2.10): (1) a dense top layer with tightly packed polymer nodules, 
(2) an intermediate layer with polymer nodules and interconnected pores, and (3) a bottom 
layer with interconnected pores. Considering that most integrally skinned asymmetric OSN 
membranes are prepared using the dry-wet phase inversion method (Mulder 1996), the 
effective thickness may be influenced by both casting thickness and evaporation time. See 
Toh et al. (2007) did not observe a significant influence of the casting thickness on the 
transport properties during pressure-driven OSN; in contrast, they suggested that the top-
layer thickness significantly increases with evaporation time. 
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This chapter reports the mass transfer rates in three different membrane operational modes: 
first, the overall mass transfer coefficient in an aqueous-organic membrane contactor 
(concentration-driven); then, this transport coefficient in a concentration-driven organic-
phase dialysis; finally, the solvent flux in a pressure-driven dead-end nanofiltration system. 
The membrane cross-section morphology was investigated using scanning electron 
microscopy (SEM). A representation of the membrane asymmetry was obtained from SEM 
pictures in addition to literature data, and used to formulate a mechanistic model of mass 
transport based on a resistance-circuit analogy. This model was compared to multivariate 
regression analyses on the experimental data. Finally, the simulations and experimental 
results were used to: (1) suggest a transport mechanism through these membranes; (2) 
characterise the effect of the membrane formation parameters so as to improve mass 
transfer rates of biphasic OSN membrane contactors. 
The work presented in this chapter has also been published as: R. Valadez-Blanco, A.G. 
Livingston, Solute molecular transport through polvimide asvmmetric organic solvent 
nanofiltration (OSN) membranes and the effect of membrane-formation parameters on 
mass transfer. Journal of Membrane Science (2008), doi: 10.1016/1 .memsci.2008.10.016 
3.2. Materials and Methods 
3.2.1. Chemicals 
Lenzing P84 co-polyimide was obtained from HP Polymer GmbH. The membrane-
preparation solvents: N,N-dimethylformamide (DMF) and 1-4-dioxane (HPLC grade) were 
purchased from Rathbum Chemicals (UK); isopropanol and toluene were obtained from 
Fisher Scientific Ltd. (UK). Mineral oil (light) was purchased from Sigma-Aldrich (UK). 
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3.2.2. Asymmetric membrane preparation 
Flat-sheet asymmetric membranes were 
prepared using the dry-wet phase inversion i -{-n' 
method. For all the membranes in this work, 
the polymer dope solution comprised 
Lenzing P84 (polyimide. Fig. 3.1) (24 
wt%), DMF (20 wt%) and 1-4-dioxane (56 
wt%). The ingredients were weighed in an 
analytical balance and stirred for 24 h at 
room temperature, after which the clear 
solution was allowed to settle for 24 h for air bubbles to disengage. The solution was then 
poured very slowly into the feeding slot of an automatic film applicator (Braive 
Instruments, Belgium) (Fig. 3.2). 
II — 
Figure 3.1. Chemical structure of Lenzing P84 
co-polyimide (20% I and 80% II) 
Casting Knf« UrecUon 
of C s d i n g 
Figure 3.2. Picture of film applicator used for 
casting asymmetric polyimide membranes. 
Figure 3.3. Dry custom-made polyimide 
asymmetric OSN membrane. 
Films were cast on a polyester backing material (Hollytex 3329, Ahlstrom) on top of a 
glass plate. After a controlled evaporation time, films were immersed into a D1 water bath 
at room temperature for at least 5 h. To conserve the membranes, they underwent solvent 
exchange, first to isopropanol followed by toluene. Finally the membranes were soaked in 
an oil bath —comprised of mineral oil (60 vol%), toluene (20 vol%) and isopropanol (20 
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vol%)— which prevented membranes from drying out and potentially developing cracks. 
Figure 3.3 depicts the picture of a newly prepared polyimide asymmetric membrane. 
The evaporation time (ET) and casting thickness (CT) were varied following a 2 x 3 
factorial combination. Two ETs were used (Factor A): 10 and 70 s, and three CTs were 
employed: 100, 250 and 500 |im. Two independent membrane batches were prepared for 
each ET-CT combination. This experimental design was applied to each of the three 
membrane operational modes: biphasic contactor, organic-phase dialysis and nanofiltration. 
3,2.3. Homogeneous dense film preparation 
A homogeneous dense film was 
prepared, with a CT of 100 pm, using 
the dope formulation described 
above. No backing material was used. 
After casting, the film was 
immediately flushed with air during 
24 h to complete dryness; thus 
translucent yellow films were 
obtained (Fig. 3.4b). The film was 
Figure 3.4. Polyimide membranes: (a) asymmetric, (b) 
homogeneous 
integrally removed from the glass plate by rinsing with DI water and carefully peeling off 
from the edges. 
3.2.4. Scanning electron microscopy (SEM) 
Four membrane samples were cut at different locations for each membrane sheet. Only one 
membrane batch was sampled for any ET-CT combination for the asymmetric membranes. 
In addition, the 100 |^ m dense membrane was also prepared for SEM. The membranes were 
soaked for 1 min in hexane to remove the conditioning oil, after which they were snapped 
in liquid nitrogen. Then, the membrane samples were mounted onto SEM stubs and 
sputtered with an Emitech K550 gold sputter coater. Finally micrographs were obtained 
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using a Leo Gemini 1525 field emission scanning electron microscope (FE-SEM) with the 
following conditions; 3 mm working distance and 5 kV acceleration voltage. 
3.2.5. Analytical methods 
Geraniol concentration analyses were performed as described in Section 2.2.2. The 
coefficients of variation of three repeated measurements of geraniol in heptane (20 g L"') 
and water (0.2 g L"') for the GC measurements were 1.2 and 0.9%, respectively. 
Benzoic acid concentrations in water were measured using a Unicam Helios Gamma 90-
250 UV spectrophotometer (UK) with the appropriate dilution in DI water. A calibration 
curve was prepared with solutions of known benzoic acid concentrations. The coefficient of 
variation of four repeated benzoic acid concentrations in water was 1.4 %. 
3.2.6. Measurement of organic/aqueous partition coefficients 
Measurements of organic/aqueous partitioning of geraniol in heptane used a method 
described in Section 2.2.6. Three independent measures were performed, with a coefficient 
of variation of 1.5% and an average mass balance of 91%. 
3.2.7. Mass transfer experiments 
3.2.7.1. Solute transfer experiments 
Two different solute transfer experiments were performed using concentration as the 
driving force; aqueous-organic contactor and organic-organic dialysis. Geraniol and 
heptane were used throughout as the solute and the organic solvent, respectively. The 
methods used for the biphasic experiments were detailed in Section 2.2.7. In this study, a 
circular membrane phase contactor was used (Fig. 3.5) based on the two-phase contactor 
described in Section 2.2.7. Aqueous and organic flow rates, 53 L h"' and 18 L h"', 
respectively, were selected from preliminary tests. 
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Stainless steel 
half-cell 
OSN membrane disc 
j 0 = 3 0 m m ^ 
- a 
Organic I 
Feed 
Solution 
t PTFE circular I 
gaskets Inlet / outlet ports 
Stin"er 
CD = 6 m m 
Aqueous / Receiving 
Solution 
Organic I Feed 
Solution 
Membrane 
module 
Membrane' 
Stirrer 
plate 
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Figure 3.5. Schematic of membrane contactor apparatus used in the determination of mass transfer rates of 
geraniol. The contactor was operated in two modes: (1) aqueous/organic biphasic experiments (aqueous and 
organic reservoirs); and (2) concentration-driven organic-organic dialysis with zero transmembrane pressure 
(receiving and feed reservoirs). Heptane was used as the organic phase. For organic-organic dialysis, a 
reservoir of organic liquid (receiving solution) replaced the aqueous solution reservoir. 
For the dialysis experiments, a circular membrane with an effective area of 7.1 cm^ was 
placed between two stainless-steel half-cells with the active layer facing the feed side of the 
dialysis system (Fig. 3.6). The membrane gaskets and tubing connections were made of 
PTFE. Both liquid flow rates were carefully adjusted (15 L h'% avg.) to give negligible 
transmembrane pressure, so as to prevent bulk permeation. An additional experiment was 
carried out at two different flow rates: low (15 L h"') and high (55 L h"') to investigate the 
effect of flow rate on the dialysis mass transfer rates. No bulk permeation was observed 
during the dialysis experiments. 
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rV-Ji--!-'. 
4 
Figure 3.6. Two-phase membrane contactor: (a) open half cell, (b) assembled membrane module. 
The OSN membrane was preconditioned by circulating heptane overnight across both sides 
of the membrane in order to remove the preservative oil from inside the membrane. Then 
the washing solvent was replaced by fresh heptane (200 mL) in the receiving side and by a 
20 g L"' solution of geraniol (2 g) in heptane (100 mL) in the feed side —the same initial 
organic concentration was used in the biphasic experiments. After circulation of the 
solutions through the membrane cell for 15 min, samples of the receiving and feed 
reservoirs were taken over time and analysed by GC. Two to three independent runs were 
carried out for each membrane batch. After testing, the membranes were soaked in bottles 
of fresh heptane —to prevent them from drying— for further use. 
3.2.7.2. Aqueous-film mass transfer coefficient experiment 
The dissolution of benzoic acid from a 
solid circular plate of benzoic acid into 
water was used to estimate the mass 
transfer coefficient (kaq) in the contactor 
(Peeva et al. 2004). To achieve this, a 
PTFE 0-ring gasket was placed on top of 
a stainless steel sintered disk which rested 
on one of the contactor's half cells, thus 
forming a circular frame. Benzoic acid 
Figure 3.7. Benzoic acid film formed on 
disk resting on contactor half cell. 
a sintered 
85 
Chapter 3. Molecular transport through OSN membranes 
powder was sprinkled into this frame thus completely covering the sintered disk, after 
which a solid benzoic acid film was obtained by melting down the acid (Fig. 3.7). Then, the 
other half cell was assembled on top of the PTFE gasket and water flow was applied on the 
benzoic acid side. Samples were taken periodically for the determination of benzoic acid 
concentrations in the aqueous solution and the calculation of kaq. This procedure was 
repeated at three different water flow rates. 
3.2.7.3. OSN experiments 
Solvent flux through OSN membranes was measured using a dead-end nanofiltration 
apparatus (Luthra et al. 2002; Scarpello et al. 2002), based on a SEPA-ST nanofiltration 
cell (Osmonics, USA) with an effective membrane area of 12.6 cm^ (Fig. 3.8). The pure 
solvent (heptane) was pressurised at 30 bar by using nitrogen gas at room temperature (-20 
°C). This pressure forced the solvent down through the test OSN membrane with the top 
layer facing upwards. The permeated solvent volume was measured at the outlet tube of the 
cell at different time intervals. Different volumes of solvent were permeated for each 
membrane until a constant flux was obtained over at least 1 h, after which the flux was 
considered to be at steady state. 
a 9 _ Permeate -kU—1— outlet 
N j supply 
(100 bar) ^ 
S EPA Cell 
Membrane 
Porous -—^ "O-rings 
—-yr 
Magnetic Measuring 
cylinder stirrer/heater 
Figure 3.8. Schematic of the SEPA-cell dead-end nanofiltration apparatus used in this study. 
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3.3. Mathematical modelling 
3.3.1. Solute transport in the aqueous-organic membrane contactor 
3.3.1.1. Calculation of the overall mass transfer coefficients 
For the biphasic system, Eq. 2.10 was used to compute the overall mass transfer coefficient 
based on the aqueous concentrations (Kaq). The overall mass transfer coefficients based on 
the aqueous and organic concentrations, Kaq and Korg, respectively, are related by the 
following equation; 
(Eq.3.1) 
3.3.1.2. Estimation of the aqueous-film mass transfer coefficients 
Experiments were carried out to evaluate the variation of kaq with flow rate. The kaq 
estimates were obtained by measuring the dissolution rate of the benzoic acid film (in place 
of the membrane) in contact with the water flow, with the following equation: 
In = (Ek,. 3.2) 
C ' - C ' ' ( f ) 
3.3.2. Solute transport in the concentration-driven dialysis process 
3.3.2.1. Resistance-circuit-analogy model 
The overall mass transfer coefficient based on the organic phase, Korg, for the organic-
organic dialysis process was calculated using a similar equation to Eq. 2.10. In this case, 
solute transport takes place from the feed to the receiving solution. Since the solvents in 
both reservoirs are the same, the feed/receiving partition coefficient (mfeed/rec) is 1.0. With 
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negligible transmembrane pressure — 
same flow rate on both sides of the 
membrane— and thus no bulk solvent 
permeation, a resistances-in-series 
model for dialysis can be expressed 
as: 
K. 
- + -
org ^org ml org 
(Eq. 3.3) 
Pore 
resistance 
Pore 
resistance s 
Top layer 
t^op 
Microporous 
layer 
(support) 
E(x), Dp(x) 
Non-pore 
resistance 
Non-pore 
resistance 
Additionally, when the resistances of 
the organic liquid films are negligible 
compared to those of the membrane, 
Eq. 3.3 becomes: 
Figure 3.9. Resistance-circuit analogy for the study of the 
mechanism for mass transport through an OSN membrane 
for the dialysis and nanofiltration operational modes. 
•^ org km' mm/org (Eq. 3.4) 
where C m 
ml org c org 
The mass transfer coefficient for a solute through a membrane layer (Fig. 3.9), km, is 
described by the following equations: 
Non-pore transport; 
Pore transport: 
j^mem _ 
I 
D 8 
L/wre org 
(Eq. 3.5a) 
(Eq. 3.5b) 
Using SEM micrographs and literature reports (Gibbins et al. 2002; Kazama & Sakashita 
2004; See-Toh et al. 2007; White 2002; White & Nitsch 2000) for modelling transport in 
the dialysis process, two distinct layers were considered for the asymmetric OSN 
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membrane: a top-skin layer (100-300 nm thick) and a porous substrate layer for depths 
larger than 300 nm (Fig. 3.9). The estimated porosity of the top layer, Stop, was considered 
constant. From analyses of the SEM pictures a curve of the porosity of the membrane as a 
function of the membrane depth from the membrane top surface, E(x), was obtained as 
elaborated in Section 3.4.5 and 3.4.6. Applying the resistances-in-series analogy to the 
asymmetric membrane (Han et al. 2003) as represented in Fig. 3.9: 
K,al = Kp + Rsuppor, (Eq- 3.6) 
^ + ^ — (Eq. 3.7) 
^org ml org ^lop ^support 
For each membrane layer, two resistances in parallel were considered: transport through the 
non-pore material (Eq. 3.5a) and through the embedded organic solvent in the pores (Eq. 
3.5b): 
^ ^ + — (Eq. 3.8) 
^layer ^mem ^pore 
Applying Eq. 3.8 to Eq. 3.7, 
^mlorg^mem ~ ^top ) + 
Kp = ^ = J — (Eq. 3.9) 
^top hop 
D g 
n /I ^ \ , org 
^m/org memO^ ^support^ (Eq. 3 10) 
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and T = 1 - In £ (Ho & Striender 1981; Wolf & Strieder 1990) 
A variable top-layer thickness, /top, was considered as a function of the membrane 
formation parameters, evaporation time (ET) and membrane thickness (MT). Initially the 
model only included ET; however, this model could not account for the variation of the 
experimental results and so it was extended to include MT. 
(Eq.3.11) 
A simulation program, gProms® v.2.3 (Process Systems Enterprise Ltd., UK), was used for 
estimating the unknown parameters of the model (Dmem, Dorg, mm/org, Stop and Ai). The 
software optimises the maximum likelihood function for the parameters to be estimated 
given the measured variables and a variance model —heteroscedastic measured values 
were considered. 
3.3.2.2. Calculation of the concentration profile as a function of membrane depth 
Considering a constant concentration in the feed and the total flux through the membrane is 
described by: 
(Eq.3.12) 
^ = ^ ,o,a! = ^ ,op = ^ suppor, (^4' 3.13) 
An organic concentration basis was used for the calculations. Assuming a negligible liquid 
film resistance, the concentration profile as a function of depth in the membrane can be 
calculated as follows: 
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= (Eq.3.14) 
= ^ (Eq.3.I5) 
^support (^) 
3.3.3. Solvent transport in pressure-driven dead-end nanofiltration process 
3.3.3.1. Resistance-circuit-analogy model 
Similarly to the dialysis study, for modelling solvent transport in an OSN system a 
resistance-circuit analogy was used (Bhattacharyya & Williams 1992b; Dejmek & Nilsson 
1989; Henis & Tripodi 1981; Machado et al. 2000). Using SEM observations and literature 
values, the variation of the pore diameter, Dp(x), as a function of the position in the 
membrane from the top surface was estimated as elaborated in Sections 3.4.5 and 3.4.6. 
Applying the resistances-in-series analogy (Eq. 3.6, Fig. 3.9) to the solvent flux equations: 
1 ^lotal 
/ 7 7 \ 
'AJP ' AJP 
= ( K , + R — ) A = 1 ^ (Eq. 3.16) 
Pp Pp AP 
where Jtotai is the total solvent volumetric flux, AP is the transmembrane pressure, and Pe is 
the solvent permeability. 
Transport through the top layer can be described by the solution diffusion model as follows 
(Mulder 1996): 
(fx,. 3-17) 
On the other hand, two parallel resistances were considered for the microporous layer 
corresponding to the transport through the membrane material and through the pores (Eq. 
3.8). A solution diffusion equation similar to Eq. 3.17 was used to describe transport 
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through the non-pore material. The Kozeny-Carman equation (Mulder 1996), which 
considers a nodular porous structure was used for the transport through the pores: 
J = — ^ ( E q . 3.18) 
18077(1-6)" Ax 
where Dp is the membrane pore diameter. 
So the microporous layer resistance, Rgupport, can be expressed as: 
180,7(1-^(%))' 
3.3.3.2. Pressure inside the membrane as a function of the membrane depth 
Considering the solvent volumetric flux through the membrane. 
AP 
J = J,c,al = J top = J supper, = (^4- 3.20), 
^tolal 
the pressure at the top-skin/porous interface, Ptop, can be calculated using Eq. 3.17 and the 
following equation, 
J = = (Eq.3.21) 
Similarly, for the microporous layer the pressure in the membrane as a function of 
membrane distance from the top interface, Psupport (x ) , can be estimated as 
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P -P fx') 
/ = 0%.3.22) 
•^support 
else Psupport (x )=0 
3.3.4. Analysis of variance and multivariate estimation 
A 2x3 analysis of variance (ANOVA) was performed for each of the operational modes: 
biphasic contactor, dialysis and OSN data using membranes formed with different 
formation parameters. Factor A (ET) comprised two levels: ETi = 10 s and ETz = 70 s; and 
Factor B (CT) consisted of three levels: CTi = 100 |im, CT2 = 250 |am and CT3: = 500 |am. 
A 95% confidence level was used to assess the significance of the factors. Similarly, linear 
multivariate regressions were employed to estimate the transport processes in this work as a 
function of ET and membrane thickness (MT). Microsoft Excel® was used for performing 
the regressions. Initially, a full quadratic polynomial model was assessed for goodness of 
fit, normality, residuals and constant variance: 
Y = po + Pi Xi + P2X2 + p3 Xi X2 + p4Xi^ + Ps Xz^ (Eq. 3.23), 
where Y is the response dependent variable, and X] = ET and X2 = MT, are the independent 
variables. Different transformations, Y' = f(Y), were used to stabilise the variance, improve 
normality and residuals for both ANOVA and multivariate regression analyses. Examples 
of successfial transformations are: Y' = Log Y, Y' = Y'% and Y' = Y"°'^ . After selecting the 
appropriate transformation, the terms of the full model were reduced by using t-tests on the 
regression coefficients and by examining the mean square error and value for the 
reduced models. Considering these factors, the best model was selected and used for mass 
transport simulations. 
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3.4. Results and Discussion 
3.4.1. Insight into the membrane formation mechanism 
The evaporation time (ET) and casting thickness (CT) had a coupled effect on the final 
membrane thickness (MT) of the OSN asymmetric membrane (Fig. 3.10a). The slope for 
ETi (10 s) is greater than that for ETz (70 s). During membrane formation, as ET increases, 
more solvent evaporates out fi-om the polymer solution, thus reducing MT. 
g 100 
E 
— ETKIOs) 
-•-O ET2(70s) 
(a) X 
100 200 300 400 500 600 
Casting thickness (^m) 
ETI (10$) 
100 200 300 400 500 
Casting thickness (pm) 
Figure 3.10. Effect of the membrane formation parameters, evaporation time (ET) and casting thickness 
(CT), on: a) the final membrane thickness (MT); and b) estimated solvent evaporation rate during membrane 
formation. Polyimide membranes were formed using the dry-wet phase inversion method. 
The volumetric solvent loss during membrane formation, from the dope solution to the final 
membrane, was calculated by considering the thickness of the initial dope solution 
(assuming a standing film), casting thickness, and the thickness of the dry final membrane. 
Solvent losses occur both by evaporation during the dry period and by solvent exchange 
during the wet period. However, since the physical conditions during the wet period 
remained constant for the two tested ETs, the total solvent loss was considered here as an 
estimate of solvent evaporation during the dry formation period. 
Fig. 3.10b shows the estimates of the evaporation rates during membrane formation as a 
function of ET and CT. Again, the slope for ETi was much higher than that for ETz. 
However, in this case the evaporation rates of the former were considerably larger than 
those of ET2 for all the CTs tested. From the latter observations, a two-fold time-dependent 
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mechanism for membrane formation was suggested (Pinnau & Koros 1993; Reuvers & 
Smolders 1987; Shojaie et al. 1994a; Shojaie et al. 1994b): (1) As evaporation takes place 
(ET increase) the evaporation rate rapidly decreases due to the formation of a top layer at 
the surface of the polymeric solution. As a result, larger evaporation rates are obtained at 
shorter ETs. However the skin formation does not completely stop evaporation as ET2 
evaporation rate still increases with CT (Fig. 3.10b); i.e, evaporation takes place at a lower 
rate after skin-layer formation —otherwise MT would be the same for different ETs. (2) As 
CT is increased, larger amounts of solvent need to be evaporated before the membrane 
envelope is formed. This causes an increase in the amount of solvent evaporated in a given 
period of time, which explains why larger CT results in higher evaporation rates, especially 
at ETi (Fig. 3.10b). 
3.4.2. Biphasic mass transfer 
A series of mass transfer experiments was performed to test the effect of ET and CT on a 
model mass transfer system: diffusive geraniol transport from the bulk organic phase 
(heptane) to the bulk aqueous phase through an OSN membrane (Fig. 3.11). 
Figure 3.11. Aqueous-organic biphasic membrane system for solute transport studies: a) organic vessel; (b) 
aqueous reservoir; (c) organic-fluid gear pump; (d) aqueous-fluid gear pump; (e) biphasic membrane 
contactor; (f) pressure gauge, (g) magnetic stirrers. 
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An organic-basis was used in the calculation of the overall mass transfer coefficients, Korg, 
for direct comparison of these values with dialysis results (later in Section 3.4.3). The 
results of this experiment showed no significant difference in Korg for the different ET-CT 
combinations (Fig. 3.12). Table 3.1, shows the ANOVA results for the biphasic 
experiment. As can be predicted from Fig. 3.12, none of the factors had a significant effect 
on Korg and no significant interaction between factors occurred (P = 0.05). 
ET, (10 s) 
ET,(70s) 
200 300 400 
Casting thickness (^m) 
600 
Figure 3.12. Effect of casting thickness (CT) and evaporation t ime (ET) on the overall mass transfer 
coefficient based on the organic phase concentrations (Korg) for geraniol transport from heptane to water in an 
aqueous-organic membrane contactor with a 7 cm^ membrane area. Data points are the average of two 
independent membrane batches. 
This was surprising since an effect of the membrane formation parameters on the mass 
transfer rates was expected. It is possible though that a dominating aqueous-film resistance 
could be leading to negligible effect of the membrane-formation parameters on Korg. To 
investigate the limiting mass transfer resistance due to the aqueous liquid film, different 
aqueous flow rates were used and the overall mass transfer coefficients based on the 
aqueous concentrations (Kaq) were calculated (Fig. 3.13) —this time an aqueous basis was 
used for comparison with an aqueous experiment below. 
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Table 3.1. Analysis of variance (ANOVA) results for the effect of membrane thickness (MT) and evaporation 
time (ET) on the performance of different membrane operation modes: two-phase membrane contactor, 
dialysis and nanofiltration. 
pd F-test Phase contactor (Korg) Dialysis (K^rg) Nanofiltration {J) 
Transformation^ Y' = Y' = Y'°^ Y ' = Y'°^ 
Factor A'' 5.99 Fo 2.25 6.04 2.88 
Fo vs. F < > < 
Result No effect Effect No Effect 
Factor 5.14 Fo 3.81 36.92 10.13 
Fo vs. F < > > 
Result No effect Effect Effect 
Interaction A-B 5.14 Fo 4.19 5.34 0.42 
Fo vs. F < > < 
Result 
No 
Interaction 
Interaction No Interaction 
Variable transformations employed to correct for variance and normality;' ' Factor A - Evaporation Time; ° 
Factor B - Casting Thickness; P < 0.05. 
The Kaq values do not show a 
significant trend for flow rates up to 
80 L h"^  (Fig. 3.13). Scatter in this 
part of the data was attributed to the 
measurement error. A remarkable 
increase in Kaq occurred for the high 
flow-rate measurements (150 L h"'; 
this was the maximum flow attainable 
in the experimental apparatus). 
Reynolds numbers (Re) were 
estimated for the different aqueous 
rates (upper axis in Fig. 3.13) 
according to the Re definition in 
Re 
Flow rate (L h ) 
Figure 3.13. Effect of the aqueous flow rate on the overall 
mass transfer coefficient based on the aqueous 
concentrations (Kg,) for geraniol transport from heptane to 
water in an aqueous-organic membrane contactor with a 7 
cm^ membrane area. The flow rate of the organic side was 
constant at 18 L h '. 
97 
Chapter 3. Molecular transport through OSN membranes 
Section 2.3.3% Re variations in the laminar and transition regions (up to around 4,000) did 
not have an effect on Kaq (Fig. 3.13). On the other hand, for the fully developed turbulent 
flow (Re ~ 8,800), Kaq underwent a considerable increase. The mass transfer in the biphasic 
system appears to be limited by the aqueous-film resistance for flow rates in the laminar 
and transition regimes, so the membrane resistance may become significant only in the 
aqueous-phase fully developed turbulent flow. 
An additional experiment was performed 
to further confirm this. The aqueous-film 2=° 
mass transfer coefficient, kaq, was ^ 
determined as a function of three aqueous _ 
160 
flow rates (Fig. 3.14) using the dissolution ~ 
rate of benzoic acid. Although the j i* 
magnitudes of the kaq coefficients do not 
Re 
match those of the Kaq obtained 
previously, the behaviour of both 
coefficients as a function of flow rate is 
similar. Likewise to the previous 
experiment, there is a major increase in kaq 
when a fully-developed turbulent flow was applied. The aqueous liquid-film resistance 
appears dominant in the laminar and transition aqueous flow regimes. 
60 eo 100 
Flow rate (L h'^ ) 
Figure 3.14. Aqueous-film mass-transfer coefficients 
as a function of flow rate obtained from experimental 
data for the aqueous dissolution of benzoic acid. 
Since the aim of this study is to understand the effect of membrane formation parameters 
on the mass transport rate, the experiments must be carried out under conditions in which 
mass transfer is dominated by the membrane resistance. However, a controlling membrane 
resistance was not easily achieved in the biphasic contactor due to flow rate limitations. An 
alternative method to study membrane mass transport is the use of an organic-organic 
dialysis system with negligible transmembrane pressure and with solvent flowing on both 
sides of the membrane at the same flow rate to prevent solvent bulk permeation. 
' Since the geometry of the contactor half-cells is non conventional, the equivalent diameter was considered at 
the inlet of the contactor cells (inlet tube diameter). 
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(Convective flow should be minimised to investigate solute diffusive transport in the 
dialysis system.) In this system the liquid resistances are greatly reduced because of 
favourable partition coefficients of the solute to the organic solvent, so it is possible to 
establish a system controlled by the membrane mass-transfer resistance. 
3.4.3. Dialysis mass transfer 
Organic basis coefficients, Korg, were used for the analysis of the dialysis experiments. As 
mentioned before, the study of the effect of the membrane formation parameters in 
diffusive mass transport implies that the membrane is the only significant resistance to 
mass transfer; i.e., the liquid film resistances at either side of the membrane not having an 
effect on Korg. 
A test was carried out to confirm this. 
The dialysis apparatus was run at two 
different flow rate levels (same flow 
rate for the feed and the receiver g 
liquids). No significant difference in the ^ 
Korg was detected at 95% confidence 
interval for the two fiow rates tested 
(Fig. 3.15). This result suggests that the 
membrane is the controlling mass 
transfer resistance in the dialysis 
Figure 3.15. Effect of the organic-phase flow rate on 
system; so the dialysis mode suggested the K o r g for geraniol transfer in concentration-driven 
dialysis mode. (The same flow rate was used at both 
here appears appropriate for the study of sides of the membrane.) Error bars indicate the 95% 
confidence interval for two independent runs. 
solute mass transfer through OSN 
membranes. 
T 
1 
20 40 60 
Receiver/Feed Flow rate (L h ) 
80 
Figure 3.16 shows the effect of ET and CT on Korg for the transport of geraniol from the 
feed to the receiving solution through the membrane. Korg decreases with casting thickness 
for both ETs. The ET effect is more subtle; for casting thickness below 250 |im, ET appears 
to have no effect on Korg. However, for CT3 (500 p.m), a longer ET seems to cause a larger 
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decrease in Korg- A homogeneous film 
(CT, 100 i^m) was also tested with no 
measurable flux taking place in an 
experiment carried out for 7 days. 
In an ANOVA analysis (Table 3.1), the 
effect of both factors, Factor A (ET) and 
Factor B (CT), was found to be 
significant (P = 0.05). As observed in 
Fig. 3.16, the effect was more 
pronounced for CT compared to ET, 
judging by the larger F-test value of the 
former (Table 3.1). This analysis also 
12H 
s 
s 
"S. . 
— — ET, (10 8) O 
O — ETj (70 s) 
200 300 400 
Casting thickness (pm) 
500 600 
Figure 3.16. Effect of casting thickness (CT) and 
evaporation time (ET) on the K r^g of geraniol diffusing 
through a polyimide membrane in organic-organic 
dialysis mode with no transmembrane pressure using 
heptane as the organic solvent (data points are average 
for two independent membrane batches). 
revealed that there is interaction between the factors. The interaction results from the 
factors ET and CT being correlated as discussed above. 
Most membrane researchers postulate that solute and solvent transport rates in asymmetric 
integrally-skinned membranes are controlled by the top layer only, while the microporous 
substrate just provides mechanical support (Cai et al. 2003; Canas & Benavente 2002; 
Pinnau & Koros 1993; Singh et al. 1998). Some other authors have mentioned the presence 
of a "transition" region between the top-layer and the open pore region, but have not related 
this layer to membrane mass transport properties (Hassan et al. 2007; Panar et al. 1973; 
Pinnau & Koros 1993; Qin et al. 2006; See-Toh et al. 2007; Stamatialis et al. 2006). 
The evaporation step during dry-wet membrane formation has been related to the formation 
and characteristics of the top layer (Krantz et al. 1986; Mohamed 1997; Pinnau & Koros 
1993; See-Toh et al. 2007; Stamatialis et al. 2006). A number of authors have concluded 
that the top layer is formed rapidly when the casting solution is exposed to air during the 
evaporation step (Mohamed 1997; Panar et al. 1973; Pinnau & Koros 1993). Considering 
this, ET was considered in this work as an indicator of the physical characteristics of the 
top layer. On the other hand, CT was used to indicate the structure of the whole membrane 
and its effect on solute mass transport. This transport involves solute diffusion through the 
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two main structural layers: (1) skin-layer, diffusion through polymeric material; (2) 
asymmetric microporous layer, diffusion through both the membrane material and through 
the pores. 
The results shows that CT has a larger effect on Korg than ET. This means that for diffusion 
during dialysis, the microporous layer rather than the top-layer is the main controlling 
resistance to solute transport. Moreover, if hypothetically the microporous layer is 
considered just as a stagnant layer of organic solvent, the resistance caused by this layer 
will be insignificant compared with that of the top-layer. This suggests that the membrane 
asymmetry plays a key role in the diffusive mass transport in the OSN membrane. 
3.4.4. Nanofiltration tests 
In order to gain deeper insight 
into the mass transfer 
mechanisms in OSN membranes, 
a series of pressure-driven dead-
end OSN tests were performed 
(Fig. 3.17). The effect of the 
membrane-formation parameters 
on the observed solvent 
volumetric flux (J) at 30 bar was 
investigated (Fig. 3.18). While J 
decreased with CT, the effect of 
ET appeared to reduce J only for 
the CT = 100 )j.m. An ANOVA 
analysis was performed on the OSN experimental data (Table 3.1): only Factor B (CT) had 
a significant effect on J(P - 0.05) and no interaction effect was found. 
Figure 3.17. Pressure-driven nanofiltration system: (a) line; 
(b) pressure regulator; (c) N2 inlet; (d) nanofiltration unit; (e) 
permeate outlet and measuring cylinder. 
These results contrast with See Toh et al. (2007) findings which suggested no significant 
CT effect on solvent flux (toluene) and a reduction in J with ET —also reported elsewhere 
(Krantz et al. 1986; Mohamed 1997; Stamatialis et al. 2006). The diverging results on the 
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CT effect with See Toh et al. can be 
understood considering the great 
difference in flux magnitude 
observed for the two solvents: 50-
140 L m"^  h"' and 2-26 L m'^ h"' for 
toluene and heptane, respectively. 
Polarity of the solvent may cause 
the remarkable flux difference for 
the two solvents: toluene is more 
polar than heptane, which have 
dielectric constants of 2.38 and 1.92, 
respectively. This behaviour is in 
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Figure 3.18. Heptane permeate volumetric flux (J) in a 
pressure-driven nanofiltration cell (30 bar) for OSN 
polyimide membranes prepared with different casting 
thickness (CT) and evaporation times (ET) —data 
points are average for two different membrane batches. 
agreement with the observations of Santos et al. (2007) on the flux of a wide range of 
solvent-membrane systems. Also, whereas toluene is slightly soluble in water 
(concentrations up to 0.5 g L " \ heptane is virtually insoluble. A highly apolar solvent such 
as heptane may suffer a greater transport resistance in the membrane, which is observed in 
terms of lower flux. As a greater interaction between the solvent and the membrane 
material takes place for heptane, transport through both the skin-layer and the asymmetric 
microporous layer become important. 
Reduction of the solvent flux with CT has been reported in the literature (Ismail & Hassan 
2006; Mohamed 1997). This phenomenon can be explained with the following mechanism 
(Reuvers & Smolders 1987; Shojaie et al. 1994a; Shojaie et al. 1994b); as CT is increased a 
larger solvent mass needs to be evaporated before the solution crosses the bimodal and the 
membrane envelope is formed. Because longer evaporation times are required for this, a 
larger depletion of solvent occurs at the top surface, which causes a greater polymer 
concentration difference between the top and the bottom of the film. This in turn results in 
an increase in membrane asymmetry which seems responsible for the solvent flux reduction 
with CT. 
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3.4.5. Membrane morphology 
SEM pictures were obtained for membranes prepared with different ET and CT conditions. 
No significant differences in membrane morphology could be found for the different 
membrane-formation tests (not shown) —e.g., top and microporous layer thickness. 
Although differences may exist, these are too subtle to allow identification by SEM. 
Despite this, here this study examines in detail the general morphology of the asymmetric 
OSN membranes and based on simple geometric considerations, suggest a structure for 
polymer nodule arrangement which includes membrane porosity and pore diameter. Two 
distinct layers were observed (Fig. 3.19a): a skin layer (or top layer) at the top of the 
membrane (90-120 nm) and an underlying microporous layer which comprised most of the 
membrane thickness (Cai et al. 2003; Kazama & Sakashita 2004; Qiao et al. 2005; See-Toh 
et al. 2007; White & Nitsch 2000). 
3.4.5.1. Top layer 
The top layer was comprised of small packs (or sacks) of polymer nodules which are held 
together to make a thin layer surface (Fig. 3.19b). The top layer (approx. 100 nm thick) was 
formed by a mono-layer of only one single nodule-pack depth with a tooth-like cross-
sectional arrangement. Because of its pack arrangement this layer was clearly distinct from 
the underlying microporous substrate (Panar et al. 1973). Similarly to Panar et al. (1973), 
packs of nodules of similar sizes to those in the top-layer were observed in the rest of the 
membrane but with a random orientation (Fig. 3.19b). 
Some of the fine channels (8 nm) between the nodule packs seemed to reach the surface, 
but this was unclear. See Toh et al. (2007) reported channels smaller than 5 nm apparently 
reaching the surface. In contrast, other authors have suggested a dense top layer (Cai et al. 
2003; Hassan et al. 2007; Kazama & Sakashita 2004; Panar et al. 1973; Pinnau & Koros 
1993; Shojaie et al. 1994b); i.e., no channels or pores reaching the surface. On the other 
hand, since the nodules (15 nm, avg.) in the pack are tightly held together (Fig. 3.19c), it is 
not possible to observe porosity within such packs. 
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Figure 3.19. SEM cross-section pictures showing different morphological features of polyimide membranes: 
(a-d) asymmetric membrane (AM); (e, f) dense film. A representation of the membrane microporous structure 
was elaborated from a thorough study on SEM micrographs. Different amplification scales were used as 
indicated in the labels at the bottom of the pictures. 
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3.4.5.2. Microporous layer 
The microporosity of the membrane increased gradually with the membrane depth from the 
top layer, which is an inherent characteristic of asymmetric membranes (Fig. 3.19b). Since 
these morphology changes take place in a continuum across the membrane thickness, it is 
difficult to define a range for the different microporosities observed in the membrane. The 
polymer structure below the top-layer consists of nodule packs of similar sizes to those of 
the top layer; however, the shapes of these packs varied from round to oval, and their 
orientation also varied in a seemingly random manner (Fig. 3.19b). Then, looking deeper 
into the membrane thickness (from 0.1 to 6-7 |im depth), the nodule packs become more 
separated from each other by increasingly wider interconnecting channels (Fig. 3.19a). 
Finally down in the well-developed microporous structure (from 8-10 jam depth), the 
interconnected pores become dominant, with the nodule packs forming the porous skeleton 
(Fig. 3.19d). Most of the nodule packs presented an oval shape with the pore size for the 
small axis of about 0.15 )j.m and that for the large axis ranging from 0.15 to 0.4 |j,m. The 
structure of the asymmetric membranes agrees with that reported in the literature (Kazama 
& Sakashita 2004; Panar et al. 1973; Pinnau & Koros 1993; See-Toh et al. 2007; Wienk et 
al. 1994; Wienk et al. 1996). 
3.4.5.3. Dense film 
Figure 3.19e shows the picture of a dense film, homogeneous membrane. The dense film 
presents a top region similar to that described above for the top layer and with the same 
thickness, 100 nm (Fig. 3.19e and 3.19f). A similar observation was reported for polyamide 
freeze-dried membranes (Panar et al. 1973). The underlying region was conformed of a 
highly plasticized nodular arrangement akin to the structure just beneath the top layer of the 
asymmetric membrane. This structure was homogeneous across the membrane thickness — 
no membrane asymmetry or pores were observed (Panar et al. 1973; See-Toh et al. 2007). 
Additionally, the dimensions of the nodule packs and nodules were similar to those 
observed in the asymmetric membrane (Fig. 3.19f). 
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3.4.5.4. Membrane morphological model 
In order to further study the morphology and transport mechanisms in OSN membranes, a 
representation of the membrane morphology was made by defining three nodular 
arrangements (Fig. 3.20): (1) top-layer, fused-nodule structure: 100 nm; (2) transition 
region, mix of nodule-pack and interconnected-pore structure: 6 jim; (3) well developed 
open-pore structure: 20-40 )a,m. 
80 nm 5 nm 
f t ' " 
30 nm 
100 nm 
TOP 
TRANSITION 
i 
MICROPOROUS 
Figure 3.20. Discrete representation of the morphology of OSN polyimide asymmetric membranes based on 
the analysis of SEM pictures. The microporous region is represented by cross-sectioned spherical shells. 
A number of geometric assumptions were defined for each layer, which do not take into 
account any fluid mechanical considerations (Fig. 3.20): Top-layer, a rectangular prism 
surrounded by a 5 nm void layer (thin channel) was considered. Transition region, the 
nodule packs were assumed to be spheres bound together and surrounded by void space 
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(channels). Microporous region, a void spherical shell formed by polymer packs was 
considered, the inner space and that between shells was formed by free volume. Based on 
these assumptions, the porosity and the pore size for each of the membrane regions defined 
above were estimated (Table 3.2). 
Table 3.2. Discrete characterisation for the morphology of OSN asymmetric membranes using simple 
geometric assumptions based on SEM observations and independent estimations". 
Membrane region Membrane depth (|im) Porosity, e Pore diameter, Dp (nm) 
Top layer 0.1 0.11 (1.0 x i o ") 
Transition 6.0 0.48 31 
Microporous 20.0 (35.0) 0.71 (0.60) 233 
" Values in parenthesis are independent estimates to the SEM structural model and were used for further 
simulations. The description of these estimates is elaborated in Section 3.4.5.4. 
After examining the values obtained from the structural model, lack of accuracy of some of 
the estimates was evident. So additional estimations were made as follows: (1) by an 
independent measurement using the dry weights of the membrane before and after oil 
removal and volumetric solvent displacement into the membrane, the total porosity of an 
asymmetric membrane was determined to be 0.6. This porosity value was further 
considered for the microporous region at a membrane depth well into the developed 
microporous region, 35 |j,m (Table 3.2). (2) the porosity obtained with the SEM structural 
model is clearly an overestimate considering that the top layer for a NF membrane should 
be approximately defect free —Mulder (1996) reported that membrane porosities above 
10"^  will cause considerable reduction in the selectivity of gas separation NF membranes. 
So a lower porosity was considered further for the structural model from numerical 
estimations (Table 3.2). (3) Three Dp values were initially considered for the top layer: 5 
nm (SEM estimate), 7 nm (See-Toh et al. 2007) and Inm (Gibbins et al. 2002); however, 
the fitted Dp (0.15 nm) in Section 3.4.6 was only comparable to the Dp reported by De 
Baerdemaeker et al. (2007). 
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3.4.6. Mass-transport numerical simulation 
Clearly the consideration of discrete membrane regions for transport modelling will lead to 
high inaccuracies since the membrane asymmetry does not present discontinuities. The 
structural model described in the previous section (Table 3.2) was used for fitting a porosity 
curve as a function of the membrane depth from the top surface, E(x), which was used in 
the transport model (Appendix A, Fig. Al): 
E(x) = 1.7 + 0.11 •ln(x) (Eq. 3.24) 
Similarly, a function of the pore diameter, Dp, on the position of the membrane from the top 
surface (Eq. 3.25) was used to fit the structural model data in Table 3.2 (Appendix A, Fig. 
A2). The fitted parameters were: a = 230.02, b = 8.84 x 10"^  and xo= 6.64 x 10"^ . 
2 , 0 4 = 0 E ^ 3 J 5 ) 
l + e * 
For numerical simulations, the actual membrane thickness (MT) was considered rather than 
CT. Mass transport data (Korg or J) were obtained for the different ET-MT factorial 
combinations. Two different numerical models were used for simulating mass transport 
through the membrane: (1) Mass-transport mechanistic model, two mass-transport 
resistances in series were considered: top and microporous layers. Additionally, parallel 
transport through the pores and the polymer was considered for each layer. (2) Multivariate 
linear regression, ET and MT parameters were considered as the independent variables 
whereas either Korg or J was the dependent variable or response. 
3.4.6.1. Simulation of the dialysis process 
A non-linear parameter estimation was performed as described in Section 3.3.2.1. The 
estimated parameters that optimised the maximum likelihood function are: Stop = 5.2 x 10'^; 
Al - 1.24 X 10"^ Dorg = 1.45 X 10"'° m^ s'^ Dmem - 1.7 X 10"'^  m^ s"' and m„/org= 0.0108. 
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On the other hand, in the regression analysis, the full quadratic model (Eq. 3.23) was 
transformed using Y'= (K^rg)^^ and reduced to Eq. 3.26 below as explained in Section 
3.3.4. The ET linear term was significant at 90% confidence level, while the rest of the 
coefficients were significant at the 95% level. 
(Eq. 3.26) 
208-7 
1.5e.7 
1.0e-7 
0.5e-7 
0/70 
Multivariate regression 
X Experimental Data 
• 1 Mechanistic model 
Figure 3.21. Experimental data, mechanistic mass-transport estimation and multivariate regression response 
surfaces for the overall mass transfer coefficient (Korg) of the model solute during a concentration-driven 
dialysis process. 
Figure 3.21 depicts the experimental data and the numerical simulations for Korg. As can be 
observed in the figure, the simulation surfaces overlap. The major divergence between the 
models occurred for the high ET-MT boundary, for which experimental data was not 
available. An assessment of the Korg prediction was made by analysing the plot of residuals 
for the models to the experimental data (Fig. 3.22). The residuals for both models are 
scattered along a band and do not present a significant pattern, which indicates that the 
simulation error is not systematically affected by factors other than those considered in the 
models. In the case of the regression analysis, this also means that the model complied with 
the assumptions of error constant variance and normality. The residuals for the mechanistic 
estimation were slightly larger than those for the regression with standard errors of 2.1 and 
1.2 X 10"^  m s"', respectively. However the precision of both models was still acceptable as 
can be observed in Figures 3.21 and 3.22. 
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The mass-transport mechanistic model 
was used to obtain the profile of the 
solute concentrations across the 
asymmetric membrane for the different 
membrane-formation conditions (Fig. 
3.23). For easier interpretation, 
concentrations based on the organic 
phase were used. The major drop in 
solute concentration occurred across the 
top layer; however further reduction in 
solute concentrations still occurred across 
the porous layer. This reduction is 
proportional to the microporous layer 
thickness. It appears that the abrupt 
change in the slope of the curves at the 
top-skin/microporous interface is 
misrepresenting the smooth change in 
porous structure observed in the SEM 
pictures. This is due to limitations of the 
structural model (Eq. 3.24) to accurately 
represent the microporous structure at 
this interface. 
The ET-MT term in the mass-transport 
mechanistic model (Eq. 3.11) has a 
counterpart in the regression model (Eq. 
^ 0 
• MuitKoriate regression 
O Mechanistic model 
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Figure 3.22. Residual plots for the mechanistic mass-
transport estimation and multivariate regression of the 
dialysis process (Kg,,'*'' -
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Figure 3.23. Simulation of the solute concentration 
profile (based on the organic solvent concentrations) 
across the membrane thickness during concentration-
driven dialysis using a mechanistic mass-transport 
model. The model is a function of the membrane 
formation parameters, evaporation time (ET) and 
membrane thickness (MT). A different measuring 
scale was used for the top layer region below 220 nm 
indicated by the vertical dash line. 
3.26). This means that the correlated ET 
and MT parameters, indicated by the ET-MT term, constitute an important factor greatly 
affecting mass transport in the membrane. 
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No proof of increasing top-layer thickness as a function of the formation parameters was 
observed in this work nor has it been reported in the literature (Kawakami et al. 1997; 
Panar et al. 1973; See-Toh et al. 2007). Therefore, the top-layer thickness does not change 
with ET, it is the asymmetry of the membrane which is affected not only by ET but also by 
CT. In fact, to explain the effect of the formation parameters on the membrane mass-
transport performance, either phenomenon, membrane asymmetry or top-layer increase, 
will be satisfactory. However, the role of the membrane asymmetry has been neglected 
mainly because the very subtle and gradual changes in morphology across the membrane 
make it difficult to define and characterise the membrane asymmetric structure. 
3.4.6.2. Simulation of the OSN process 
As membrane porosity increases 
with depth, negligible resistance is 
expected to occur after reaching a 
specific membrane depth. 
Accordingly, the resistance to 
transport, Rsupport(x), was found to 
present a maximum (R u^pport™*) aAer 
which Rsupport(x) dropped down to 
zero. Below this depth, Rsupport™* 
becomes independent of the total 
membrane thickness. 
Using the ETl-MTl experiment 
(10s - 35|a,m) as a reference test, the 
Top-skin / microporous 
layer interface 
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Figure 3.24. Estimation of the pressure profile across the 
membrane thickness (MT) using a parametric mass-
transport model. Data from the ET,-MT, test (10s-35|im) 
were used for the simulations. 
lumped parameter D s d K s was estimated considering Rsupport""^  = Max ( R s u p p o r t ( x ) ) in Eq. 
3.19. Maximum R s u p p o r t ( x ) was obtained at around 2 pm membrane depth. Since R s u p p o r t ( x ) 
dropped down below 2 pm depth, at this point pressure on the membrane fell down to zero 
(Fig. 3.24). As pressure difference is the driving force for OSN transport, no significant 
driving force was present beyond this point. In contrast with the literature which considers 
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the top-layer as the only controlling resistance or active layer, the model predicts that 
significant driving force also exists in the microporous region (up to 2 |im depth). 
The mechanistic mass-transport model indicated that Rsupport(x) was independent of the total 
membrane thickness (Fig. 3.24). However, this is clearly not consistent with the ANOVA 
results in which CT had a significant effect on mass transport during OSN. So it is 
concluded that the mechanistic model suggested here is insufficient to explain solvent 
transport in nanofiltration as a function of the formation parameters. 
Using a multivariate linear regression, a quadratic model was obtained with all the 
coefficients significant at 95% confidence level: 
y ' '" = + jg . .Mr + jg;. + jg;. M r ' (Eq. 3.27) 
E 
Predicted response surface 
X Experimental data 
Figure 3.25. Experimental data and multivariate regression response surface for the solvent flux (J) as a 
function of the membrane formation parameters —evaporation time (ET) and membrane thickness (MT)— 
during a pressure-driven nanofiltration process. 
Figure 3.25 shows the surface response for the solvent flux, J, as a function of the 
formation-parameters ET and MT. The quadratic function fitted the data well. The plot of 
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residuals were acceptable with a standard error of 5.4 x 10"^  m s"' (not shown). The model 
predicts that for an increase in MT from 35 pm to 215 pm the flux will considerably 
decrease for both ETs. On the other hand, for an increase in ET at low MT (35 pm) the flux 
will have a reduction from 7.2 to 4.0 x 10"^  m s"^ , and almost no difference at high MT (210 
pm) from 1.0 to 0.9 x 10"^  m s ' \ Thus, it is concluded that MT has an important 
contribution to mass transport during OSN, which agrees with the previous ANOVA 
results. However, as discussed in Section 3.4.4, this behaviour appears to be largely 
influenced by the physicochemical structure of the solvent employed. 
Since a precise microporous morphology could not be measured in this study, the SEM 
structural model could not take into account the effect of MT on J for the mass-transport 
mechanistic model. This effect is, nevertheless, very clear from both the ANOVA analysis 
and the regression model. Therefore, similarly to the dialysis analysis, it was concluded that 
the porous asymmetry across the microporous layer is the controlling factor in the OSN 
solvent transport, rather than the top-layer thickness. The asymmetry of the microporous 
layer is affected by both formation-parameters, ET and CT, but especially by the latter. 
3.5. Conclusions 
The membrane-formation parameters, ET and CT showed a coupled effect on the 
membrane thickness (MT) which was explained in terms of top-layer formation during 
membrane casting. For a concentration-driven dialysis and pressure-driven OSN both ET 
and CT (or MT) had significant effects (P = 0.05) on mass transport. Casting thickness has 
the greatest effect on membrane mass transport rates and can be used to improve these rates 
in diffusion-mode membrane systems. Multivariate regression was used to model both 
operational modes with an acceptable fit. 
A representation of the membrane asymmetry was obtained from SEM pictures and 
literature data and used to formulate a mass-transport mechanistic model based on a 
resistance-circuit analogy. Two well-defined structures were identified: a top layer and a 
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microporous layer. Assuming a variable top-layer thickness, dialysis transport was 
adequately described with this model; however, no differences in top-layer thickness were 
observed by SEM. Moreover, no proof of increasing top-layer thickness as a function of the 
formation parameters has been reported in the literature. Additionally, in contrast to the 
regression, the OSN mass-transport model could not account for MT effects on solvent flux 
due to difficulties on the characterisation of the microporous asymmetry of the membrane. 
Therefore it is concluded that the membrane-formation parameters ET and CT have a 
coupled effect on the development of the asymmetric structure in the microporous layer, 
with CT having the most significant effect. Furthermore, it is the microporous asymmetry 
of the membrane which controls the membrane mass-transport rates, rather than the top-
layer thickness. 
OSN membranes with improved mass transport rates can greatly assist in reducing mass 
transfer limitations in MBB systems. In the development of these membranes both ET and 
CT need to be considered, with CT being the most important. The main goal will be to form 
an ultra thin membrane (very low CT) which possesses satisfactory mechanical resistance. 
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Model Biotransformation II. Aqueous Systems 
Outline 
4.1. Background and Literature Review 
4.2. Materials and Methods 
4.3. Results and Discussion 
4.4. Conclusions 
4.1. Background and Literature Review 
In Chapter 2, Model Biotransformation I was used to assess the feasibility and reliability of 
the OSN-MBB system for performing an enantiospecific biotransformation of hydrophobic 
molecules. This model reaction proved to be simple and effective to test the main thesis of 
this work and also provided a means of comparison with previous work carried out in the 
Separation Engineering and Technology (SET) research group at Imperial College using 
non-porous membrane MBBs. In this chapter, a second model reaction was selected, Model 
Biotransformation II, based on the outstanding enantioselectivity and good yield reported in 
the literature for this reaction (Homann et al. 2004), and on its great potential as a precursor 
in organic asymmetric synthesis: the reduction of acetophenone to S'-phenylethanol by the 
yeast Rhodotorula glutinis. This chapter investigates the product-formation kinetics and 
substrate feeding strategies in aqueous media for Model Biotransformation 11. 
A whole-cell redox biotransformation of a useful chiral product which results in high 
enantioselectivity, yield and volumetric productivity is very attractive for the production of 
chiral synthons in the fine chemical synthesis. The main factors in the development of an 
enantioselective bioreduction process are: (1) high enantiomeric excess (ee); (2) high 
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conversion yield; and 3) high volumetric productivities (Chartrain et al. 2001; Nakamura et 
al. 2003; Patel et al. 2004). As an initial stage, biocatalyst selection is carried out generally 
considering only the first two bioreduction factors (ee and conversion yield). Current 
research utilises high-throughput semi-automatic screening for rapid identification of 
enzymatic selectivity and activities (Chartrain et al. 1995; Chartrain et al. 2001; Homann et 
al. 2004; Miya et al. 1996; Patel et al. 2004; Shafiee et al. 1998; Shimizu et al. 1984; 
Yasohara et al. 1999). After biocatalyst selection an important amount of work is necessary 
to achieve satisfactory volumetric productivities at the desired production scale (Buhler et 
al. 2003a; Buhler & Schmid 2004; Chartrain et al. 2001; Dingier et al. 1996; Nakamura et 
al. 2003; Wong et al. 2002). 
Substrate concentration in the biomedium has been identified as the most important factor 
affecting the enantioselectivity of biocatalysts (D'Arrigo et al. 2000; Nakamura et al. 
1993a; Nakamura et al. 1993b; Nakamura et al. 1995; Nakamura et al. 2002; Patel 2000). 
Also, the substrate or product concentration in many cases inhibits the biocatalyst activity. 
Taking this into consideration, substrate concentration in the biomedium as well as feeding 
strategy are of paramount importance in the performance of biotransformations (Boontawan 
& Stuckey 2006; Carragher et al. 2001; Celik et al. 2004; Chartrain et al. 1999; Doig et al. 
2003; Fontanille & Larroche 2003; Haberland et al. 2002; Hack et al. 2000; Held et al. 
1999; Stark et al. 2003). 
There are few reports on the product formation kinetics of whole-cell biotransformations. 
The method of initial rates using batch biotransformations is the method of choice for most 
of the studies surveyed: Rivas et al. (2003) reported that the biotransformation of thiophene 
was first and zero order for growing and resting cells, respectively, with respect to the 
reaction substrate. Anderson et al. (1992) reported that the production of 3,4-
dihydroxyphenyl-L-alanine followed a pseudo first-order rate for each reagent in a 
multicomponent reaction. Similar equations were reported for an immobilised-cell propene 
oxidation (Brink & Tramper 1986a). Brink and Tramper (1987) formulated a simple 
propene-oxidation model assuming zero-order reaction kinetics and a first-order 
deactivation rate caused by product inhibition. 
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Michael is-Menten type kinetics have been used to study the inhibition caused by reactant(s) 
(Anderson et al. 1992; Buhler et al. 2006; Celik et al. 2004) and products (Brink & Tramper 
1986b; Leon et al. 2002). Buhler et al. (2006) used this type of kinetics to model the 
competitive use of NADH by growing cells for two different purposes: substrate 
consumption or energy production. Van der Meer et al. (1993b) modelled the inhibitory 
effect of 1,2-epoxyoctane on the growth and activity of the biocatalyst using a power-
function of the product concentrations. A similar inhibitory equation was reported by 
Levenspiel (1999). In general, even in the case of Michaelis-Menten models, most of the 
kinetic studies use semi-empirical methods since the kinetic equation is commonly fixed a 
priori for fitting the data. 
The enantioselective reduction of ketones in organic synthesis plays a major role in the 
production of chiral intermediates which can then be modified for the synthesis of fine 
chemicals (Nakamura et al. 2003). The reaction of acetophenone to chiral phenylethanol 
has been widely studied as a model reaction for ketone bioreductions (Andrade et al. 2004; 
Andrade et al. 2006; Caron et al. 2005; De Temino et al. 2005; Ferloni et al. 2004; Findrik 
et al. 2005; Groger et al. 2004; Homann et al. 2004; Hoq et al, 1984; Hoq et al. 1985; 
Hummel 1990; Hummel 1999; Hummel et al. 
2003; Inoue et al. 2005; Kurbanoglu et al. 2007; 
Vaidya et al. 1994b; Weckbecker & Hummel 
2004; Weckbecker & Hummel 2006; Westgate 
et al. 1998; Zhang et al. 2007; Zymanczyk-Duda 
et al. 2004). Homann et al. (2004) performed this 
reaction at a 10 mL scale using Rhodotorula 
glutinis as the biocatalyst. They reported a good 
yield (59%) and an excellent ee (>99%) for the 
production of S'-phenylethanol (Fig. 4.1). 
NADH 
{DrN^DPH) + hf 
NAD 
(or mcp*) 
HO, 
-Phenylethanol Acetophenone 
Figure 4.1. Model Biotransformation II: 
reduction of acetophenone to S'-phenylethanol 
by Rhodotonda glutinis. 
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In this work the above reaction was implemented in a 1 L scale bioreactor. Although this is 
a case-specific application, the study of both the reduction reaction and the biocatalyst 
performance possesses great relevance in the context of ketone reduction 
biotransformations as illustrated above. The kinetics and metabolism of the reaction were 
studied, and different fed-batch strategies were used, attempting to improve the reaction 
performance in terms of volumetric productivity and ee. The performance of the reactor 
was assessed and compared with the literature. Following this study, Chapter 5 addresses 
two strategies for in-situ product removal: aqueous-organic emulsion and membrane 
bioreactors. 
4.2. Materials and Methods^ 
4.2.1. Chemicals 
Acetophenone (99%), Aph, was purchased from Acros Organics (Belgium). Phenylethanol 
(98%), Phe, was obtained from Sigma-Aldrich (Germany). HPLC-grade n-hexane was 
purchased from Fisher Scientific Ltd (UK). Enantiopure standards (> 99%), R and .S-Phe (> 
99%) were obtained from Alfa-Aestar (UK). KOH (97%), H2PO4 and H2SO4 and volatile 
fatty acids (VFA) used as HPLC standards (acetic, formic, propionic, isobutyric, butyric, 
isovaleric and valeric) were purchased from BDH-VWR (UK). 
4.2.2. Analytical methods 
Concentrations of hydrophobic solutes were determined using an Agilent 6850 Series II 
Network Gas Chromatograph system (USA) with an HP-Chiral 20B capillary column (30 
m X 250 |im nominal diameter x 0.25 |j.m film thickness, J&W scientific, USA) equipped 
with a flame ionisation detector. In addition, this column allowed the precise quantification 
' As Chapter 4 deals with aqueous-media reactions all the concentrations implicitly refer to the aqueous 
phase. 
118 
Chapter 4. Model biotransformation II. Aqueous systems 
of the R and S enantiomers of the reaction product (Phe). Retention peaks for the 
enantiomers were determined with the use of R and S'-Phe standards. The coefficients of 
variation of three repeated measurements of heptane solutions (2.0 g L"^ ) were determined 
for Aph as 0.9%; and for R and S-Phe as 0.5 and 0.6%, respectively. External standards 
were prepared and injected for all the sample runs. Prior to analysis, biotransformation 
samples were kept refrigerated at 4 °C to reduce further catalytic activity. 
The analyses of the biotransformation aqueous samples included the concentration 
determination of hydrophobic solutes, biomass, glucose and VFA. In a complete analysis, 
1.5 mL were pipetted from the 6.5 mL biomedium samples (in 12 mL PPCO centrifuge 
tubes, Nalgene, UK) to 1.6 mL centrifuge tubes, and used for glucose and VFA tests. The 
remaining 5 mL were analysed for hydrophobic solutes and biomass. 
For analyses of hydrophobic solutes in the aqueous bioreactor (Aph, R and S'-Phe) 5 mL of 
sample were vortexed (Heidolph Reax Top tube vortex. Model 541, Germany) for 30 s 
together with 2 mL of n-hexane to extract the solutes into the organic phase. The tubes 
were centrifuged at 13,000 x g for 10 min in a Biofuge centrifuge (Heraeus Instruments, 
Germany). Then, 1 \xL of the organic phase was injected onto the GC for solute 
determination. After this, the liquid was disposed from the tubes and the biomass pellet was 
resuspended and washed with DI water. The tubes were centrifuged again and a 5 mL 
volume of DI water was added to restore the initial biomass concentration. 300 [iL of this 
suspension were diluted in 4.5 mL of DI water and its optical density was measured with a 
Helios Gamma 90-250 UV spectrophotometer (Unicam, UK). Only 50 |xL of biomass 
suspension were used for high-cell cultures (> 10 g biomass L"^ ) —fed-batch and high-
glucose cultivations. The coefficient of variation of three independent biomass 
measurements was 4.0% (14 g biomass L"^). Separately, a calibration curve was prepared 
for biomass concentrations as a function of optical density in the appropriate concentration 
range. Liquid samples were filtered through a constant-weight 0.2 p,m cellulose nitrate 
membrane (Whatman Ltd., UK), retaining the biomass. The samples were left to dry at 
room temperature to constant weight for at least 24 h. 
119 
Chapter 4. Model biotransformation II. Aqueous systems 
For the determination of glucose and VFA concentrations, the 1.6 mL biomedium samples 
were centrifuged in a Micro Centaur centrifuge (MSB, UK) at 13,000 rpm for 5 min. Then, 
a 0.5 mL aliquot was dissolved in 2 mL of DI water and filtered through a 0.2 )j,m Acrodisc 
syringe filter (Pall Co., UK) for HPLC sample injection. In the case of high-glucose 
cultivations (> 20 g L'^) a 0.5 mL:4 mL dilution was used instead. The analyses employed a 
reverse-phase LC-IOAT HPLC pump (Shimadzu, Japan) fitted with an Aminex HPX-87H 
ion exclusion column (Biorad, USA). The HPLC system was equipped with an SPD-lOA 
UV-vis detector for VFA analyses (preset at 210 nm) and an RID-1 OA differential 
refractive index detector for glucose determinations (Shimadzu, Japan). The degassed 
mobile phase, a solution of 0.01 M H2SO4 in DI water, was pumped through the column at 
a flow rate of 0.68 mL min"'. The column was maintained at 55 °C in a Shimadzu CTO-
lOAC column oven. External aqueous standards were used for VFA and glucose 
determinations and were analysed along with the HPLC tests. 
4.2.3. Strain and culture growth 
Rhodotorula glutinis ATCC-16740 was 
purchased from American Type Culture 
Collection (USA). The freeze-dried 
culture was rehydrated with 5 mL sterile 
water for 4 h, after which an inoculum 
was obtained and cultured in sterile YM 
agar plates —3 g yeast extract (Merck, 
Germany), 3 g malt extract and 10 g 
glucose (Sigma-Aldrich, Germany), 5 g 
meat peptone and 20 g of agar (BDH-
Figure 4.2. Cultured plates in YM agar for colony 
propagation of Rhodotonila gliitinis ATCC-16740. 
VWR, UK) in 1 L of DI water— and incubated at room temperature for 48 h. After cell 
colonies were formed, the plates were refrigerated at 4 °C and used as stock for shake-flask 
culfivation (Fig. 4.2). In addition, 5 mL of sterile glycerol were added to the tube and 
mixed; subsequently, the tube was stored at - 70 °C for later use. 
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An inoculum was obtained from the agar plates and grown in 100 or 200 mL shake flasks 
(500 mL screw-cap flasks) at 200 rpm and 30 °C in a New Brunswick Scientific Inc. 
incubator shaker (USA). The culture medium was prepared identically to the YM agar 
plates except for the addition of agar (standard medium preparation). Then it was left to 
grow for 48 h, after which it was either used: (1) directly in small-scale biotransformations 
of 200 mL shake-flasks or 15 mL carousel tubes (1 g L"' average biomass concentration); 
or (2) as a new inoculum (pre-culture) for a IL-scale bioreactor with an inoculum:media 
volume ratio of 100 mL:900 mL. 
4.2.4. Shake-flasks and carousel-tubes biotransformations 
A known amount of the biotransformation substrate (Aph) was added to previously 
cultured cells under aseptic conditions. Two repeat reactions were carried out for each 
experimental condition. The reaction medium, in shake flasks or carousel tubes, was 
incubated at 30 °C under constant stirring. 5 mL samples were obtained from the shake 
flasks at regular time intervals under aseptic conditions. The carousel-tube 
biotransformations were carried out in a carousel parallel-reaction station (Radley 
Discovery Technologies, UK); this apparatus provided the tubes with uniform magnetic 
stirring and temperature conditions. Samples from the carousel-tube reactions (5 mL) were 
obtained only at the end of the biotransformations. 
4.2.5. Fed-batch shake-flask tests 
A number of substrate additions (5 or 10 mg) were made into 100 mL biomedium flasks at 
24 h time intervals —equivalent to Aph concentrations of 0.05 and 0.1 g L ' \ respectively. 
Samples were obtained prior to substrate additions. 
4.2.6. Product inhibition test 
Different amounts of racemic Phe (rac-Phe) were aseptically added to cell cultures in 
carousel tubes together with an initial substrate addition (0.5 g L"'). Substrate and rac-Phe 
concentrations were measured before and after the test. Blank samples were also prepared 
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with no rac-Phe addition. The -S-Phe production was quantified by subtracting the ^-Phe 
amount before the carousel reaction from that detected at the end of the run. 
4.2.7. Bioreactor for biotransformations 
A 2 L Bioflo I stirred bioreactor (New Brunswick Scientific Ltd, UK) was fitted with an O2 
probe, a thermocouple and a glass pH probe. Air at a flow rate of 0.5 L min"' was bubbled 
into the bioreactor. The pH was controlled at a value of 7.0 by addition of 4M KOH or 2M 
H2PO4. The reactor was maintained at a constant temperature of 30 °C using a heating 
jacket. Dissolved oxygen concentration, pH and temperature were read periodically. 100 
mL of shake-flask pre-culture were inoculated in 900 mL bioreactor sterile medium 
prepared as above, giving a working volume of 1 L. A 400 rpm stirring rate and 10 g L"' 
initial glucose concentration, [Glujo, were used as the standard medium cultivation. High 
biomass concentration cultures were prepared using two different methods: (1) Fed-batch 
cultivation. A standard cultivation medium (1 L) was grown for 24 h, after which sterile 
medium was added to the reactor at a feed rate of 0.4 mL min"' with a 600 rpm stirring 
speed. The medium comprised 25 wt% glucose, 2.5 wt% peptone, and 1.5 wt% yeast and 
malt extracts; (2) Batch cultivation. A high [Glu]o (40 g L"') and a stirring speed of 600 
rpm were used.. Samples for growth monitoring were obtained after the reactor reached 30 
°C. The growth rate of R. glutinis was determined from the exponential phase of batch 
cultivations at different [Glu]o (Bailey & Ollis 1987; Kovarova-Kovar & Egli 1998). 
Following a growing period (24 h for standard cultivations), O2 consumption declined, 
indicating that a stationary growth phase was reached. At this point an initial Aph pulse was 
added to the bioreactor and an initial 5 mL sample was obtained after 5 min, followed by 
periodic sampling to track the progress of the reaction. When no additional substrate or 
glucose was added to the biomedium, the reactor was called batch reactor, in contrast to the 
fed-batch reactors defined below. Batch reactors were used for studying product formation 
kinetics. 
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4.2.8. Effect of processing conditions on biotransformation 
Table 4.1 lists the processing conditions and reactor configurations used for characterising 
the performance of the IL scale reactor biotransformations. 
4.2.8.1. Anaerobic biotransformation 
Following bioreactor pre-culture propagation, nitrogen gas was sparged into the reactor, 
instead of air, to remove dissolved oxygen thus creating anaerobic conditions. After 15 min 
of nitrogen sparging, a batch biotransformation was commenced with continued nitrogen 
sparging. 
Table 4.1. Operational conditions for IL-scale aqueous bioreactors. 
Reactor name Working 
volume 
(L) 
Culture 
growth 
[Biomass]o 
(g]L^) 
So 
(g L^) 
Fed mode" Aph feed 
(g h"' or 
(g L^)) 
Glucose 
feed 
(g h"' or 
(g L ' ) ) 
Aph Glu 
Grow-FB 1.0 Batch 4 0.5 Int. 
(25h) 
Int. 
(45h) 
(0.5) (10) 
FB-Int 1.5 Fed-batch 14 1.1 Int. 
(22h) 
Cont. (1.3) 1.5 
FB-Cont 1.4 Fed-batch 21 0.7 Cont Int. 
(24h) 
0.20 (10) 
FB-Cont-Glu-1 1.0 Batch 15 0.8 Cont. Cont. 0.24 1.5 
FB-Cont-Glu-2 1.0 Batch 14 0.8 Cont. Cont. 0.16 1.5 
^ Aph = acetophenone feed; Glu = glucose feed; Int. = intermittent; Cent. = continuous. For intermittent 
feeding mode in parenthesis: (time of pulse-addition). 
4.2.8.2. Growing-cells fed-batch biotransformation (Grow-FB) 
An Aph pulse (0.5 g) was added to the reactor (0.5 g L"') after bioreactor inoculation with 
pre-culture, thus stimulating cell growth and biotransformation concomitantly in the 
bioreactor. Additional substrate (0.5 g) and glucose (10 g) pulses were added to the 1 L 
reaction media at 25 and 45 h, respectively. 
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4.2.8.3. High-cell intermittent fed-batch bioreactor (FB-Int) 
The fed-batch cultivation with continuous addition of growth medium produced a 1.5 L 
culture with high biomass concentration. After culture growth, the biotransformation was 
started with a 1.1 g L'^  initial substrate concentration (So); an intermittent substrate pulse 
(1.3 g L" )^ was added at 22 h. 
4.2.8.4. High-cell continuous fed-batch bioreactor (FB-Cont) 
High-cell reactors used a stirring speed of 600 rpm. Two different feeding strategies were 
used; (a) fed-batch continuous substrate addition, FB-Cont, during which substrate only 
was added (0.2 g h"^), with the reactor prepared using a fed-batch cultivation (Section 
4.2.7); (b) fed-batch continuous substrate and glucose addition, FB-Cont-Glu, during 
which substrate (0.24 g h'^) and glucose (1.5 g h" )^ were continuously added to the reactor. 
In this case, the reaction media was grown with a single batch cycle using a 40 g L"' [Glu]o. 
Continuous substrate addition was achieved by using a 10 mL air-tight syringe (SGE, UK) 
fitted to an automatic syringe infusion pump (Harvard Bioscience, USA). 
4.2.9. Biotransformation performance parameters 
The following concepts were used for characterising the performance of the Model 
Biotransformation II (Chapters 4 and 5): 
p 
Product yield Y = 
p 
Specific activity SA = 
biomass x t 
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S-Phenylethanol enantiomeric excess (ee): (5') ee (%) = 
( s ) + m 
xlOO. 
4.3. Results and Discussion 
4.3.1. Shake flask and carousel tube experiments 
4.3.1.1. Effect of initial substrate concentrations 
Shake flasks experiments were 
performed for screening biocataiyst 
activity, which consistently resul-
ted in enantiopure biotransforma-
tions (S-Phe selectivity). Figure 4.3 
shows the effect of So on the 
specific activity considering 24 h 
reaction intervals. The specific 
activity increased with So. A 
reduction in the reaction rate took 
place for samples taken at 48 h. 
However the activity drop for the 
lowest So (0.1 g L"^ ) was caused by 
the lack of substrate availability. 
I 
E 
.2 6 
St 
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* 
£ 2H 
u 
I 
\ 
\ 
— • — 0.1 g L-' 
— • — 0.2 g L ' 
A — 0.3 g L ' 
— — 0,5 g L ' 
X — 1.0 gL-^ 
. 
\ 
\ 
\ 
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Time (h) 
60 70 80 
Figure 4.3. Specific activity as a function of time for different 
initial acetophenone concentrations in shake-Oasks 
biotransformations of acetophenone to ^-ptienylethanol by R. 
ghitinis. 24 h reaction intervals were considered in 
calculations. 
since Aph consumption after 24 h reaction was 0.84 mol eq. For higher concentrations, the 
reduction in specific activity was not caused by substrate limitations. After 48 h, the 
biocatalytic activity remained constant up to 72 h. The specific activity did not drop to zero, 
but a constant low-level activity remained for an extended period. 
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4.3.1.2. Substrate inhibition 
An additional experiment was 
performed to test the inhibitory effect of 
So on the biocatalyst activity (Fig. 4.4). 
Similarly to the previous experiment, 
the specific activity increased with So 
until an inhibitory concentration was 
exceeded (3 g L"'). Some activity was 
observed at So up to 20 g L"\ which is 
above the solubility of acetophenone in 
water (4.2 g L"') (Fletcher et al. 1996). 
The observed increase in specific 
activity at this concentration was 
probably due to cell permeabilisation in 
the presence of dispersed acetophenone. 
Run 1 
Acetophenone Initial concentration (g L ) 
Figure 4.4. Effect of the intial acetophenone 
concentration on the peformance of the 
biotransformation of acetophenone to S-phenylethanol 
in carrousel tubes (24 h run). Two independent runs 
were performed (x-axis not at scale). 
4.3.1.3. Fed-batch 
biotransformations 
shake-flasks 
Figure 4.3 showed a great reduction in 
specific activity with reaction time. To 
gain a deeper insight, small substrate 
amounts were intermittently added (fed-
batch) into shake flasks (0.05 and 0.1 g 
L"') at 24 h intervals (Fig. 4.5). In 
contrast to the batch experiments (Fig. 
4.3), the resulting specific activity was 
high during prolonged reaction periods 
for both Aph-addition levels. The yields 
for all the batches were close to 1 mol 
0.05 a L 
B1 (24 h) B2 (48 h) 83 (72 h) 
Batch number (time) 
Figure 4.5. Fed-batch biotransformation of acetophenone 
to 5-phenylethanol by R. glutinis in shake flasks. Two 
tests were performed in duplicate using different batch 
substrate additions equivalent to acetophenone 
concentrations of 0.05 and 0.1 g L"'. Substrate pulses 
were added every 24 h during 72 h. Error bars represent 
the 95% confidence interval for two independent runs. 
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eq., with an almost stoichiometric 5'-Phe total yield (0.98 mol. eq.) for a total Aph 
concentration equivalent to 0.3 g L"'. This is in contrast to the 0.9 mol eq. yield obtained for 
this concentration in the batch experiment, which indicates that the fed-batch strategy 
improved the conversion efficiency of the biocatalyst. For this reason, fed-batch reactors 
were used extensively further in this work. 
4J.L4. Effect ofNADPH 
At present the enzyme responsible for Model Biotransformation II (Fig. 4.1) has not been 
identified; thus the cofactor dependence of the enzyme is still not clear. Aph reduction by a 
NADH-dependent carbonyl reductase from Candida parapsilosis was reported to produce 
5'-phenylethanol (Peters et al. 1993; Rissom et al. 1999). On the other hand, Findrick et al. 
(2005) and Mertens et al. (2003) reported a NADPH dependent alcohol dehydrogenase 
(ADH) from Thermoanaerohacter sp. catalysing the Aph reduction with ^'-alcohol 
selectivity. 
To investigate the cofactor dependence for the model reaction a shake-flask 
biotransformation was performed in which NADPH was added directly to the reaction 
media. An additional purpose of this test was to observe the effect of external NADPH 
addition on the reaction yield and biocatalytic activity. Two NADPH concentrations were 
used: 0.12 and 1.0 mol eq., and two substrate concentrations: 0.5 and 1 g L"'. The activity 
of the cells was compared to that without NADPH addition. No significant difference in 
reaction activity was observed with cofactor addition at the 95% confidence interval (data 
not shown). Considering this result and assuming that cofactor availability is limiting the 
productivity of the yeast, it was hypothesized that the model reaction is carried out by a 
NADH-dependent oxidoreductase. However, further tests with NADH and NADPH 
additions in a free-cell enzymatic system need to be performed to attest this hypothesis. 
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4.3.1.5. Product inhibition 
The effect of the addition of rac-Phe on 
the biocatalyst performance was studied 
with constant So (Fig. 4.6). Concentra-
tions of rac-Phe above 0.5 g L"' severely 
inhibited the biocatalyst activity compared 
to the control. A total halt to bioreduction 
activity occurred at rac-PhE 
concentrations higher than 2 g L ' \ 
indicating a severe disruption of the cell 
metabolism or cell death. 
Average 
rac-Phenylethanol initial concentration (g L ) 
Figure 4.6. Effect of initial phenylethanol 
concentration on the catalytic activity during a 24 
h reaction period for the biotransformation of 
acetophenone to S-phenylethanol by R. glutinis. 
Two independent runs were performed. 
4.3.2. Kinetics of product formation 
Product formation and cell growth kinetics for the model biotransformation were studied in 
1 L batch bioreactors. Figure 4.7 shows an example of a resting-cell biotransformation with 
So = 0.4 g L'^  and no glucose addition. The maximum product concentration, Pmax, was 0.32 
g L"' (0.87 mol eq. yield) at 22 h, after which no further change in product concentration 
was observed and biomass concentration started to fall. Acetic acid began to form early in 
the reaction (3 h) with a peak at about 7.5 h. Product formation was systematically coupled 
to the production of a metabolite in large amounts which was preliminarily characterised as 
valeric acid using HPLC and external standards. However, the overall mass balance in the 
reactor could not account for the valerate production determined by HPLC. In addition, no 
chemical or biochemical route was found in the literature for the production of valeric acid 
during the reaction. A precise identification of the metabolite was not possible in this work. 
Despite the analytical limitations and due to the relevance of the metabolite to the reaction, 
the unknown compound was treated as valeric acid for further analysis. 
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Figure 4.7. Example of a 1 L batch biotransformation in a 2 L bioreactor for the reduction of acetophenone to 
•S'-phenylethanol by R.glutinis. Reactor performance was followed by measuring the product, biomass, acetate 
and valerate concentrations as a function of time. A 0.4 g L"' initial acetophenone concentration was used; no 
glucose was added during the biotransformation. 
As for the previous example, a series of batch biotransformations were performed using 
different levels of So (Fig. 4.8). At first glance we can observe that for all the So tested, a 
remarkably high reaction rate takes place within a very short period of time (5 min) just 
after Aph addition. The product formation rate during this high-rate reaction period, termed 
Phase-1, increased with Sq. Following this period, product concentrations increased at a 
much reduced rate, and eventually no further increase was observed. 
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Figure 4.8. Product concentration profiles for 1 L batch biotransformations of acetophenone to S-
phenylethanol by R. gliitinis using different acetophenone initial concentrations (0.2 to 2.0 g L"'). 
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The method of the initial rates was used to determine the order and the reaction constant 
according to the following equation (Atkins & De Paula 2002): 
log(5L4' )o = " • log So + log Eq. 4.1 
In order to kinetically characterise the Phase-1 reaction, the logarithm of the initial specific 
activity was plotted against the logarithm of Sq. The initial specific activity was calculated 
from data obtained at 5 min of reaction'. With this consideration, the experimental data 
yielded a linear curve with acceptable fit (Appendix B, Fig. Bl) and the Phase-1 rate was 
estimated to be a first-order reaction with a reaction constant ki = 4.8 h''. No inhibitory So 
concentrations were reached in the concentration range tested. This is consistent with the 
carousel-tube substrate-inhibition tests (Fig. 4.4) which indicated Aph inhibition at So > 3 g 
L-\ 
A two-stage reaction course can be 
clearly observed in Fig. 4.8. The 
reaction period following the first 
reaction stage, called Phase-2, was 
studied considering the linear part 
of the product-formation curves in 
Fig. 4.8. Phase-1 reaction rates 
were at least two orders of 
magnitude greater than their 
Phase-2 counterparts. Depending 
on So, two different Phase-2 rates 
were observed (Fig. 4.9): (1) for So 
up to 0.5 g L"', the Phase-2 
reaction rate increased with So; (2) 
for So > 0.5 g L"\ the reaction 
Po" (9 L ' ) 
0.1 0.2 0.3 0.4 0.5 
E '» -
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/ \ 
Experimental data 
Sub-inhibitory curve 
Inhibitory curve 
/ 
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0.0 0.5 1.0 1.5 2.0 
Figure 4.9. Phase-2 reaction rates for the I L batch 
biotransformation of acetophenone to S-phenylethanol by R. 
glutinis as a function of: (1) the initial substrate concentration 
(bottom axis), So; (2) the product concentration at the 
beginning of Phase-2 period (top axis), Pq. A stage-wise 
regression was performed for the rate curves considering two 
stages: subinhibitory ( ) and inhibitory ( - • - ) . The 
calculation of the reaction rate (specific activity) considers 
only the linear part of the data which follows the Phase-1 
reaction period. 
' A more accurate kinetic estimation requires experimental data within the first 5 min of reaction. 
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rates decreased as So was increased. Apparently an inhibitory So was reached in the latter; 
however, considering the product concentrations at the start of Phase-2 (Fig. 4.9, top axis), 
Pq^ ,^ it appeared evident that the 5'-Phe produced in Phase-1 inhibited the biotransformation, 
consistently with the carousel-tube product-inhibition results (Section 4.3.1.5). 
The analysis of the Phase-2 reaction using a Michaelis-Menten type equation (Celik et al. 
2004) was not successful probably due to the sharp discontinuity in the experimental data at 
So = 0.5 g L"' (Fig. 4.9). Judging by the fact that just few data points were obtained at So < 
0.5, this discontinuity may be caused by low precision in the measurements. Despite this 
limitation, the available data was further used to model the Phase-2 rate. Considering the 
above discontinuity, a piece-wise analysis was performed and two rate equations were 
obtained for Phase-2: 
(1) A first-order reaction rate was obtained for sub-inhibitory product concentrations (Po" < 
0.22 gL'^): 
=6.0 .^0+0.41 Eq. 4.2 
Since Phase-1 reaction occurs at an outstandingly high rate, little resistance to the diffusion 
of substrate and product to (and from) the biocatalyst is evident in the cell. Considering 
this, the concentrations of Aph and Phe in the cell membrane may play a significant role in 
the reaction mechanism. However, a deeper study of this reaction in isolation is needed to 
explain the observed chemical shock. 
(2) A deactivation power-law rate was obtained for inhibitory product concentrations (Po" > 
0.22 g L"'). Similar equations have been reported in the literature for product inhibition 
(Levenspiel 1999; Vandermeer et al. 1993). 
Eq.4.3 
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Despite the fact that carousel-tube product-inhibition experiments (Fig. 4.6) used high Pq (> 
0.5 g L"') compared to the obtained in the kinetic experiments, the reaction rates in the 
former tests for Pq = 0.5 and 1.0 g L"^  were in good agreement with the Phase-2 rate 
equation (Eq. 4.3). So, in conclusion it is assumed from this study that the 
biotransformation kinetics follows a two-step rate law; Phase-1 (SA^) and Phase-2 (SA"). 
4.3,3. Kinetics of cell growth 
R. glutinis growth followed Monod-type growth kinetics with a maximum growth rate, 
Umax, of 0.17 h"' (Appendix B, Fig. B2). A similar result (|J.max= 0.20 h"') was reported for 
R. glutinis L-1816 at 25 °C using glucose as the carbon source and basal media (Martinez et 
al. 2006). Ratledge and Hall (1979) reported a biomass wash-out in a continuous culture of 
R. glutinis NCYC154G at a dilution rate of 0.12 h"' growth under glucose or nitrogen 
limitations. 
Cultures with high biomass concentration (> 10 g L"') were achieved by using fed-batch 
cultivations (continuous growth-media addition) subsequently to the standard batch cycle. 
Biomasss concentrations up to 20 g L"' were obtained with this method. A second biomass-
concentration sigmoid curve takes place after the first batch cycle with a |a = 0.03 h"' which 
was low compared to |j.max- Since high biomass concentrations could be achieved with a 
single-cycle batch culture using high [Glu]o (> 40 g L"^), this method was used as an 
alternative for high-cell cultivation. 
To study the relationship between cell growth and product formation, a IL batch 
biotransformation was carried out using growing cells and So = 0.5 g L"'. Unfortunately 
with the available data it was not possible to define the exponential-growth phase with 
precision (Fig. 4.10). Nevertheless the specific growth rate, (x, was estimated as 0.21 h"' 
considering a lag phase of 6 h from previous growth-kinetic experiments. The estimated |a, 
is close to that obtained in the kinetics experiment for jXpiax, and to that reported in the 
literature. This means that the growth rate was not affected by the cells' biotransformation 
activity at So < 0.5 g L ' \ 
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Figure 4.10. Effect of growth conditions on the performance of the 1 L batch acetophenone biotransformation 
by R. ghitinis using 0.5 g L"' acetophenone concentration at the beginning of culture growth, Grow-FB. 
Substrate (0.5 g) and glucose (10 g) pulses were added at 25 and 45 h, respectively. 
4.3.4. Effect of processing conditions on reaction kinetics 
In order to obtain product formation kinetic information from the fed-batch 
biotransformations, step-wise analyses were performed using discrete linear reaction 
intervals; in this way, partial reaction rates were estimated. Biomass concentration during 
most of the experiment was relatively constant except for the growing-cell 
biotransformation. In this case, an average biomass concentration was used for the 
calculation of the specific activities. 
4.3.4.1. Growing-cell biotransformation (Grow-FB) 
Product formation increased linearly with time independently of cell growth: productivity 
was constant during both the exponential and the stationary growth phases (Fig. 4.10). At 
24 h reaction time, Aph was nearly depleted (0.85 mol eq. Aph consumption) and a 0.65 
mol eq. yield was obtained with a specific activity of 5 mg h"' g"' biomass —unconverted 
Aph was apparently consumed by the cells during growth. At this time, an Aph pulse was 
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added producing a 50-fold increase in the reaction rate. This rate was in the same order of 
magnitude as the Phase-1 rates studied earlier, and similarly, it lasted for a very short 
period of time (5 min) which was immediately followed by a low reaction rate (5.5 mg h"' 
g'^  biomass). 
Despite negligible biotransformation product formation occurring in the latter period, the 
biocatalyst consumed large amounts of Aph (0.7 mol eq.), which was indicated by a 
reduction in the mass balance (Fig. 4.10). The biocatalytic activity was boosted again (3.5 
mg h"' g'^  biomass) when a glucose pulse was added to the reactor (10 g L"') at 43 h, and 
remained constant until the end of the reaction run. Although this rate was slower than the 
initial productivity during the growth phase, it was within the rate range estimated from the 
Phase-2 kinetics. The fact that the biotransformation activity restarted with the addition of 
glucose suggests that during the unproductive period the cells were suffering carbon 
starvation, thus using Aph for maintenance only. 
4.3.4.2. Anaerobic biotransformation 
During an anaerobic biotransformation, only Phase-1 reaction was observed after which no 
further ^-Phe was produced; however substrate was continuously consumed and 
metabolised by the cells, probably as a carbon source. 
4.3.4.3. Intermittent fed-batch biotransformation with high cell concentration (FB-Int) 
Following fed-batch cultivation leading to high cell concentration, a 1.5 L 
biotransformation was started with So = 1.3 g L"' (Fig. 4.11a). The Phase-1 reaction was 
slightly low (127 mg h"^  g"^  biomass) but in the range of the kinetic model. A possible 
explanation for this may be that the high [Glu]o in the biomedium at the start of the reaction 
(34 g L"') suppressed the biocatalyst activity (Fig. 4.11b). Similar observations have been 
reported in the literature (Buhler et al. 2003b; Chartrain et al. 2001; Reddy et al. 1996). 
The period that followed Phase-1 (1.5 - 5h, dashed vertical lines in Fig. 4.11a) presented a 
Phase-2 production rate (3.4 mg h"^  g"' biomass) and a reduction in the mass balance 
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probably due to Aph degradation by the cells. A significant rate reduction occurred after 
this period to 0.7 mg h"' g"' biomass. This was attributed to product inhibition since the 
product concentration at this stage (0.47 g L"^ ) surpassed the inhibitory concentration. The 
inhibited rate was nevertheless lower than that calculated with Eq. 4.3. (1.9 mg h"' g"' 
biomass). 
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Figure 4.11. Fed-batch biotransformation at higli biomass concentration with intermittent substrate addition, 
FB-Int. Performance of the 1.5 L biotransformation of acetophenone to 5-Phenylethanol by R. ghUinis after a 
constant fed-batch cultivation period. A 2 mL substrate pulse (1.3 g L"') was added at 22 h of reaction, (a) 
Product, substrate and biomass concentrations over time; (b) glucose, valerate, acetate and isobutyrate 
concentrations over time. 
Concomitantly, considerable amounts of valeric acid were accumulated in the reactor. 
Product inhibition tests in Section 4.3.1.5 demonstrated that phenylethanol addition to the 
biomedium causes severe inhibition to the biocatalyst activity. This behaviour was in 
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agreement with the rate equation obtained with the kinetic model in the inhibitory range 
(Section 4.3.2, Eq. 4.3). Therefore, the reaction product was considered further as the main 
cause of inhibition to the biocatalyst. 
Surprisingly, the productivity was re-established at 18 h within the range of the sub-
inhibitory Phase-2 rates (3.4 mg h"^  g"' biomass). In contrast to the Grow-FB reactor, the 
reaction rate was enhanced despite both reactors suffering glucose limitations. However in 
the case of FB-Int, glucose was depleted just prior to this period so glucose starvation was 
not severe; at this stage the cells should be able to use their energy reserves (threalose and 
glycogen) for maintenance (Aranda et al. 2004; Cappaert & Larroche 2004; Jorgensen et al. 
2002). In addition, the valeric acid produced in Phase-1 was apparently consumed by the 
cells at this stage (Fig. 4.11b). However, a similar reduction in valeric acid concentration 
was not observed in later experiments. Nevertheless, it was established that glucose and 
acetate have an important regulatory effect on the rate increase. The influence of acetic acid 
accumulation in redox biotransformations has been reported previously (Buhler et al. 
2003b; Cappaert & Larroche 2004; Park et al. 2006). 
Similarly to the growing biotransformation, when a second Aph pulse was added to the 
bioreactor, the reaction rate underwent a 40-fold increase to 146 mg h"' g"' biomass, which 
corresponds to a Phase-1 order of magnitude (Fig. 4.1 la). A remnant high-activity (11 mg 
h"^  g"^  biomass) was observed during the following hour, after which productivity 
considerably decreased to 0.4 mg h"' g"' biomass, close to that predicted by the Phase-2 
inhibitory rate equation (Eq. 4.3, 0.6 mg h'^  g"' biomass). The addition of the Aph pulse 
also corresponded to a considerable increase in acetic and valeric acid concentrations —the 
latter to a greater extent— which remained constant for the rest of the reaction (Fig. 4.1 lb). 
The high-cell culture was more robust than previous reactor cultures. The cells were able to 
recover their activity after the initial Phase-1 period, thus overcoming an inhibitory product 
concentration (0.5 g L"^). In addition, the reactor allowed a second 1.3 g L"' substrate pulse 
with a reaction rate in the Phase-1 range. 
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4.3.4.4. High-cell continuous fed-batch biotransformation 
Continuous and slow addition of Aph directly to the bioreactor was performed aimed at 
obtaining stable and continuous production of ^-phenylethanol using two different fed-
batch modes (Fig. 4.12): 
(1) Fed-batch continuous injection (substrate only): FB-Cont 
Despite the fact that a large amount of Aph was continuously added to the reactor, substrate 
concentration remained low (< 0.2 g L" )^ during most of the reaction run (Fig. 4.12A1). In 
addition, a remarkably low mass balance was observed during the first 7 hours of reaction. 
This suggests that major substrate absorption by the biomass took place in this system. 
Since no initial Aph pulse was added to the bioreactor, a very low reaction rate (22 mg h"' 
g"' biomass) was observed over the first 5 min. Following this period, two reaction rates 
were observed: first (0.1-10 h), the rate was constant at about 1.3 mg h"' g"^  biomass; 
second, the rate increased to 3.2 mg h"' g"^  biomass at about 14 h and was kept constant 
until 26 h (Fig. 4.12A1). Along with the rate transition, glucose and acetic acid 
concentrations were metabolised and depleted (Fig. 4.12A2), thus probably derepressing 
the biocatalytic activity. 
Significant valeric acid accumulation occurred in the first hour of the reaction (Fig. 
4.12A2). Following this period, acetate concentration increased to a peak corresponding to 
the start of a valeric acid plateau (up to 19 h). When acetic acid was depleted, valeric acid 
resumed its accumulation at a high rate, thus reaching a high concentration similar to that 
obtained in the FB-Cont reactor. The high concentrations of ^-Phe caused a total cessation 
of the biotransformation activity at 26 h, which was indicated by a start on Aph 
accumulation in the bioreactor (Fig. 4.12A1). Finally, in an attempt to maintain the 
biocatalytic activity, glucose was added to the reactor (10 g L"') at 24 h; however, this 
addition did not appear to avoid biocatalyst inactivation (Fig. 4.12A2). 
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Figure 4.12. Continuous-addition fed-batch bioreactor for the reaction of acetophenone to 5'-Phenylethanol by 
R. glutinis at high biomass concentration. Two feeding strategies were used: (A) (left) FB-Cont, 0.2 g h"' 
substrate addition and (B) {right) FB-Cont-Glu-1, 0.24 g h"' substrate and 1.5 g h"' glucose addition. Plots 
above: product and substrate concentrations, and amount of substrate added over time. Plots below: glucose, 
biomass, acetate and valerate concentrations over time. 
(2) Fed-batch injection (substrate and glucose): FB-Cont-Glu 
In addition to Aph, glucose was also fed to the bioreactor, aiming at preserving biocatalyst 
activity. Two experiments were conducted, FB-Cont-Glu-1 and FB-Cont-Glu-2, using 
different substrate additions, respectively: 0.24 g h'^  and 0.16 g h"\ Since the performance 
of the two reactors was similar, only FB-Cont-Glu-1 will be discussed in detail. The 
performance of FB-Cont-Glu-2 is depicted in Appendix B (Fig. B3). 
Similarly to the FB-Cont test, significant substrate absorption by the biocatalyst occurred in 
the FB-Cont-Glu-1 reactor. Aph absorption was indicated by the low mass balance during 
the first 15 h (Fig. 4.12B1), as substrate concentrations remained constant at a low level (< 
0.2 g L"'). The initial reaction rate (210 mg h"' g"' biomass) was relatively low but in the 
range of the Phase-1 rate. The lower [Glu]o in this experiment (9 g L"'), compared to those 
in FB-Int and FB-Cont, appears to reduce glucose repression of the biotransformation. This 
138 
Chapter 4. Model biotransformation II. Aqueous systems 
mechanism is reinforced considering that high Phase-1 rates were obtained in the batch 
reactors which contained no glucose at the start of the reactions, so apparently no 
significant glucose repression of the biotransformation ocurred. Thus, the glucose level in 
the reactor appears to regulate the Phase-1 biocatalytic activity. 
After Phase-1, the biotransformation followed two reaction periods similarly to FB-Cont: 
(1) first (2-15h), reaction occurred at a productivity of 1.7 mg h"' g"' biomass, and valeric 
acid accumulated reaching a plateau at 5 h which corresponded (similarly to FB-Conf) to a 
decrease in acetic acid concentration (Fig. 4.12B2); (2) second (> 15 h), the reactivation of 
valeric acid production at 15 h corresponded to an increase in product concentration with 
time (Fig. 4.12B1); i.e., at this stage a second Phase-2 period with augmented productivity 
(5.1 mg h"^  g'^  biomass) was triggered and was held until the end of the run. The start of 
this period clearly corresponded to the total depletion of acetic acid in the bioreactor (Fig. 
4.12B2) similarly to the FB-Cont test (Fig. 4.12A2). Since in FB-Cont-Glu-1 glucose was 
constantly fed, an effect of glucose on the regulation mechanism can be disregarded. This 
suggests that acetic acid concentration regulates the metabolism of the biotransformation 
involving 6'-Phe productivity and valeric acid accumulation during the Phase-2 period. 
Additionally the latter period presented a slight increase in the rate of glucose accumulation 
(Fig. 4.12B2) concomitantly with a large increase in mass balance and Aph accumulation 
(Fig. 4.12B1); the latter contrasted with the constant Aph concentrations observed in FB-
Cont. The observed substrate accumulation may be caused by the release of retained Aph 
by the cells due to cell damage (or permeabilisation). Moreover, a partial and progressive 
disruption of the cells' metabolism probably caused the observed reduction in glucose 
consumption. 
4.3.4.5. Enantiomeric excess (ee) 
All the batch biotransformations (shake flasks, carousel tubes and bioreactor) and the 
Grow-FB reactor yielded enantiomerically pure products. However, considering the first 30 
h of the IL-scale reactors, a reduction in the biocatalyst enantioselectivity was observed for 
the FB-Cont run (Fig. 4.13). 
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A great reduction in [Glu] during the 
valeric acid plateau in Fig. 4.12B1 
seems to be related to the ee drop. 
Glucose concentration possibly regu-
lated the enzymatic activity, with the 
effect that it enabled enzymes with R-
selectivity (Chartrain et al. 2001; Reddy 
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seems to be a complex mechanism in which not only glucose is involved. 
Additionally, the FB-Cont-2 reactor also suffered a drop in the ee at 25 h (Fig. 4.13). This 
behaviour was similar to that observed in some systems in Chapter 5. As reaction time 
increases, the catalytic system tends to lose its enantioselectivity, probably due to changes 
in the biomedium composition and cell metabolism. 
4.3.4.6. Summary of results 
The two intermittent fed-batch experiments, Grow-FB and FB-Int, displayed their 
maximum overall productivity after the second substrate addition where a Phase-1 rate was 
observed (Table 4.2, in parenthesis). Following this fast reaction, a slow reaction period 
occurred, thus considerably reducing the overall productivity. This means that productivity 
in the intermittent fed-batch reactors does not depend on the overall reaction time, but on 
the time of substrate pulse addition. This is a very important consideration in reactor 
design, as processing times can be greatly reduced using intermittent substrate additions. 
The continuous fed-batch reactors, FB-Cont and FB-Cont-Glu, resulted in similar Pmax; 
however, higher overall maximum specific activity was obtained in the latter (Table 4.2). A 
reason for this may be the lack of an initial Aph pulse in FB-Cont which caused a very slow 
Phase-1 reaction (Table 4.2) since this reaction period has a significant impact on the final 
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overall productivity. These reactors consistently presented two sub-inhibitory Phase-2 rates 
(Table 4.2) which depended on the substrate and product levels. 
Table 4.2. Summary of productivity results obtained for the fed-batch reactors described in Table 4.1^. 
Reactor name Volume 
(L) 
P m a x 
(g L')b 
Overall 
maximum 
rate" 
Phase-1 
rate 
Phase-2 
rate (sub-
inhib.)'' 
Phase-2 
rate 
(inhib.)= 
2"^ pulse 
rate 
Grow-FB 1.0 0.5 (0.6) 2.7 (5.4) NA 5.0 0.6 260 
FB-Int 1.5 1.4(1.5) 2.3 (3.5) 122 3.4 (1)0.7 
(2) 0.4 
146 
FB-Cont 1.4 1.4 2.6 22 (1)1.3 
(2)3.2 
0.0 NA 
FB-Cont-Glu-1 1.0 1.4 4.8 210 (1)1.7 
( 2 ) 5 ^ 
NO NA 
FB-Cont-Glu-2 1.0 1.4 4.5 370 (1) 1.2 
( 2 ) 5 j 
0.0 NA 
^ Reaction rates (specific activity) in mg h"' g"' biomass; NA = not applicable; NO = not observed. 
'' Maximum product concentration. For the intermittent tests, maximum product concentration after second 
substrate pulse. 
° Reaction rate (specific activity) at overall maximum product concentration. In parenthesis: (rate after second 
substrate pulse for intermittent experiments). 
Two consecutive sub-inhibitory periods were observed in the continuous fed-batch runs. 
® Two discontinuous inhibitoiy periods were observed for the FB-Int reactor. 
Interestingly, all the IL-scale fed-batch experiments reached the same final product 
concentration regardless of their operational mode (Table 4.2). This behaviour indicates a 
reproducible biocatalyst performance despite the fact that no repeat runs were carried out 
for the different process conditions. In addition, it also may imply that a maximum 
inhibitory concentration of product was reached whereby no additional productivity 
occurred due to severe cell damage. 
Comparing intermittent and continuous substrate addition, it seems that similar 
productivities can be achieved using either feeding strategy (Table 4.2). However 
considering that the "chemical-shock" reaction rate {Phase-1) observed in this work is two 
orders of magnitude greater than Phase-2 rate, the intermittent method clearly can provide 
the best time-space yield. Since repetitive substrate additions may be performed to increase 
the final reaction yield (as for the FB-Int run), the time intervals between substrate 
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additions and Aph amounts can be optimised for obtaining the maximum overall 
productivity (Celik et al. 2004; Kovarova-Kovar et al. 2000). However, product 
accumulation will necessarily lead to the final cessation of the biocatalyst activity, as 
observed in all the IL-scale fed-batch runs (Table 4.2). 
4.4. Conclusions 
Using an empirical stage-wise kinetic model, batch biotransformations were characterised 
as two-stage reactions: (1) Phase-1, a high-rate first-order reaction which occurs in a short-
time interval (first 5 min) similar to a "chemical shock" (Eq. 4.1); (2) Phase-2, a drastic 
decrease in the reaction rate which, depending on Phase-1 product accumulation, was sub-
inhibitory (increasing first-order, Eq. 4.2) or inhibitory (decreasing power function, Eq. 
4.3). 
Product accumulation inhibited the biotransformation. Consistently in the fed-batch 
experiments, when a maximum product concentration was reached, a complete and 
irreversible cessation of the biocatalyst activity occurred, probably due to severe damage or 
death of the cells. A reaction by-product, which could not be identified in this work, 
accumulated in the bioreactor concomitantly with product formation. Glucose has an 
important regulatory effect on the metabolism of the cell. High [Glu]o (> 20 g L"') 
repressed the Phase-1 reaction; whereas glucose starvation obliged the cells to utilise 
acetophenone as a carbon source. The acetic acid level modulated product and by-product 
accumulation during the Phase-2 period. Biotransformation and cell growth are uncoupled. 
Only the Phase-1 reaction occurred under aerobic conditions. 
Two substrate fed-batch regimes were compared: intermittent and continuous. Intermittent 
substrate additions produced reaction rates with the same order of magnitude as the Phase-
1 rates. For the continuous fed-batch reactors, apart from the initial Phase-1 reaction an 
additional high-rate reaction was not observed, because no substrate pulse was added (no 
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"chemical shock"). Compared to the continuous reactors, the intermittent method clearly 
holds a greater potential for enhanced space-time yields as it takes advantage of the Phase-
1 high reaction rates. However, product accumulation inevitably leads to a total cessation of 
the biocatalyst activity, thus highlighting the importance of in-situ removal of these 
compounds during the biotransformation. Strategies for in-situ product removal are 
addressed in Chapter 5. 
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Chapter 5 
Model Biotransformation II. 
Aqueous-Organic Systems: 
Emulsion and Membrane Reactors 
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5.2. Materials and Methods 
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5.4. Conclusions 
5.1. Background and Literature Review 
Chapter 4 reported the reaction kinetics for the biotransformation of acetophenone to S-
phenylethanol in aqueous media. Using an empirical kinetic model, batch 
biotransformations were characterised as two-stage reactions: (i) Phase-1, a high-rate first-
order reaction which occurs in a short-time interval (first 5 min) similar to a "chemical 
shock"; (ii) Phase-2, a drastic decrease in the reaction rate which, depending on Phase-1 
product accumulation, was sub-inhibitory (increasing first-order) or inhibitory (decreasing 
power function). A reaction by-product, which could not be identified in this work, 
accumulated in the bioreactor concomitantly with product formation. Despite the analytical 
limitations, the unknown compound was treated as valeric acid for further analysis. 
Different feeding strategies were used, aiming at improving the reactor volumetric 
productivity. However, beyond a key concentration, product inhibition or toxicity seemed 
to cause a drastic reduction in the reaction rates and eventually the total cessation of the 
biocatalyst productivity. 
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In-situ product removal strategies have been widely used in biotransformations (Freeman et 
al. 1993; Held et al. 2000; Lye & Woodley 1999; Schmid et al. 2001) to: (1) reduce the 
inhibitory or toxic effects caused by accumulation of the biotransformation product in the 
biomedium; (2) aid product separation from the reaction media, thus reducing downstream 
processing; (3) reduce side reactions by "keeping" the product in a non reactive phase; (4) 
allow for an increased substrate loading in the extracting phase and continuous substrate-
feeding to the aqueous phase. 
Different reactor configurations have been used among which the most important are 
absorbing resins and two-phase aqueous-organic systems (emulsion and membrane 
bioreactors). These methods are based on the preferential affinity of the product for a 
second phase; this phase can be a solid (absorbing resins) or a liquid (two-phase systems). 
In the case of membrane bioreactors the product partitions to two distinct phases: a solid 
(membrane) and a liquid phase (organic solvent). 
Absorbing resins have recently received considerable attention (Anderson et al. 1995; 
DArrigo et al. 1997; Held et al. 1999; Hilker et al. 2004a; Hilker et al. 2004b; Rojanarata et 
al. 2004; Shorrock et al. 2004; Vicenzi et al. 1997). One of the reasons for their use is the 
lower biocatalyst toxicity of resins compared to the organic solvents used in two-phase 
reactors (Vicenzi et al. 1997). However, resins require extensive reactor workup; often need 
to be coupled with additional solvent extraction and filtration steps (Hoist & Mattiasson 
1991); and require a special solid-phase extraction compartment for preventing resin 
damage (Held et al. 2000). 
The use of direct-contact biphasic (DCB) reactors has provided a useful tool for 
biotransformations (Buhler et al. 2003b; Lilly 1982; Vansonsbeek et al. 1993; Woodley & 
Lilly 1990; Wubbolts et al. 1996); large-scale processes have been reported in the literature 
(Buhler et al. 2003a; Furuhashi & Takagi 1984; Panke et al. 2002; Shaw et al. 2003; 
Wubbolts et al. 1994). However, the intensive mixing of biomedium and aqueous phases 
can cause strong emulsions which considerably increase the difficulty of downstream 
separation processing. 
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Additionally, the direct contact of the organic phase with the biocatalyst can inhibit or even 
stop the productivity of the latter (Brink & Tramper 1985; Chakraborty et al. 2005; Cruz et 
al. 2004; de Carvalho et al. 2004; Femandes et al. 2002; Husken et al. 2003; Jiang et al. 
2002; Osborne et al. 1990; Rojas et al. 2004). Previously, Section 2.4 described how a 
toluene organic phase completely stopped the biotransformation activity of baker's yeast in 
a DCS reactor. In addition, using standard centrifugation, only a low recovery of the 
organic phase from the emulsified phase was possible, and a small but significant aqueous 
volume remained emulsified in the organic phase (Section 2.4.6). A common step for 
product recovery from biotransformations is distillation. Mathys et al. (1998) reported that 
the distillation costs were doubled for product separation of the recovered organic phase in 
the presence of emulsified aqueous impurities. However, distillation is only possible for 
volatile solvents. In the case of phenylethanol, with a boiling point of 204°C, distillation 
requires either high temperature or vacuum, or both. 
Membrane bioreactors for biotransformations (MSB), described in Chapter 2, have been 
used for circumventing the problems of emulsion formation and organic-solvent toxicity 
encountered in DCB systems, while enabling substrate and product transport. Besides this, 
membrane extraction allows for the practical implementation of continuous processes with 
in-situ product removal (Freeman et al. 1993). 
Chapter 2 demonstrated the feasibility of using an organic solvent nanofiltration (OSN) 
membrane for the biotransformation of geraniol to (7?^-citronellol by baker's yeast. Due to 
the very small (nano scale) pores of these membranes, no significant adsorption of 
surfactants from the aqueous phase into the membrane pores takes place, thus preventing 
the phase breakthrough observed in MBBs based on microporous membranes (Hoq et al. 
1984; Pronk et al. 1988; Vaidya et al. 1994b; Westgate et al. 1998). In addition, a 
characteristically low swelling gives OSN membranes excellent resistance to a wide range 
of solvents (Linder et al. 1993a; White 1993; White 2001), in contrast to non-porous 
silicone rubber membranes (Doig et al. 1999b). 
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The main issue encountered in the use of the OSN-MBB system is the moderate-to-low 
mass transfer rates obtained with OSN membranes. Section 2.4 showed that the adjustment 
of the reactor and membrane module configuration can help to increase the membrane area 
per reactor volume, and thus enhance the volumetric productivity. Additionally, a feeding 
strategy which continuously provides substrate directly to the aqueous phase can be useful 
to alleviate the mass transfer resistance inherent in the membrane (Boontawan & Stuckey 
200GX 
An additional important factor in two-phase reactors is the selection of the organic solvent. 
The solvent needs to be carefully chosen considering several factors such as: organic-
aqueous partition coefficient for model solutes, toxicity of the organic phase to the 
biocatalyst, effect of organic solvent on ee, volatility and explosion hazards (Brink & 
Tramper 1985; Bruce & Daugulis 1991; Chakraborty et al. 2005; Collins & Daugulis 1999; 
Cruz et al. 2004; Jiang et al. 2002; Laane et al. 1987; Osborne et al. 1990; Rojas et al. 2004; 
Villela et al. 2003). 
This chapter follows the study of Model Biotransformation II in Chapter 4: reduction of 
acetophenone to ^-phenylethanol by whole cells of Rhodotorula glutinis (Fig. 4.1). Two 
different aqueous-organic reactors were used: DCB and OSN-MBB reactors. The latter 
used an integrally skinned asymmetric OSN membrane, Starmem™ 122. A search for a 
suitable solvent was conducted considering the factors outlined above. Different feeding 
strategies were used aiming at improving the productivity of the system. The kinetic model 
developed in Chapter 4 was used to explain product formation behaviour in biphasic 
reactors. Finally, the overall performance of the reactors as well as the feasibility and 
potential of the bioreduction are discussed. 
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5.2. Materials and Methods 
Details of the analytical methods, microbial storage and propagation, as well as general 
bioreactor conditions are described in Section 4.2. This section elaborates on the additional 
experimental methods specifically used in this chapter. 
5.2.1. Chemicals and membrane 
Acetophenone (99%), Aph, n-heptane and n-hexadecane were purchased from Acros 
Organics (Belgium). Dibutyl ether (DBE), toluene, n-hexane and n-octanol were purchased 
from Fisher Scientific Ltd. (UK). Phenylethanol (98%), Phe, di-isopropyl ether, 4-methyl-
2-pentanone, isoamyl acetate and methyl tert-butyl ether were obtained from Sigma-
Aldrich (Germany). Enantiopure standards (>99%), R and 5'-Phe were obtained from Alfa-
Aestar (UK). Ethyl acetate, KOH (97%), H2PO4 and H2SO4, and volatile fatty acids (VFA) 
used as HPLC standards (acetic, formic, propionic, isobutyric, butyric, isovaleric and 
valeric acids) were purchased from BDH-VWR (UK). Starmemi""^ 122 membranes (W.R. 
Grace & Co., USA), polyimide asymmetric membranes with a nominal molecular weight 
cut off of 220 g m o r \ were kindly supplied by Membrane Extraction Technology Ltd. 
(UK). 
5.2.2. Analytical methods 
Analyses of hydrophobic solutes in organic and aqueous phases, and determination of the R 
and 5'-Phe were performed by GC. HPLC analyses were employed for the quantification of 
VFA and glucose. For the MBB systems, 1 mL samples were obtained from the organic 
reservoir and 1 \iL injected directly into the GC. Aqueous analyses were treated as in 
Chapter 4. For DCB samples, the reactor stirrer was stopped and the emulsified phases 
were allowed to settle for 1 min. Following this, a 1.4 mL sample of the top emulsified 
phase was obtained and centrifuged in a Micro Centaur centrifuge (MSE, UK) at 13,000 x 
g for 5 min. Then 1 mL of the top organic phase was pippeted out and directly injected into 
the GC (1 pL). 
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Samples for the dibutyl-ether DCB experiment in Section 5.3.2 were centrifuged at 17,000 
X g for 10 min in a Biofuge centrifuge. The samples were then slowly poured into 
separation funnels and were left in repose for 1 h. Finally, the bottom aqueous phase was 
analysed as detailed in Section 4.2.2. 
5.2.3. Strain 
Rhodotorula glutinis ATCC-16740 was purchased from American Type Culture Collection 
(VA, USA) (Section 4.2.3). 
5.2.4. Organic/aqueous partition coefficients ( n i o r g / aq ) 
The partition of Aph or Phe solutes between the organic solvents studied and the aqueous 
phase (DI water) were measured according to Section 2.2.6. The coefficients of variation 
for three measurements using n-heptane were 0.85% and 5.8% for Aph and Phe, 
respectively, with Phe morg/aq < 1.0. Only one determination was performed for the rest of 
the solvents. 
5.2.5. DCB carousel-tube biotransformations 
The carousel-tubes direct contact biphasic (DCB) biotransformations were carried out in a 
carousel parallel reaction station. These tests were used to screen the biocompatibility of a 
broad number of solvents and to study the effect of the initial organic-phase Aph 
concentration, S°%, on the biocatalyst activity. An organic solution with an initial organic 
concentration (S°'^ ®o) of 5 g L"' was aseptically added to the biomedium after 48 h of growth 
with an aqueous:organic volume ratio of 15 mL:3 mL, after which the biotransformation 
took place over 96 h. Solvent biocompatibility experiments were undertaken with S°'^ ®o = 5 
g i ; ' . 
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5.2.6. Effect of dissolved hydrophobic substances in biomedium 
An experiment was performed to test the effect of aqueous-dissolved hydrophobic 
substances on the biocatalytic activity. Selected organic solvents were dissolved in 15 mL 
of 48h-cultured biomedium in carousel tubes at concentrations which were about 80% of 
their aqueous solubility limits. Aph was subsequently added to the tubes (1 g L"') and the 
reactions were carried out over 72 h. 
5.2.7. IL-scale bioreactors for biotransformations 
5.2.7.1. Direct contact biphasic reactors (DCB) 
Following bioreactor pre-culture propagation in 1.5 L of media, an organic solution 
containing Aph was added to the biomedium with an aqueous:organic volume ratio of 1.5 
L:0.15 L. Either n-heptane or dibutyl ether (DBE) was used as a solvent, and two different 
S°% were used; 5 and 20 g L"'. 
5.2.7.2. Membrane bioreactors for biotransformations (MBB) 
Similar apparatus configuration, methods, and numerical calculations were used for the 
mass transfer and MBB experiments as in Section 2.2.7 but different substrate feeding 
modes were tested in this study (Fig. 5.1). The average volumetric flow rates were 80 and 
18 L h'^  for the aqueous and organic sides, respectively. DBE was used as the organic 
solvent and also to precondition the membrane prior to its use (Section 2.2.7). 
Two mass transfer experiments were performed: (1) single solute: a solution of either Aph 
in DBE (20 g L" )^ or Phe in water (1 g L"^ ) was used as the feed; (2) two counter-diffusing 
solutes: both Aph and Phe were loaded in the organic and aqueous phase, respectively, with 
concentrations as above. Two independent runs were carried out for each test. Mass 
balances accounted for more than 99% mass of both Aph and Phe. 
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All the MBB experiments started with an 
aqueous:organic volume ratio of 1 L:0.1 L. 
The organic solvent was firstly circulated 
through the organic side of the system. After 
reactor culture growth, water at 90 °C was 
circulated through the MBB aqueous side for 
15 min to provide hygienic conditions for the 
cells. Then the biomedium was pumped 
through the MBB aqueous side at 80 L h" ;^ 
subsequently, the organic liquid was pumped 
through the other side of the membrane at 18 
L h ' \ Following this, periodic sampling of 
the organic (1 mL) and aqueous (6.5 mL) 
vessels was carried out, as well as readings 
of the bioreactor conditions (O2, temperature 
and pH). Two feeding strategies were used in 
the MBB reactors (Table 5.1): 
Organic 
— side 
(V= 37.5 mL) 
Aqueous 
side 
OSN 
""membrane 
(A= 150 cm^) 
KOH 
OSN 
membrane Substrate" 
Aqueous solution / 
bioreactor 
Organic solution 
Figure 5.1. Schematic of aqueous/organic 
membrane contactor used for: (1) mass transfer 
experiments and (2) membrane bioreactor for 
biotransformations (MBB) using organic solvent 
nanofiltration (OSN) membranes. The dashed line 
for substrate feed shows the different feeding 
strategies used: a) initial substrate addition to the 
organic side; b) direct substrate addition to the 
biomedium by an automatic syringe injector. 
(1) Organic-phase substrate loading. These reactors contained low biomass concentrations 
(< 7 g L"') as they were cultured with just a 10 g L"' initial glucose concentration ([Glu]o). 
Aph was loaded into the organic phase prior to the reaction. Two different in DBE 
were used: 20 g L"' {MBB-20) and 40 g L'' {MBB-40). For the latter, an initial Aph pulse 
was added to the aqueous phase, S% (0.5 g L"'). An additional MBB run was carried out 
with S°% = 20 g L"' and intermittent glucose pulse additions (10 g) at 0, 22 and 47 h 
{MBB-Glu). 
(2) Aqueous-addition fed-batch reactor. A biotransformation with continuous substrate 
addition to the aqueous medium was performed using an automatic syringe infusion pump. 
High biomass concentrations (> 10 g L"') were achieved in the reaction media by using a 
single-cycle batch cultivation with 40 g L"' [Glu]o (Section 4.2). These reactors were 
supplied with an initial Aph pulse (S% = 0.75 g L"') into the aqueous phase. Two different 
continuous fed-batch strategies were used: (a) MBB-FB: only substrate addition (0.2 g h"'); 
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(b) MBB-FB-Glu: substrate (0.1 g h"^ ) and glucose (1.5 g h"') were continuously added to 
the reactor (Table 5.1). 
Table 5.1. Experimental conditions for the MBB runs for the biotransformation of acetophenone to S-
phenylethanol by R. glutinis. 
Reactor name [Biomass]o 
(g L^) 
S'"»o 
( g L ' ) 
8% 
(g L ' ) 
Aqueous feed mode'' Aph feed'' 
(g h"' or 
Glucose feed"' 
(g h"' or 
(gL-')) 
Aph Glucose 
MBB-20 7.0 20 0.0 No No NA NA 
MBB-40 6.0 40 0.5 No No NA NA 
MBB-Glu 6.2 20 0.0 No Int. 
(0 .22 .47 h) 
NA (10) 
MBB-FB 7.8 0 0.8 Cont. No 0.2 NA 
MBB-FB-Glu 16.7 0 0.8 Cont. Cont. 0.1 1.5 
Aqueous feed mode: intermittent (Int.) and continuous (Cont.). For intermittent feeding mode, in 
parenthesis: (time of pulse addition). 
'' Intermittent feeds in parenthesis (g L"'), NA = not applicable. 
5.3. Results and Discussion 
5.3.1. Solvent selection 
A number of organic solvents were selected as candidates for performing the model 
biotransformation. Table 5.2 lists the relevant physical characteristics in descending log P 
order. Large solvent log P has been related to higher biocatalyst compatibility. With this 
consideration, n-hexadecane would possess the highest biocompatibility followed by n-
heptane and DBE. 
However, as Phe is slightly polar, Phe partition between the solvent and water, morg/aq, is an 
important consideration for solvent selection. Table 5.3 shows the measured morg/aq for a 
range of solvents in ascending order of Phe partition coefficient. Comparing Table 5.2 and 
Table 5.3 it can be seen that increasing log P results in lower morg/aq- Thus a compromise 
exists between log P and morg/aq for solvent selection. 
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Table 5.2. Physical properties for different extraction solvents tested. 
Solvent Molecular weight 
(g mol"') 
Boiling point 
r c ) 
Water solubility (%) logP" 
Ethyl acetate 88.1 77.1 8.5° 0.7 
Methyl tert-butyl ether 88.2 55.2 5.8'' 1.0 
1-Pentanol 88.2 137.0 z.s"" 1.4 
4-Methyl-2-pentanone 100.2 117.0 1.9'' 1.4 
Di-isopropyl ether 102.2 68.5 1.2'' 1.9 
Isoamyl acetate 142.0 130.2 2.8" 2.2 
Toluene 92.1 110.6 4.5'' 2.5 
n-Octanol 130.2 194.5 0.05" 2.9 
Di-butyl ether 130.2 142.5 0.03'' 2.9 
n-Heptane 100.2 98.4 = 0 4.0 
n-Hexadecane 226.4 287.0 ~0 8.8 
^ (Faber 2004; Laane et al. 1987; Osborne et al. 1990; Villela et at. 2003). 
'' CDS database (Fletcher et al. 1996). 
Perry's Chemical Engineering Handbook (Perry & Green 1997). 
Table 5.3. Partition coefficients of phenylethanol and acetophenone for different water/organic-solvent 
systems. 
Solvent Phenylethanol Acetophenone 
Partition 
coefficient 
(niorg/aq) 
Mass balance (%) Partition 
coefficient 
(niorg/aq) 
Mass balance (%) 
n-Heptane 0.3 91 13.5 96 
n-Hexadecane 0.5 92 7.1 99 
Toluene 5.3 100" 31.3 100" 
Di-butyl ether 7.3 99 17.3 98 
1-Pentanol 9.3 92 23.5 98 
Ethyl acetate 9.5 100"= 62.0 100'' 
4-methyl-2-pentanone 14.0 98 21.6 99 
Di-isopropyl ether 17.2 90 54.3 98 
Isoamyl acetate 19.4 99 51.9 95 
^ Only organic measurements were considered. 
'' Only measurements of the aqueous phase concentrations were considered here as ethyl acetate both 
evaporated and dissolved in water yielding high mass balance errors. 
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DCB biotransformation activity tests were performed with the solvents listed in Table 5.2. 
From the solvents tested, only n-heptane, n-hexadecane, di-isopropyl ether (IPE) and DBE 
presented significant productivities (data not shown). These solvents were used further in 
the biphasic reactions with the exception of IPE which was ruled out because of its high 
volatility (Table 5.2). 
To gain further insight into the reasons 
why some of the tested solvents 
yielded no reaction, aqueous biotrans-
formations were carried out by using 
sub-saturation solvent concentrations 
in aqueous media (80% of the 
solubility limit). The biotransformation 
activities were compared to a blank in 
which no solvent was added, and are 
reported in terms of log P increasing 
order (Fig. 5.2). The biocatalytic 
activity corresponded to a low-to-null 
production at low log P, and in general 
increasing log P resulted in a higher 
biocatalytic activity. This is consistent 
YWd 
Substrate consumption 
Solvent 
solubility 
EA(0.7) MP (1.4) P0H(1.4) IPE (18) IAA(2j) Blank 
Organic solvent (Log P) 
Figure 5.2. Effect of dissolved organic compounds (each 
at about 80% of its respective solubility limit) on the 
activity of the biocatalysis for the biotransformation of 
acetophenone to 5-phenylethanol: product yield and 
substrate consumption. The experiment was carried out 
in carousel reaction cells for 72 h. An initial Aph 
concentration of 1 g L"' was used. Key; ethyl acetate 
(EA), 4-methyl-2-pentanone (MP), pentanol (POH), 
isopropyl ether (IPE), isoamyl acetate (lAA). Log P for 
each solvent is in parenthesis and solvent solubility (%) 
is indicated on top of the solvent bars. 
with expectations based on enzymatic activity as a function of log P (Faber 2004; Laane et 
d.1987) . 
However, productivity comparable to that of the blank was obtained for lAA (moderate log 
P) despite the poor activity observed for this solvent in the biphasic test. In addition, since 
lAA favours the partition of both substrate and product (Table 5.3), a low S '^' was detected 
in the DCB tests (0.1 g L"^). Since the sub-saturated and DCB tests had similar lAA 
aqueous concentrations (~ 22 g L"'), apparently the direct contact of the organic phase and 
the cells inhibited the reaction, rather than the aqueous-dissolved organic solvent. Similar 
biphasic systems have been reported previously in the literature (Buhler et al. 2003b; 
Buhler et al. 2006; Cruz et al. 2001; Cruz et al. 2002; Grivel & Larroche 2001). On the 
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other hand, while no activity took place in the IPE aqueous experiment, large amounts of 
substrate were consumed in comparison with the rest of the tests (Fig. 5.2). The cells were 
apparently active in the presence of IPE, but the dissolved solvent probably inhibited 
specific enzymes related to the biotransformation. 
5.3.2. Effect of initial substrate concentration using DCB carousel-tubes 
After suitable solvents were selected, this 
section reports the effect of S°% on the 
biocatalyst specific activity. With n-heptane 
as the organic solvent, a maximum 
productivity was obtained at = 10 g L"' 
(Fig. 5.3). Since Phe morg/aq (0.3) is 
unfavourable for n-heptane, a considerable 
amount of product in the aqueous phase was 
not quantified. A 10-fold increase in the 
productivity was estimated by considering 
organic/aqueous equilibrium. Considering 
equilibrium, maximum aqueous product 
concentration (0.9 g L'^), P^ ^max, was 
reached at = 10 g L"\ This high 
n 0.2 -
20 40 60 
in heptane (g L ') 
Figure 5.3. Effect of the initial organic substrate 
concentrations on the specific activity (96 h run) in 
direct-contact biphasic (DCB) biotransformations 
of acetophenone to ^-phenylethanol in carousel 
tubes and n-heptane as the organic phase (20% 
vol). The specific activity takes into account only 
the amount of product in the organic phase. Error 
bars represent the 95% confidence interval for two 
independent runs. 
product concentration probably prevented further increases in productivity for S°% above 
10 g L"'; this phenomenon was studied later in further detail. The low Phe partition for this 
solvent evidently poses a serious drawback for the use of n-heptane in the model 
biotransformation. 
An of 70 g L"^  severely reduced the biotransformation activity, almost to a negligible 
level. Considering equilibrium for this concentration, an S^ ^ = 5 g L"' was estimated. In 
Chapter 4, > 3 g L"' was found to be inhibitory for the biocatalyst, so the initial 
substrate concentration was clearly inhibitory for the cells, thus causing negligible 
productivity. 
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A similar test was performed using DBE 
as the organic phase (Fig. 5.4). Because of 
the favourable product partitioning to 
DBE, these biotransformations yielded 
higher specific activities than those using 
n-heptane. A maximum overall 
productivity, which considered aqueous 
and organic concentrations, was obtained 
at S°% = 20 g after which no 
significant increase in specific activity was 
observed. 
The estimated equilibrium agreed with 
2.0 
! " 
i " 
^ 1,4 
f 10 -
^ 0.8 -
1 0.6 
i . . 
a 
w o j 
0.0 J 
0 20 40 60 SO 
S°'^, in dibufyl ether (g L"') 
Figure 5.4. Effect of the organic substrate 
concentrations on the specific activity (96 h run) in 
direct-contact biphasic (DCB) biotransformations of 
acetophenone to iS-phenylethanoi in carousel tubes 
and dibutyl ether as the organic phase (20% vol). 
The specific activity takes into account the amount 
of product in the aqueous and organic phases. Error 
bars represent the 95% confidence interval for two 
independent runs. the measured concentration (0.1 g L" ) and 
was in the sub-inhibitory range according to the Phase-2 kinetic model in Chapter 4. Since 
product inhibition was negligible, the fact that the productivity did not increase further with 
S°% may be due to reaction rate limitations during the Phase-2 reaction period. In contrast 
to the n-heptane reaction, a high biocatalyst activity was observed for = 80 g L"' 
because due to the favourable partition, Aph did not reach an inhibitory aqueous 
concentration (S^ = 2 g L"'). 
5.3.3. DCB bioreactor experiment 
1.5 L DCB bioreactors were used to study the effect of S°% on the reaction rate as a 
function of time (Fig. 5.5). Two levels were used: 5 and 20 g L"'. Interestingly, while 
similar product-formation courses were followed by both experiments (Fig. 5.5a), higher 
substrate consumption took place in the 20 g L"' test (Fig. 5.5b). This scenario is 
comparable to the previous DCB tests (Fig. 5.3 and 5.4) in which, when a maximum 
productivity was reached, no further productivity increase took place as a function of S°%. 
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Similarly to the aqueous reactors in 
Chapter 4, two reaction stages were 
observed in the DCB batch reactors. 
Phase-1 is a very fast reaction step 
which takes place in the first 5 min and 
which governs the final reactor 
productivity. Considering equilibrium 
aqueous concentrations, the initial 
overall specific activities for both 
substrate concentrations were similar 
(120 mg h'^  g"' biomass) and were of 
the same order of magnitude as the 
kinetic-model Phase-1 rates. Since the 
reaction rate was high, the Phase-1 
period was probably mass-transfer 
limited —thus specific activity became 
independent of S°'^ ®o-
The system becomes kinetically limited 
in the Phase-2 period as the reaction 
rate was greatly reduced, by factors of 
70 and 35 for S°% = 5 and 20 g L"', 
0 .4 
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Figure 5.5. 1.5 L Direct-contact biphasic (DCB) 
biotransformation in a 2 L bioreactor for the reduction 
of acetophenone to S-phenylethanol by R. glutinis using 
n-hexadecane as the organic phase with a 1.5 L:0.15 L 
aqueous:organic volume ratio using two different initial 
substrate concentrations in the organic phase: 5 and 20 
g L"'. (a) organic product concentrations; (b) organic 
substrate concentrations. respectively. Due to the significant 
reaction rate reduction, this stage has little effect on the overall productivity. 
Biotransformation and substrate consumption stopped at about 24 h for both S°%, similarly 
to Chapter 4 results, which seems to indicate that the cells were damaged or dead. As cells 
perform under non-growing conditions they will eventually age and die as part of their 
natural cycle. 
Despite the fact that n-heptane and n-hexadecane are biocompatible, the very poor partition 
coefficient of these solvents for Phe makes them unsuitable for this reaction. On the other 
hand, DBE provides favourable partition behaviour for both Aph and Phe; in addition, this 
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solvent possesses high hydrophobicity which makes it biocompatible, as confirmed in the 
previous biphasic tests. With these considerations DBE was the solvent selected for 
biphasic reactors. Nevertheless, in a DCB run, DBE was totally stripped out of the 
bioreactor due to high aeration and stirring speed; so this solvent was not suitable for the 
IL-scale DCB biotransformation. In the following section DBE was used as the organic 
solvent in MBB reactors. 
5.3.4. Membrane bioreactor for biotransformations (MBB) 
In order to assess the mass transport 
capabilities of the membrane contactor, Kaq 
was obtained for the transport of a solute 
(substrate and/or product) between the bulks 
of the aqueous and organic phases through an 
OSN membrane. Two different tests were 
performed: single solute transport and dual 
solute counter-diffusion (Fig. 5.6). 
For the single solute tests, despite the Aph 
partition being considerably greater than the 
Phe counterpart (Table 5.3), Kaq was higher 
for the latter. This may be due to differences 
in the affinities of the solutes for the 
Single solute Counter-diffusion 
Exper iment 
Figure 5.6. Overall mass transfer coefficient 
based on the aqueous concentrations (Kaq) for the 
substrate (acetophenone) and product 
(phenylethanol) of the model biotransformation 
through an OSN Starmem^"^ 122 membrane in a 
rectangular flat-sheet two-phase contactor. The 
two phases consisted of water (IL) and DBE 
(O.IL). Two different diffusion modes were used: 
single solute diffusion and dual solute counter-
diffusion. Error bars represent the 95% 
confidence interval for two independent runs. 
membrane material. For example, a higher 
Phe partition in the membrane (> m^/aq) compared to that of Aph would result in a higher 
Kaq for the former. This indicates that the Starmem™ 122 membrane is slightly polar, 
consistent with what has been previously reported (Zhao & Yuan 2006a). In the 
bidirectional test, the Kaq of Phe apparently decreased to a value similar to the Aph 
counterpart. However Kaq is not expected to change, so the apparent reduction in Phe Kaq 
derives from assuming a constant morg/aq in the calculation of Kaq (Doig et al. 1999b): it is 
the Phe partition which significantly changes in the presence of Aph. 
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Considering the kinetic model, the demand for product and substrate to support the Phase-1 
reaction rate is too high (~ 4,000 mg h"') compared to the mass rates provided by the 
membrane contactor (~ 83 mg h"'), so this phase will be mass-transfer limited. On the other 
hand, the Phase-2 period should be limited by the reaction rates (~ 20-50 mg h"^). The 
remaining part of this section examines if acceptable productivity can be practically 
achieved in the MBB system. 
5.3.4.1. MBB: organic-phase feed 
Substrate was fed to the organic phase using two different S°%: 20 g L"' {MBB-20) and 40 
g L"' (MBB-40). An initial substrate pulse was added to MBB-40 which produced a Phase-1 
reaction of 360 mg h"' g"' biomass (Fig. 5.7B2) with the same order of magnitude as 
estimated from the kinetic model. No significant Phe accumulation in the aqueous phase 
occurred after the initial reaction period for either S°% (Fig. 5.7). This confirms the 
hypothesis above for the MBB systems: whereas Phase-1 was mass-transfer limited, 
Phase-2 was controlled by the reaction rate. Furthermore, the Phase-2 periods for both 
reactors were not substrate limited since Aph accumulated in the aqueous phase during the 
first 15 h (Fig. 5.7, below). Substrate accumulation was more significant for the MBB-40 
reactor because of the higher concentration driving force in this run. In addition, DBE 
concentration was always low (< 50 mg L"') as DBE was stripped out of the system due to 
the high aeration and stirring rates. 
The Phase-2 reaction rate was higher for MBB-20 (2.5 mg h"' g"' biomass) than for MBB-40 
(1.0 mg h'^  g"' biomass). The biocatalytic activity stopped at 20 and 15 h in the MBB-20 
and MBB-40 reactors, respectively (Fig. 5.7, yield plots). Since an initial substrate pulse 
was added in the latter, product was rapidly formed, reaching a concentration of 0.27 g L"^  
in the aqueous phase after 1 h of reaction; this concentration is in the inhibitory range 
according to the kinetic model (P^ "^  = 0.22 g L"', Section 4.3.2). However, the reaction was 
expected to continue in this run, although at a reduced rate, so the cessation of the 
biocatalyst activity seemed to be caused by a severe cell disruption, similar to that observed 
for the DCB reactors. Biomass concentration suffered a drastic reduction (Fig. 5.7, below) 
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probably due to glucose starvation as well as aging and lysis of the cells, which ultimately 
led to the termination of all biocatalyst activity. 
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Figure 5.7. Batch MBB system for the biotransformation of acetophenone to 5-phenylethanol by R. ghitinis 
using dibutyl ether (DBE) as the organic solvent. The substrate was fed into the organic phase at two different 
concentrations; (A) (left) MBB-20, 20 g L"' organic only; (B) (right) MBB-40, 40 g L"' organic and 0.5 g L"' 
aqueous. Plots above (A1 and Bl) : organic product and substrate concentrations; Plots below (A2 and B2): 
aqueous product, substrate, DBE and biomass concentrations. 
5.3.4.2. MBB: Effect of glucose addition (MBB-Glu) 
Intermittent glucose pulses were added to the MBB (0, 22 and 47 h) aiming at improving 
the reactor productivity, and at extending the duration of the biocatalytic activity. The 
addition of a glucose pulse at 22 h allowed product formation for a longer period of time 
compared to the previous MBB runs, although at a lower rate, with a P°'^ max of 2.4 g L"' at 
45 h (Fig. 5.8a). Biomass concentration remained constant for 24 h after the glucose pulse. 
However, an additional glucose pulse at 47 h was not able to maintain the biocatalytic 
activity, probably due to cell aging and death —cell lysis was indicated by the significant 
drop in the biomass concentration (Fig. 5.8b). 
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Figure 5.8. Intermittent glucose-addition MBB system for the biotransformation of acetophenone to S-
phenylethanol by R. ghitinis using dibutyl ether (DBE) as the organic solvent, MBB-Glii. The organic phase 
(0.1 L) was loaded with 20 g L"' of Aph. Three discrete glucose pulses (10 g) were added to the aqueous 
reactor (1 L) at times 0, 22 and 47 h. (a) (above) organic product and substrate concentrations (' equilibrium 
concentrations with aqueous phase at 70 h); (b) {below) aqueous product, substrate, DBE and biomass 
concentrations. 
Similarly to the non-glucose MBBs above, Phase-2 reaction was not substrate limited as 
Aph accumulated in the aqueous phase during the first 20 h and remained constant 
throughout (Fig. 5.8b). A sub-inhibitory Phase-2 reaction rate (3.9 mg h"' g"' biomass) 
during the first 20 h produced a P^ '^ max = 0.4 g L"' at 20 h. This concentration was 
maintained at the same level throughout the run. Subsequently, product formation 
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continued at an inhibitory rate (1.2 mg h"' g"' biomass) for a further 24 h (Fig. 5.8a). This 
result implies that for the previous non-glucose tests, glucose starvation caused a major cell 
disruption leading to cessation of biotransformation. 
5.3.4.3. MBB: Continuous fed-batch injection 
Taking into consideration that membrane substrate transfer rate limits the Phase-1 period 
which governs the overall productivity, continuous substrate feed to the biomedium was 
used in order to alleviate mass transfer resistance. Figure 5.9 depicts a picture of the OSN-
MBB fed-batch system. Two different continuous feeding strategies were used: (a) 
substrate only addition (MBB-FB); (b) substrate and glucose addition (MBB-FB-Glu). 
Figure 5.9. Picture of the OSN-MBB system with continuous substrate addition to the bioreactor for the 
biotransformation of acetophenone to 5-phenylethanol by Rhodotorula glutinis. (a) automatic syringe injector, 
(b) membrane phase contactor, (c) organic reservoir, (d) bioreactor. 
The glucose reactor {MBB-FB-Glu) achieved a larger P°'^ ®max (7.0 g L ' \ 92 h) than the non-
glucose MBB (4.0 g L'\ 48 h) (Fig. 5.10). The former reactor had the longest period of 
biocatalytic activity in this work (88 h), which implies that glucose is an important factor 
for cell stability and catalytic activity (Buhler et al. 2003b). 
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The progress of the reactions can be better observed in the aqueous phase where the 
product is formed (Fig. 5.11, top). An initial substrate pulse was added to the MBBs (S% = 
0.75 g L"^). Initial reactions in the first 5 min were in the same range of the Phase-1 kinetic 
model for both MBBs, with MBB-FB having a higher rate than MBB-FB-Glu, 470 and 220 
mg h"' g"' biomass, respectively. The biomass concentration in the glucose-added reactor 
was more than double the concentration of the MBB-FB. Considering that the volumetric 
productivities for both reactors were very similar (~ 3.6 mg L"' h''), mass transfer in the 
reactor biomedium seemed to limit the Phase-1 reaction of MBB-FB-Glu, with volumetric 
productivity becoming independent of biomass concentration. 
MBB'FB 
I —k*. 
1UU 
£ 80 
-20 "3 i 
1 GO 3 
K n '• F 40 
- 10 L. 1 5 
S 20 -
Q n - Q 
1 - -
I 
PM 
- — Mass balance 
(b) / 
/ 
/ 
/ 
e 
10 r 
Time (h) T ime (h) 
Figure 5.10. Organic substrate and product concentrations during the continuous-fed-batch MBB 
biotransformation of acetophenone to 5-phenylethanol by R. ghitinis using dibutyl ether (DBE) as the organic 
solvent (aqueous:organic volumes, ILiO.lL). Prior to the reaction, the cells were cultivated in batch mode for 
high biomass concentration (Section 4.2). Two different aqueous-phase feeding strategies were used: (a) 
MBB-FB, continuous substrate addition: 0.2 g h ' \ (b) MBB-FB-Glu, continuous substrate addition (0.1 g h"') 
and glucose addition (1.5 g h"'). 
Following the Phase-1 period both runs presented a stationary period of about 18 and 38 h 
for the MBB-FB and MBB-FB-Ghi, respectively, in which productivity was close to zero 
and which is indicated by the low yields in Fig. 5.10. The actual productivity in the MBB 
system is indicated by the overall S-Phe production which considers both liquid phases 
(Appendix C). The concentration of the valeric acid compound, which is produced 
concomitantly with the reaction, remained constant during this period. In addition, acetic 
acid was produced and then further degraded by the cells at about 20 h (Fig. 5.11, below). 
Additionally, during the lag period, despite the fact that a large amount of Aph was 
continuously added to the reactor, substrate concentrations in the aqueous and organic 
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phases remained low (Figs. 5.10 and 5.11). This phenomenon was indicated by a low mass 
balance during this period (Fig. 5.10), which suggests that major substrate absorption by 
the biomass took place in the bioreactors at this stage. Apparently Phase-2 reaction stage 
started only after cells were saturated with substrate. During the stationary period (or 
productivity lag phase) the cells may be adapting their internal metabolism to the new 
environment as substrate was continuously added to the reactor (Section 2.4.2). 
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Figure 5.11. Aqueous-phase performance during the continuous-fed-batch MBB biotransformation of 
acetophenone to 5-phenylethanoI by R. glutinis using dibutyl ether (DBE) as the organic solvent 
(aqueous/organic volumes: IL/O.IL). Prior to the reaction, the cells were cultivated in a batch mode for high 
biomass concentration (Section 4.2). Two different aqueous-phase feeding strategies were used: (A) (left) 
MBB-FB, continuous substrate addition: 0.2 g h"'; (B) (right) MBB-FB-Glu, continuous substrate addition: 
0.1 g h"' and glucose addition: 1.5 g h"'. Plots above (A1 and Bl) : product, substrate and DBE concentrations 
and Aph feed; Plots below (A2 and B2): glucose, biomass, valerate and acetate concentrations. 
After this lag period, a Phase-2 reaction started (Fig. 5.10, yield plot); the rate of this 
reaction was higher for MBB-FB (7.4 mg h"' g"^  biomass) compared to MBB-FB-Glu (1.6 
mg h"' g"' biomass). An increase in the rate of glucose accumulation took place in MBB-
FB-Glu at about 40 h (Fig. 5.11B2) possibly indicating that glucose repression is causing 
the slow reaction rates observed in this reactor. 
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When P^\ax = 0.96 g L'^  was reached in the MBB-FB reactor (Fig. 5.1 lAl) , the reaction 
rate suffered a drastic reduction to 0.5 mg h"' g"' biomass which preceded the total cessation 
of activity at 42 h (Appendix C). In the case of the MBB-FB-Glu the reaction rate decreased 
gradually: 1.6 (39 h), 1.3 (45 h), 1.1 (68 h) mg h"' g"' biomass, until a P^max = 0.91 g L"' 
was reached (Fig. 5.11A2) at which complete cessation of the biotransformation occurred 
(Appendix C). Since the P^max for these reactors were quite similar, it appears that, 
irrespective of glucose and substrate feeding strategies, P^ '^ max ~ 0.9 g L"' caused 
irreversible cell disruption or death which in turn terminated all catalytic activity. 
This phenomenon was observed also in the aqueous reactors in Chapter 4, although in that 
case, consistent toxic-limit concentrations of 1.4 g L"^  were observed. As discussed in 
Section 4.3.4.6, despite the fact that no repeat runs were carried out for the different process 
conditions, this behaviour appears to indicate the reproducibility of the biocatalytic 
reaction. The discrepancy of the toxicity limits between the aqueous and MBB reactors may 
be related to the time at which P^ '^ max is reached: in the aqueous reactors P^ ma% was reached 
at about 24 h, whereas in the MBB reactors this concentration was reached at 42 and 88 h 
in the MBB-FB and MBB-FB-Glu runs, respectively. As reaction time increases the 
biocatalyst may be more susceptible to cell decay and chemical toxicity. 
As previously discussed, considering that the biocatalyst is reacting under a non-growing 
regime (even in the case of glucose addition), aging and dying of the cells must eventually 
occur. Evidence of this is the fact that considerable cell lysis, quantified as the decrease in 
biomass concentration, occurred in both MBB-FB and MB-FB-Glu after 24 and 45 h, 
respectively (Fig. 5.11, below). However, the rate of biocatalyst deactivation can be 
mitigated by the provision of glucose for cell maintenance, as can be attested by the 
prolonged biocatalyst activity obtained in the MBB-FB-Glu reactor. 
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5.3.4.4. Enantiomeric excess (ee) 
Enantiopure biotransformations were 
achieved in most of the aqueous-phase 
experiments in Chapter 4. However, a 
decrease in the product ee (organic basis) 
was observed in the MBB tests (Fig. 
5.12) in which the ee dropped to values 
of 90% for some of the runs. Cappaert 
and Larroche (2004) reported a similar 
reduction in the ee during a DCB reactor 
experiment. The batch MBBs resulted in 
the highest ee reduction. A large ee loss 
% - M88-40 W88-20 
• MBB-Glu MBB-FB MBB-FB-Glu 
40 
Time (h) 
Figure 5.12. ^-Phenylethanol ee (%, organic basis) 
during the reduction of acetophenone by R. ghitiiiis 
for the different MBB reactors used in this study. 
appears to take place after 17 h for these reactors. In Sections 5.3.4.1 and 5.3.4.2, it was 
suggested that at this stage cells suffered significant carbon starvation, so the influence of 
glucose metabolism could be affecting the final ee of the biotransformations (Chartrain et 
al. 2001; Reddy et al. 1996). However, the mechanisms for enantiomeric regulation of the 
biotransformation are complex, and may involve several factors apart from glucose 
starvation. For example, no reduction in ee was observed for other glucose-starved systems 
such as the DCB bioreactors (Section 5.3.3) and the aqueous batch reactors (Chapter 4). 
Comparing the continuous fed-batch reactors, it can be observed that the most stable 
enantioselectivity was observed in the MBB-FB-Glu run with 97% (88.2 h) at P°'^ ®max- In 
contrast, the non-glucose reactor experienced a considerable ee drop down to 95% at 
P°'^ ®max- The reduction in the ee corresponded to two metabolic phenomena taking place 
concomitantly: (1) the consumption of the initial glucose until its total depletion during the 
first 20 h; and (2) a plateau in the concentrations of the valeric-acid metabolite (Fig. 
5.11A2). A similar pattern was observed in an aqueous-phase continuous fed-batch reactor 
{FB-Cont) in Section 4.3.4.5. Once again the level of glucose seems to be a key factor in 
the regulation of the biocatalytic enzymatic activity, so as to enable enzymes with {R)-
selectivity thus reducing product ee (Chartrain et al. 2001; Reddy et al. 1996). 
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5.3.4.5. MBB: Summary of results 
Similarly to the aqueous reactors in Chapter 4, the higher biomass concentration of the fed-
batch reactors made them more robust and productive compared to the batch systems 
(Table 5.4). On the other hand, glucose-added reactors presented higher product 
accumulation in the organic phase, P°'^ ®max, than their non-glucose counterparts. Cells used 
glucose for maintenance which gave them longer catalytic activity and stability compared 
to reactors with no glucose added. 
The presence of considerable amounts of substrate at the end of the MBB runs is unwanted, 
firstly because substrate is wasted, and secondly because the presence of high amounts of 
substrate makes product purification less efficient. MBB-40 and MBB-FB had the largest 
substrate residuals; the first, due to the high initial substrate concentration (40 g L"') 
combined with the low biocatalyst activity; whereas in the second, the substrate feed rate 
was too fast compared with the reaction rates, so large amounts of substrate accumulated in 
the organic phase. Substrate feed rate was reduced for MBB-FB-Glu, so that no significant 
substrate accumulation was observed until late in the run (68 h). Substrate accumulation 
can be minimised by precise modulation of the substrate feed rate, as was observed in this 
run. 
Table 5.4. Productivity performance of membrane bioreactor for biotransformations (MBB) for the reduction 
of acetophenone to S-phenylethanol by R. glutinis using different feeding strategies and experimental 
conditions. 
Reactor name porg 
(g]L^) 
paq 
( g F ) 
oaq 
^ max 
(g L ' ) 
[Biomassjavg 
(g L ' ) 
ee^ 
(^-). % 
SA," 
(mg h"' g"' 
biomass) 
S A ^ 
(mg h"' g"' 
biomass) 
MBB-20 1.6 0 .27 0 . 2 2 5 .0 93 1.7 4.1 
MBB-40 1.5 0 .23 0 . 8 2 4 .8 9 4 3 .4 4 .5 
MBB-Glu 2 . 4 0 .37 0 .17 5 .0 91 2 .7 4 .6 
MBB-FB 4 .0 0 .96 1.55 8 .6 96 2 .7 5 .0 
MBB-FB-Glu 6 .9 0 .91 0 .67 14.0 97 1.2 1.3 
" (5-) ee% in the organic phase at P°^ ®max-
^ SAi— specific activity at P°'®max-
° SA2—specific activity at maximum overall S-phenylethanol production. 
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Two overall reaction rates were calculated: SAi, which considers the combined reaction 
rate and mass transfer rate —specific activity at P°^ ®max; SA2, which considered only 
reaction rate: specific activity at maximum total ^-Phe production in the biphasic system 
(Table 5.4). Since in general the MBBs were mass transfer limited, SA2 rates were greater 
than SAi rates, with the exception of the MBB-FB-Glu reactor in which both rates were 
similar. 
MBB-FB-Glu showed the highest product accumulation, and its biocatalyst activity had the 
longest duration of all the biotransformations in this study (88 h). However, despite the 
outstanding biocatalyst stability, the overall reaction rates (SAi) for this run were the 
lowest. Glucose addition has a two-fold effect on the biotransformation: (1) providing 
carbon source to the cells and allowing them to continue their metabolism and catalytic 
activity; (2) slowing down the reaction rate. These combined effects resulted in the 
remarkably prolonged product formation activity. Furthermore, because of the reduced 
productivities, the reaction rates (SA2) were comparable to the combined reaction and 
transport rates (SAi); i.e., mass transport was not the limiting factor in this run. 
Additionally, in-situ product removal allowed the long cell activity in MBB-FB-Glu as the 
product concentration was kept below 0.9 g L"' during the first 80 h of reaction. This 
prevented the reactor reaching a critically toxic product concentration. A toxicity limit of 
product accumulation (> 0.9 g L"') was observed to cause an irreversible cessation of all 
biocatalytic activity probably due to cell damage or death, similarly to the observations in 
the aqueous bioreactors (Chapter 4). 
5.3.5. Overall comparison of reactors for biotransformations 
The DCB reactors using n-hexadecane or n-heptane are not suitable for the 
biotransformation since product partition did not favour the organic solvent. For example, 
the maximum organic product concentration achieved in these reactors was 0.25 g L ' \ 
which considering equilibrium, was distributed as follows: 95% to the aqueous phase and 
only 5 % to the organic phase. In addition, when a solvent with a higher partition was used, 
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dibutyl ether (DBE), the solvent was stripped out of the reactor because of the reactor's 
high aeration and stirring speed. 
Although most of the MBBs were mass transfer limited, their reaction rates were 
comparable to those of the aqueous systems in Chapter 4 with even longer biocatalytic 
activity due to in-situ product extraction. The continuous addition of glucose remarkably 
increased the duration of the catalytic activity. In addition, similarly to the aqueous reactors 
in Chapter 4, in the MBBs: (1) higher biomass concentrations enhanced the biocatalyst 
robustness, stability and productivity; (2) glucose metabolism seems to cause a reduction in 
the ee; (3) a product-concentration toxic limit (0.9-1.0 g L"') was found to cause irreversible 
cessation of all biocatalytic activity. 
The MBB-FB produced 5'-Phe at a similar rate (5.0 mg h"^  g"' biomass) to that of the 
aqueous reactors in Chapter 4 (Table 4.2), and with a total production equivalent to 1.2 g 
L"' aqueous concentration. In addition, higher overall i'-Phe production was achieved in the 
MBB-FB-Glu than in the aqueous reactors, although at a lower rate, which accounted for an 
equivalent aqueous concentration of 1.6 g L"^ Furthermore, this MBB resulted in an 
acceptable reaction rate, the longest catalytic activity, and avoided additional cumbersome 
downstream processing to recover the product from the bioreactor phase required in 
aqueous and DCB reactors. 
5.4. Conclusions 
Different aqueous-organic biphasic reactors were studied in this work for the 
biotransformation of acetophenone to the slightly polar ^-phenylethanol by whole cells of 
Rhodotorula glutinis. The membrane bioreactors for biotransformations (MBB) using 
organic solvent nanofiltration (OSN) membranes clearly resulted in the best overall 
performance since: (1) direct contact biphasic reactors are not suitable for this particular 
reaction with the selected solvents; (2) compared to aqueous reactors in Chapter 4, MBB 
169 
Chapter 5. Model biotransformation II. Aqueous-organic systems 
reactors resulted in acceptable reaction rates, higher overall ^-phenylethanol formation, and 
avoided the need for a cumbersome downstream processing to recover the product from the 
bioreactor phase. Further improvements to the MBB biotransformation are possible by 
replacing the organic phase with fresh solvent to re-establish the product concentration 
driving force, thus preventing toxic accumulation of product in the aqueous phase. 
Additionally, the substrate feed rates (or intermittent pulse addition) can be adjusted as to 
minimise substrate accumulation in the organic phase to reduce further product purification. 
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6.1. Significance and Implications 
6.1.1. A novel MBB system using OSN membranes 
This work demonstrated the feasibility of using OSN membranes for the implementation of 
a novel MBB system. This achievement has significance in the technological development 
of membrane bioreactors for biotransformations, in particular, and bioreactors and phase 
contactors, in general. Due to the nanostructure of the active separation layer of the 
membrane, OSN membranes prevented aqueous breakthrough, which overcomes the main 
limitation of porous membrane reactors. On the other hand, these membranes possess low 
swelling in the presence of organic solvents which give them solvent resistant properties, in 
contrast with silicone rubber membranes. The membrane contactor system allowed 
acceptable mass transfer rates of hydrophobic molecules for in-situ substrate addition to the 
bioreactor and product extraction to the organic phase. The same principle utilised in this 
work for OSN-MBB systems can be used to perform non-dispersive solvent extractions, 
such as aqueous/organic extraction of pollutant organic compounds from aqueous streams. 
Additionally, this project also confirms and further applies the physicochemical mechanism 
outlined by previous researchers related to aqueous breakthrough in microporous 
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membranes, which was the key motivation of this project. This mechanism consists of the 
progressive adsorption of surface active compounds (present in the biomedium) into the 
pore walls, thus changing the membrane wettability from hydrophobic to hydrophilic and 
greatly reducing the pressure breakthrough, which ultimately leads to aqueous-organic 
dispersion. As OSN membranes are comprised of an active layer which is virtually non-
porous (or with pore radii in the nanoscale), this dense structure hinders the passage of 
surface active compounds into the pores, thus no reduction in the breakthrough pressure 
occurs and no aqueous-organic dispersion takes place in these systems. In this line, to 
further understand the surface phenomena taking place in the OSN-membrane, it would be 
particularly interesting to measure the breakthrough pressure of OSN membranes in the 
presence of surfactant aqueous solutions, and to test the effect of a range of surface active 
molecules with different molecular sizes on the breakthrough pressure. 
6.1.2. Effect of membrane asymmetry on membrane mass transport rates 
This work is the first to relate the porous asymmetry across the membrane thickness to the 
mass transport performance of the OSN membrane. Although still at a preliminary stage, a 
structural model was suggested to represent the porosity and pore-diameter profile across 
the membrane thickness. With the aid of this model, the mass transport rate was described 
for a couple of OSN membrane operational modes using a resistance-circuit analogy which 
considered transport through the porous and non-porous materials of the membrane. 
Resistance-circuit analogies have been used before in nanofiltration for serial or parallel 
transport. The model developed here considered two resistances in series, top and 
microporous layer resistances, each comprising two parallel resistances: (1) transport 
through the pores (pore-flow model) and (2) transport through the membrane material 
(solution-diffusion model). This transport model provides a new insight into the mass 
transfer mechanisms in OSN membranes, as it has brought to light the great importance of 
the microporous structure of the membrane (specifically in the 0.1 - 1.0 |a.m depth) for 
molecular transport rates through the membrane. The significance of the microporous layer 
has been assumed unimportant in the literature to date. This finding is very encouraging to 
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develop a more robust structural model for studying mass transport mechanisms in OSN 
membranes. 
6.1.3. Effect of membrane formation on membrane mass transport 
This work studied the role of two membrane formation parameters (evaporation time and 
casting thickness) on the mass transport of hydrophobic molecules through OSN 
membranes. This is the first study in the literature involving design of experiments using 
analysis of variance for testing the effect of membrane formation parameters on mass 
transport performance. Notwithstanding that ANOVA methodologies have been widely 
used in science and engineering, previous studies on membrane formation are based on 
empirical approaches in which, in most of the cases, no statistical inferences can be made 
about the results. The approach conducted in this work may have significance in the 
development of more systematic design of experiments for testing new membranes and 
formation parameters. The two membrane formation parameters studied in this work 
significantly influenced mass transport rates. Casting thickness had the greatest impact. 
With the findings obtained in this study, it is possible to develop a membrane with 
improved mass transport rates. Additionally, lower casting thicknesses may be tested, 
aiming at obtaining higher mass transfer rates while conserving satisfactory membrane 
mechanical resistance during operation. 
6.1.4. Kinetics of product formation for a model biotransformation 
The kinetics of product formation during biotransformation processes is generally poorly 
understood. This work presented a simple but original approach which allowed the study of 
product formation kinetics of complex batch reaction systems. The empirical kinetic model 
featured an unusual reaction profile for Model Biotransformation II: an outstandingly high 
reaction rate period in the first 5 min, followed by a greatly reduced reaction rate period 
(two orders of magnitude lower). An important aspect of this reaction is that biocatalyst 
activity and viability were not terminated after the first reaction period. 
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To the author's knowledge no similar product formation kinetics for a biotransformation 
have been reported in the literature. A reason for this is that few biotransformation studies 
follow the progress of the reaction over time, and very rarely at the early stages of the 
reaction. However, it is highly possible that other biocatalysed systems present similar 
reaction mechanisms, so this work highlights the importance of gaining more knowledge 
about the product-formation kinetics of these reactions, and their biochemical implications. 
The very nature of this two-stage biotransformation, especially the high reaction rate 
period, deserves an in-depth study of the biochemical principles of reaction. On the other 
hand, it may be convenient to bolster the model developed in this work with a more 
phenomenological approach. However, this requires a greater understanding of the reaction 
mechanisms and biocatalyst metabolism involved in the biotransformation system, e.g. the 
roles of glucose and acetic acid in the regulation of the reaction. 
6.1.5. Comparison of fed-batch strategies for model biotransformation 
This work comparatively assessed the performance of reactors for biotransformations using 
three different feeding strategies: organic-phase feeding and direct-aqueous feeding 
(intermittent and continuous). A kinetic model was used to explain the productivity 
performance for the different feeding systems. The findings in this area can assist in the 
deeper understanding of the effect of feeding strategy on the biocatalytic performance. For 
example, it was possible to assess the advantages of the intermittent method in contrast 
with the continuous-fed method for the aqueous reactors, although the same logic appears 
less applicable to membrane reactors. Selection of the feeding strategy is made with a great 
deal of empiricism in current biotransformation research. Further research is needed to 
relate feeding strategies to the biochemical mechanisms of reaction. 
6.1.6. Comparison of two model biotransformations with the OSN-MBB 
The fact that this work studied two different model biotransformations —comprising 
different substrate, product and biocatalyst— helped to attest to the feasibility, reliability, 
scope and usefulness of the OSN-MBB system; moreover, considering that the reagents 
involved were of different chemical nature: while Model Biotransformation I consists of 
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nonpolar molecules, the product for Model Biotransformation II is slightly polar. The 
difference in the model systems, specifically the polarity of the reaction product, helped to 
highlight some characteristics of the OSN-MBB that were not evident in the nonpolar 
system. The OSN-MBB was remarkably suitable for Model Biotransformation II since the 
solvent selected for this biotransformation was not appropriate for a direct contact biphasic 
reactor, which made the OSN-MBB the best choice in this case. This feature does not 
undermine the acceptable performance obtained with the OSN-MBB system in Model 
Biotransformation I, but it provides a further insight into the capabilities and usefulness of 
the OSN-MBB, which can greatly expand the applicability of these reactors to 
biotransformations. 
6.2. Conclusions and Final Remarks 
The main aim of this thesis was fulfilled: a new approach was presented for the 
biotransformation of hydrophobic molecules using a membrane bioreactor for 
biotransformations (MBB) and an organic solvent nanofiltration (OSN) membrane. The 
new system was successfully employed as a strategy for in-situ substrate addition to, and 
product removal from, the bioreactor. The proposed reactor avoids the formation of 
emulsions and mitigates the solvent toxicity observed in direct contact biphasic (DCB) 
reactors, thus expanding the range of solvents that can be used to assist biotransformations. 
Additionally, the use of OSN membranes overcomes the problems of phase breakthrough 
and poor membrane organic solvent resistance, previously observed in microporous and 
non-porous MBBs, respectively. 
Although with lower titer, OSN-MBB reactors provided an acceptable productivity for 
Model Biotransformation I with a much cleaner product compared to DCB systems. 
Furthermore, for the synthesis of the slightly polar 5'-phenylethanol in Model 
Biotransformation II, the OSN-MBB was the only viable alternative, as no suitable DCB 
systems were found in this work. Using a study of the kinetics of product formation for 
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Model Biotransformation II, the direct addition of substrate to the bioreactor was 
determined to be the best feeding strategy. This allowed the development of OSN-MBB 
systems with the best overall performance compared to both aqueous and DCB bioreactors. 
In conclusion, the OSN-MBB resulted in a suitable system for performing 
biotransformations of hydrophobic molecules and provides important advantages in its 
overall performance over other state-of-the-art technologies. 
The main limitations of the OSN-MBB system is the moderate-to-low mass transfer rates 
obtained with OSN membranes, which can potentially undermine the benefits of the new 
reactor outlined above. Two approaches can be used to address this issue, (1) the increase 
of membrane area per reactor volume, and (2) the improvement of the mass transfer rates of 
OSN membranes. The first approach will be suggested as future work in the next section. In 
line with the second approach, fundamental work was conducted in this thesis to understand 
the mass transfer mechanisms of hydrophobic molecules through OSN membranes as a 
function of the membrane formation parameters, evaporation time and casting thickness, in 
a concentration-driven mass transport system. Surprisingly, casting thickness has the 
greatest effect on the membrane mass transport rates and can be used to improve these rates 
in the membrane system. 
More specifically, the work in this thesis can be categorised into three main areas: (1) 
biotransformation kinetics and performance in aqueous media; (2) mass transport 
mechanisms in OSN membranes; (3) development of OSN-MBB systems. 
1) Two model biotransformations were used in this work. Model Biotransformation I was 
previously studied in Andrew Livingston's research group. Since previous knowledge 
on the aqueous-media kinetics and bioreactor performance existed for this 
biotransformation, this model reaction was used only for testing the feasibility of the 
new OSN-MBB system to perform biotransformations of hydrophobic compounds. 
Nevertheless, along and at the conclusion of this project, important gaps in the 
knowledge of the reaction mechanisms of this model biotransformation were 
recognised. Directions for future work in this area are suggested in the following 
section. 
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On the other hand, little information existed in the literature for the kinetics, 
mechanisms and performance of the second model biotransformation selected in this 
work, the reduction of acetophenone to S'-phenylethanol by Rhodotorula glutinis 
whole cells. This task was addressed in Chapter 4 with the aim of characterising the 
model reaction in terms of product formation kinetics and reactor conditions. 
Particularly, the performance of the model reaction using different substrate feeding 
strategies in aqueous media as a preliminary stage for further OSN-MBB 
implementation was studied. 
Model Biotransformation II was uncoupled from cell growth. Both substrate and 
product were found to be inhibitory, with product inhibition being more significant. 
The aqueous batch biotransformations were characterised as two-stage reactions: (1) 
Phase-1, a high-rate first-order reaction occurs in a short-time interval (first 5 min) 
similar to a "chemical shock"; (2) Phase-2, a drastic decrease in the reaction rate 
which, depending on Phase-1 product accumulation, was sub-inhibitory (increasing 
first-order) or inhibitory (decreasing power function). Glucose has an important 
regulatory effect on the biotransformation metabolism; (1) Phase-1 reaction is 
controlled by glucose level in the bioreactor; (2) cells require a minimum glucose level 
(i.e., no glucose starvation) for self-maintenance, viability and for performing the 
model biotransformation. 
The effects of two substrate feeding strategies on the biotransformation productivity 
were investigated; intermittent and continuous. A high productivity period was 
obtained in the intermittent systems only, caused by the pulsed substrate addition 
(chemical shock). With this consideration, apparently the intermittent method could 
hold a greater potential for enhanced space-time yields as it takes advantage of the 
Phase-1 fast reaction rates. However, product accumulation irremediably leads to the 
eventual cessation of the biocatalyst activity. This issue is an indicator of the need for 
in-situ removal of these compounds during the biotransformation to prevent 
biocatalyst inactivation. 
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2) As mentioned above, mass transport of hydrophobic molecules is of paramount 
importance in the development of OSN-MBB systems. Mass transport mechanisms 
were studied in three different parts of this thesis. Chapter 2 addressed the study of the 
mass transport of the substrate and product of Model Biotransformation I (geraniol and 
citronellol, respectively) through OSN membranes in an aqueous-organic biphasic 
contactor. Two organic solvents were used, n-hexadecane and toluene. Using a 
resistances-in-series model, it was concluded that for the n-hexadecane system, the 
membrane was the main mass transfer resistance, whereas for the toluene system the 
contribution of the aqueous liquid film mass transfer resistance became predominant. 
Two factors determined this behaviour; organic/aqueous partition coefficient and 
viscosity of the organic solvent. 
In Chapter 5, similar mass transfer studies were carried out for the substrate and 
product of Model Biotransformation II, acetophenone and phenylethanol, with dibutyl 
ether (DBE) as the organic solvent. Based on the results of this and the above mass 
transfer systems, it can be concluded that the membrane/aqueous partition -i.e., the 
affinity of the solute for the membrane— has an important effect on the mass transfer 
rate. Along the same lines, it was found that Starmem™ 122, the commercial 
membrane used in the OSN-MBB systems, has a slightly polar note so that it has 
affinity for mildly polar organic molecules such as phenylethanol. Thus the membrane 
provides higher mass transport rates for these molecules in comparison with less polar 
solutes. 
Chapter 3 further studies mass transport mechanisms in OSN membranes, particularly 
focusing on the membrane transfer resistance. The effect of the membrane-formation 
parameters, evaporation time (ET) and casting thickness (CT), on the mass transfer 
rates was considered so as to identify the key controlling parameters. Different 
operational modes were used: aqueous-organic biphasic contactors, organic-organic 
concentration-driven dialysis and dead-end pressure-driven OSN. Both evaporation 
time and casting thickness (or membrane thickness, MT) had significant effects on 
mass transport, the latter with the most important effect. 
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A structural model of the membrane asymmetry was formulated from SEM studies. 
Two mathematical models were used to represent mass transport in the membrane, a 
multivariate regression and a mechanistic mass-transport model. The latter considered 
a resistance-circuit analogy and a structural model of the membrane porous 
asymmetry. This study brought to light the coupled effect of the membrane-formation 
parameters, ET and CT, on the development of the asymmetric structure in the 
microporous layer. Moreover, a main conclusion of this research is that the top-layer 
thickness is not controlling the membrane solute-transport rates but the microporous 
asymmetry of the membrane; especially, the microporous transition region in the 
interface between the top-layer and the microporous support (~ 0.1 pim - 1 )j,m). 
Unfortunately, because of time constraints, the findings obtained in this fundamental 
study could not be applied to the OSN-MBB systems. An outline for further research 
in this area is suggested in the next section. 
3) Two reactors for in-situ product recovery were used in this work: aqueous-organic 
direct contact biphasic (DCB) reactor and OSN-MBB systems. DCB reactors were 
used as a starting point in the development of the OSN-MBB as well as for 
comparative studies with the new reactor. In Chapter 2, the feasibility and usefulness 
of the OSN-MBB to perform biotransformations of hydrophobic molecules was 
demonstrated by comparing its performance to a DCB reactor. In this OSN-MBB 
system, substrate feeding to the bioreactor was accomplished by loading the substrate 
into the organic phase. The progress achieved in this study was described above in the 
main conclusions as this part of the research directly relates to the principal objective 
of this thesis. 
In a retrospective analysis of the OSN-MBB system for Model Biotransformation I in 
Chapter 2, it was identified that the major cause for limitations on the reactor's 
performance was the organic-phase feeding strategy. This feeding mode relies heavily 
upon the membrane transfer rates to provide substrate to the bioreactor. Since only 
moderate mass transfer coefficients can be achieved with the Starmem^"^ 122 OSN 
membrane, the system was mass transfer limited, and thus the OSN-MBB did not take 
advantage of the catalytically active period of the biocatalyst (which was time 
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limited). Organic-phase feeding also poses a critical issue for the further purification 
of the reaction product from the residual substrate. Since the separation of the 
substrate and product of biotransformations is frequently difficult, complete substrate 
depletion is necessary with this feeding mode. To tackle this issue, the OSN-MBB for 
Model Biotransformation II employed the direct addition of substrate to the bioreactor, 
either intermittently or continuously (Chapter 5). This feeding mode brings relief to 
the mass transfer resistance inherent in the membrane and provides a means of 
controlling substrate concentration in the bioreactor. 
In Chapter 5, the Model Biotransformation II was implemented at a IL-scale using 
two different m-j-zYw-product-removal strategies: DCB and OSN-MBB. Dibutyl ether 
was selected as the organic solvent based on log P, organic/aqueous partition and 
biocompatibility. The OSN-MBB system resulted in the best overall performance 
considering that (1) direct contact biphasic reactors are not suitable for this particular 
reaction with the tested solvents; (2) compared to aqueous reactors in Chapter 4, MBB 
reactors resulted in acceptable reaction rates, higher overall 5'-phenylethanol 
formation, and avoided the need for cumbersome downstream processing to recover 
the product from the bioreactor phase. However, similarly to the aqueous reactors in 
Chapter 4, a critical toxic concentration was observed in the OSN-MBB systems after 
which no more productivity occurred, thus obscuring the benefits of the in-situ 
product-removal strategy. Practical ways to overcome this issue with the present OSN-
MBB system will be suggested in the following section. 
As is mentioned above, presence of considerable amounts of substrate at the end of the 
MBB runs is unwanted, firstly because substrate is wasted, and secondly because the 
presence of high amounts of substrate makes product purification less efficient. The 
use of an organic-phase feeding mode in Chapter 5 caused large residual substrate 
concentration in the organic phase in the same manner to that discussed for the first 
OSN-MBB system. On the other hand, when direct substrate addition to the bioreactor 
was used, the residual substrate concentrations depended on: (1) the substrate feeding 
rates in the case of continous feeding or; (2) the amount and time of the substrate 
addition in the case of the intermittent method. Thus the direct substrate addition to the 
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aqueous phase permits one to effectively minimise substrate accumulation by precise 
modulation and control of the substrate feed rate or pulse addition, respectively. 
6.3. Areas for Future Research 
The previous section highlighted the main limitations in the results and scope of this thesis 
that are important to the further understanding and development of the OSN-MBB system. 
This section outlines some areas for future research to address these limitations. 
6.3.1. Biochemical mechanisms in whole-cell reduction biotransformations 
The reaction metabolism of the biotransformation, especially Model Biotransformation I, 
needs to be studied in more detail. Initial research can follow a similar strategy to that used 
in this work for Model Biotransformation II: (1) study the product formation kinetics in 
aqueous media and the course of the metabolites during the biotransformation; (2) 
investigate the effect of feeding mode on biotransformation performance. This preliminary 
study would give an insight into the biochemical processes taking place during the reaction, 
which may assist with the improvement of the OSN-MBB performance. 
In line with this strategy, a comparative study of the mechanisms involved in two different 
model biotransformations can be of great interest for the further understanding of whole-
cell bioreductions. These would find similarities and differences in the behaviour of the 
model reaction systems based on their biochemistry and processing conditions, such as, 
cofactor dependence, growth and non-growth biotransformations, aerobic vs anaerobic, 
substrate coupling, etc. 
As a further step in this direction, fundamental studies on the reaction mechanisms involved 
in the model biotransformations are needed. These studies firstly need to account for the 
relevant metabolites taking part in the bioreductions as well as the reaction by-products, 
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and then to elucidate mechanisms of reaction and their ultimate effect on the 
biotransformation performance. 
In a similar manner, despite the fact that a good understanding of the kinetics and 
performance of the Model Biotransformation II was gained in this thesis, there still 
remained important phenomena taking place during the biotransformation that could not be 
explained. 
As mentioned in Sections 4.3.2 and 6.1.4 the mechanism and kinetics for Phase-1 reaction 
are of extraordinary relevance in the field of redox biotransformations. An in depth study of 
this reaction in isolation is recommended to explain the observed "chemical shock". In 
Section 4.3.2 it was suggested that the concentrations of substrate and product in the cell 
membrane may play a significant role in the reaction mechanism. 
It is especially relevant to understand the role of glucose and acetic acid in the regulation of 
the biocatalyst performance measured by parameters such as ee, yield, productivity and cell 
viability. A systematic study could be conducted to address this issue. Findings in this area 
could greatly assist the development of more robust, reproducible and predictable 
biotransformation systems. For example, if the course of a batch reaction is further 
understood and predicted, an automatically-controlled substrate feed can be used to 
minimise substrate residual in the organic phase at the end of the run. 
In the study of this biotransformation, a toxic product concentration was observed at which 
immediate and complete cessation of biocatalytic activity occurred. Despite this work 
hinting at some phenomena causing the catalyst inactivation, an investigation into the 
physical and biochemical mechanisms involved at the molecular level may improve the 
understanding of chemical poisoning during biotransformations. 
6.3.2. Phase contactor with increased membrane area per reactor volume 
Two main membrane contactor systems may be considered; hollow fiber modules and 
spiral-wound membrane elements. Since recently considerable progress has been achieved 
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in Andrew Livingston's group in the construction of spiral-wound elements for pressure-
driven nanofiltration using OSN membranes, a novel spiral-wound module for phase 
contacting was designed and constructed in this research. However, due to technical 
difficulties and time constraints the contactor could not be satisfactorily used for the 
implementation of OSN-MBB systems. The main technical issue encountered in the design 
is that the space between membrane layers needs to be sufficient to allow acceptable 
biomedium flow between the membrane envelopes. Additionally the membrane spacer 
needs to be flexible and smooth enough not to damage the membrane. 
An alternative design will consist of two separated modules: biotransformation reactor and 
extraction module (Chang et al. 1992; Liese et al. 1996; Shin et al. 2001); the biomass is 
retained using a microfiltration membrane and the permeate is pumped into the membrane 
extraction module, thus preventing biomass from clogging the membrane contactor. 
Ultrafiltration membranes have been employed to perform the extraction stage. However, 
the implementation of this reactor configuration has two drawbacks: (1) the hydraulic 
system becomes very complicated; (2) separate filtration and extraction stages are required, 
which is in contrast to the most important attribute of OSN membranes as to act in direct 
contact with a biomedium phase without suffering phase breakthrough. 
6.3.3. Asymmetric microporous structure in OSN membranes 
Research opportunities in this area are promising as an important scientific gap was 
identified in this work which could be further addressed and greatly assist in the 
understanding of membrane mass transport mechanisms. Specifically, it is suggested to 
characterise the asymmetric porous structure of OSN membranes across the membrane 
thickness, and to relate this structure to the mass transport properties of the membrane. This 
work may involve the use of imaging technology, such as transmission electron microscopy 
(TEM), tightly coupled to computational data mining systems, or the implementation of 
less conventional analyses such as the use of conductimetric and colorimetric methods with 
specialised probes. 
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6.3.4. Development of improved OSN membranes for OSN-MBB processes 
From the knowledge gained in this work on the fundamental principles of mass transport in 
OSN membranes, it is possible to develop and optimise new membranes with enhanced 
mass transport rates for use in MSB systems. The performance of the new membranes can 
be assessed and compared with that of commercially available membranes. 
6.3.5. High biomass concentrations for Model Biotransformation II 
High-cell cultures in Chapters 4 and 5 were more robust than standard-cultivation 
biomedia. In the former, cells were able to receive a second substrate pulse with a reaction 
rate in the Phase-1 range. Further research aimed at obtaining higher concentrations of 
R.glutinis is recommended. This study could employ fed-batch procedures or other 
biomass-production techniques such as cell harvesting by centrifugation. 
6.3.5. A continuous bioreactor for Model Biotransformation II 
In principle, a continuous reactor seems advantageous over batch reactors as the biocatalyst 
concentration and activity can be ideally maintained for long time intervals. Since 
biotransformation is not coupled to cell growth, hypothetically the biotransformation 
activity will be unaffected by continuous cell growth. However, the operation and 
maintenance of continuous reactors can be cumbersome, moreover considering that 
biomedium is circulated by the membrane contactor and that the biotransformation is 
ideally carried out under aseptic conditions. In addition, the dilution rate should be 
maintained very low for two reasons: (1) to avoid possible undesired reactions because of 
excessive growth rate, and (2) to minimise losses of product and substrate in the overflow. 
A final consideration is that since a rich medium is used to provide nutrients to the cells, the 
occurrence of side reactions and reduction in enantioselectivity is more likely. Despite all 
of these issues, a successful continuous biotransformation appears very attractive. 
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6.3.6. Further development of the OSN-MBB systems 
1. As mentioned in the previous section, to fully test the capabilities of the OSN-MBB 
reactor for Model Biotransformation I, it is recommended that substrate is added 
directly to the biomedium, rather than through the organic phase. The main issue of 
this feeding mode is that the hydrophobic nature of geraniol will require a careful 
monitoring and control of the geraniol concentration in the reactor so that this 
concentration does not increase beyond its water solubility limit. 
2. In Model Biotransformation II a critical toxic concentration was found to completely 
inactivate the biocatalyst in both aqueous and OSN-MBB systems. Since the organic 
and aqueous reservoirs in the MBB work independently, the organic phase can be 
replaced with fresh solvent without affecting the operation of the aqueous-phase 
reactor. Considering that the mass transfer system works close to equilibrium, the 
concentration in the bioreactor can be maintained at a level which does not exceed the 
critical toxic concentration (~ 0.9-1.0 g L"^). In this manner, cells may be maintained 
catalytically active for prolonged periods of time. 
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Figure Al. Membrane porosity as a function membrane thickness, E(x): morphological-model data and fitted 
curve. 
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Figure A2. Pore diameter as a function membrane thickness, Dp(x); morphological-model data and fitted 
curve. 
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Log Sg 
Figure B l . Plot of the logarithm of the initial specific activity, (SA%, versus the logarithm of the initial 
substrate concentration (So) used in the determination of the rate equation of the Phase-1 reaction period for 
Model Biotransformation II. 
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Figure B2. Plot of the specific growth rate (n) versus initial glucose concentration ([Glu]o) for the 
determination of the maximum specific growth rate (n^az) of Rhodotorula glutinis in the cultivation system 
used for Model Biotransformation II. 
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Figure B3. Continuous-addition fed-batch bioreactor for the reaction of acetophenone to 5-Phenylethanol by 
R. gliitinis at high biomass concentration {FB-Cont-Glu-2). Both, substrate (0.2 g h"') and glucose (1.5 g h"') 
were continuously added to the bioreactor. Time course for the product and substrate concentrations, amount 
of substrate added, and biomass. 
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